RowId,YearStart,LocationAbbr,LocationDesc,DataSource,PriorityArea1,PriorityArea2,PriorityArea3,PriorityArea4,Class,Topic,Question,Data_Value_Type,Data_Value_Unit,Data_Value,Data_Value_Alt,Data_Value_Footnote_Symbol,Data_Value_Footnote,Low_Confidence_Limit,High_Confidence_Limit,Break_Out_Category,Break_Out,ClassId,TopicId,QuestionId,Data_Value_TypeID,BreakOutCategoryId,BreakOutId,LocationId,Geolocation
NHANES~1999-2000~59~NH001~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.3,7.3,,,6.4,8.4,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH001~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.9,7.9,,,6.8,9.0,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH001~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.6,8.6,,,7.1,10.4,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH001~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),9.7,9.7,,,8.0,11.6,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH001~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.2,6.2,,,5.1,7.4,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH001~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.3,6.3,,,5.2,7.6,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH001~AGE02~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.0,1.0,,,0.2,3.9,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH001~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.3,1.3,,,0.9,2.0,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH001~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.7,9.7,,,8.0,11.6,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH001~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),23.9,23.9,,,20.6,27.6,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH001~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),10.4,10.4,,,8.9,12.2,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH001~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,23.0,33.5,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH001~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.2,8.2,,,7.1,9.5,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH001~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.0,8.0,,,6.8,9.5,Race,Non-Hispanic White,C1,T1,NH001,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH001~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.3,6.3,,,5.1,7.8,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH001~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.2,8.2,,,6.4,10.5,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH001~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH001~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH001~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH001~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH001~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH001~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.8,8.8,,,5.1,14.7,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH001~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.5,7.5,,,6.5,8.6,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH001~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.2,8.2,,,7.3,9.1,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH001~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.3,8.3,,,7.0,9.7,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH001~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),9.4,9.4,,,8.3,10.7,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH001~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.8,6.8,,,5.7,8.2,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH001~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.1,7.1,,,6.0,8.4,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH001~AGE02~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.1,1.2,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH001~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.5,2.8,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH001~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.8,7.8,,,5.8,10.6,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH001~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),27.0,27.0,,,23.5,30.8,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH001~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),10.5,10.5,,,9.2,12.0,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH001~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),34.6,34.6,,,29.1,40.6,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH001~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,7.2,9.7,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH001~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.3,8.3,,,7.2,9.5,Race,Non-Hispanic White,C1,T1,NH001,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH001~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.1,8.1,,,6.5,10.1,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH001~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),9.8,9.8,,,8.2,11.7,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH001~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH001~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH001~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH001~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH001~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH001~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH001~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.7,8.7,,,7.2,10.5,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH001~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.8,8.8,,,7.4,10.3,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH001~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),9.7,9.7,,,8.1,11.7,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH001~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.1,9.1,,,7.2,11.4,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH001~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.3,8.3,,,6.8,10.1,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH001~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.0,8.0,,,6.7,9.6,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH001~AGE02~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH001~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.1,3.0,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH001~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.9,8.9,,,6.6,11.9,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH001~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),29.6,29.6,,,25.3,34.2,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH001~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),12.0,12.0,,,10.1,14.3,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH001~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),32.9,32.9,,,29.0,37.0,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH001~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.8,8.8,,,7.3,10.5,Race,Non-Hispanic White,C1,T1,NH001,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH001~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.6,9.6,,,7.9,11.6,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH001~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.7,8.7,,,7.2,10.5,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH001~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.4,7.4,,,6.0,9.1,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH001~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH001~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH001~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH001~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH001~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH001~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH001~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.0,8.0,,,6.9,9.2,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH001~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.0,8.0,,,7.2,8.8,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH001~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.6,8.6,,,7.3,10.1,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH001~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),9.2,9.2,,,8.4,10.1,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH001~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.4,7.4,,,5.9,9.2,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH001~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.1,7.1,,,5.8,8.6,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH001~AGE02~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.0,1.0,,,0.4,2.7,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH001~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,1.0,2.4,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH001~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.9,7.9,,,6.5,9.7,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH001~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),26.9,26.9,,,24.6,29.3,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH001~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),10.8,10.8,,,9.4,12.3,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH001~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),34.7,34.7,,,30.2,39.4,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH001~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.9,8.9,,,7.6,10.4,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH001~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.0,8.0,,,7.2,9.0,Race,Non-Hispanic White,C1,T1,NH001,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH001~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),9.3,9.3,,,7.8,11.0,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH001~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.0,8.0,,,6.5,9.8,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH001~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH001~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH001~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH001~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH001~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH001~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.8,5.8,,,3.6,9.2,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH001~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.8,7.8,,,6.8,9.0,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH001~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.6,7.6,,,6.7,8.7,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH001~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.9,8.9,,,8.0,9.9,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH001~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.6,8.6,,,7.6,9.8,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH001~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.1,7.1,,,5.7,8.7,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH001~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.6,6.6,,,5.4,8.1,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH001~AGE02~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.1,1.6,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH001~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,1.0,2.4,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH001~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.6,7.6,,,6.2,9.3,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH001~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),26.7,26.7,,,22.5,31.5,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH001~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),10.5,10.5,,,9.0,12.1,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH001~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),31.8,31.8,,,26.6,37.6,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH001~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.6,8.6,,,7.2,10.3,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH001~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.6,7.6,,,6.3,9.1,Race,Non-Hispanic White,C1,T1,NH001,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH001~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.5,8.5,,,6.8,10.5,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH001~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.7,7.7,,,6.2,9.6,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH001~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH001~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH001~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH001~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH001~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.8,6.8,,,4.4,10.4,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH001~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.9,7.9,,,5.4,11.3,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH001~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.0,7.0,,,6.2,7.8,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH001~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.3,7.3,,,6.3,8.5,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH001~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.9,8.9,,,7.9,10.1,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH001~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.9,8.9,,,7.6,10.5,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH001~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),5.8,5.8,,,4.8,7.0,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH001~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.4,5.4,,,4.5,6.4,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH001~AGE02~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),0.5,0.5,,,0.2,1.5,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH001~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.4,1.4,,,0.9,2.2,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH001~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.1,8.1,,,7.0,9.3,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH001~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),22.1,22.1,,,19.0,25.6,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH001~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.9,9.9,,,8.6,11.3,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH001~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),28.9,28.9,,,26.1,32.0,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH001~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.1,8.1,,,6.7,9.7,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH001~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.0,7.0,,,6.0,8.1,Race,Non-Hispanic White,C1,T1,NH001,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH001~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.6,7.6,,,6.4,9.0,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH001~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.2,8.2,,,7.2,9.2,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH001~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH001~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH001~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH001~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH001~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),5.0,5.0,,,3.0,8.2,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH001~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.3,6.3,,,4.0,9.8,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH001~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.0,7.0,,,6.3,7.7,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH001~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.5,7.5,,,6.6,8.5,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH001~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,7.1,10.1,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH001~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.1,8.1,,,7.1,9.3,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH001~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.0,6.0,,,5.4,6.6,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH001~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.7,6.7,,,6.0,7.4,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH001~AGE02~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.1,1.1,,,0.4,2.9,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH001~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,1.0,2.5,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH001~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.9,6.9,,,5.9,8.1,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH001~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),24.3,24.3,,,22.3,26.5,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH001~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),10.1,10.1,,,9.1,11.1,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH001~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),29.8,29.8,,,25.8,34.1,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH001~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.0,8.0,,,6.9,9.3,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH001~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.7,6.7,,,6.0,7.5,Race,Non-Hispanic White,C1,T1,NH001,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH001~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.8,7.8,,,6.7,9.2,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH001~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.3,8.3,,,7.1,9.7,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH001~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),4.1,4.1,,,3.0,5.7,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH001~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.8,4.8,,,3.7,6.1,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH001~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),5.0,5.0,,,3.7,6.6,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH001~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.7,6.7,,,5.5,8.2,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH001~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.7,7.7,,,5.8,10.2,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH001~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.1,7.1,,,4.7,10.7,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH001~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.9,7.9,,,7.0,8.8,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH001~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.2,7.2,,,6.3,8.1,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH001~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.3,8.3,,,7.1,9.7,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH001~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.8,8.8,,,7.6,10.3,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH001~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.0,7.0,,,5.6,8.8,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH001~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.2,6.2,,,5.0,7.8,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH001~AGE02~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.4,1.2,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH001~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.2,2.8,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH001~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.7,6.7,,,5.6,8.0,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH001~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),25.8,25.8,,,23.3,28.6,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH001~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),10.6,10.6,,,9.4,12.0,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH001~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),29.5,29.5,,,25.0,34.5,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH001~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.1,9.1,,,7.8,10.6,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH001~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.4,7.4,,,6.2,8.8,Race,Non-Hispanic White,C1,T1,NH001,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH001~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.9,6.9,,,5.8,8.3,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH001~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.6,6.6,,,5.7,7.8,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH001~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.8,4.8,,,3.8,6.1,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH001~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.3,6.3,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH001~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.9,5.9,,,4.8,7.2,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH001~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),4.7,4.7,,,3.7,5.9,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH001~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),5.5,5.5,,,3.8,7.8,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH001~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.4,6.4,,,4.8,8.6,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH001~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.1,7.1,,,6.4,7.8,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH001~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.9,7.9,,,7.0,9.0,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH001~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.6,8.6,,,7.5,9.7,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH001~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.3,9.3,,,8.0,10.7,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH001~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.8,5.8,,,4.8,7.0,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH001~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.7,6.7,,,5.5,8.0,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH001~AGE02~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.1,2.2,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH001~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,1.0,2.4,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH001~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.9,7.9,,,6.6,9.5,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH001~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),22.3,22.3,,,19.4,25.4,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH001~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),10.7,10.7,,,9.5,12.0,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH001~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),26.6,26.6,,,22.2,31.5,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH001~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,7.1,9.9,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH001~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.7,6.7,,,5.8,7.8,Race,Non-Hispanic White,C1,T1,NH001,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH001~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,7.0,10.1,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH001~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.6,8.6,,,7.3,10.2,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH001~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.4,5.1,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH001~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.7,3.7,,,2.5,5.6,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH001~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),4.8,4.8,,,4.0,5.7,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH001~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.4,6.4,,,5.6,7.3,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH001~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.1,9.1,,,6.1,13.4,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH001~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),9.2,9.2,,,6.5,12.8,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH001~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.9,8.9,,,7.7,10.3,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH001~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.8,7.8,,,6.9,8.8,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH001~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),9.6,9.6,,,8.2,11.1,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH001~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),10.6,10.6,,,8.8,12.7,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH001~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.4,7.4,,,5.9,9.3,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH001~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.3,6.3,,,5.0,7.9,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH001~AGE02~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),0.5,0.5,,,0.2,1.5,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH001~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,1.2,2.3,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH001~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.6,9.6,,,7.5,12.2,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH001~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),24.3,24.3,,,21.4,27.5,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH001~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),12.1,12.1,,,10.4,14.1,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH001~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),31.0,31.0,,,27.3,35.1,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH001~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),10.4,10.4,,,8.7,12.4,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH001~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.1,8.1,,,6.9,9.4,Race,Non-Hispanic White,C1,T1,NH001,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH001~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.0,8.0,,,6.7,9.4,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH001~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.9,7.9,,,6.7,9.4,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH001~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.1,4.1,,,2.6,6.5,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH001~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH001~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),4.7,4.7,,,3.3,6.7,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH001~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.9,5.9,,,4.3,8.0,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH001~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.2,8.2,,,5.5,12.2,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH001~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.0,8.0,,,4.9,12.9,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH004~OVR01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.9,3.9,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH004~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,3.0,4.2,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH004~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),5.5,5.5,,,4.4,6.8,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH004~GEN01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.9,4.9,,,4.0,6.0,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH004~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.4,2.7,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH004~GEN02~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,1.4,2.7,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH004~AGE02~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.5,0.5,,,0.1,4.2,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH004~AGE04~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.3,1.3,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH004~AGE05~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),5.0,5.0,,,3.9,6.2,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH004~AGE06~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),9.9,9.9,,,8.1,12.1,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH004~AGE07~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.7,4.7,,,3.9,5.7,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH004~AGE08~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),12.1,12.1,,,9.7,15.1,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH004~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.8,3.8,,,3.1,4.5,Race,Non-Hispanic White,C1,T3,NH004,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH004~RAC01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,3.3,4.5,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH004~RAC02~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.4,3.7,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH004~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,1.9,4.9,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH004~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH004~RAC03~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH004~RAC04~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH004~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH004~RAC07~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH004~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH004~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.5,3.5,,,2.9,4.1,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH004~OVR01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.6,3.9,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH004~GEN01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.0,5.1,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH004~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.5,4.5,,,3.6,5.5,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH004~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.3,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH004~GEN02~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.3,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH004~AGE02~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.1,0.1,,,0.0,0.9,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH004~AGE04~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.7,0.7,,,0.3,1.5,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH004~AGE05~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,1.9,5.3,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH004~AGE06~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),12.0,12.0,,,10.0,14.4,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH004~AGE07~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.7,5.5,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH004~AGE08~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),15.1,15.1,,,12.1,18.7,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH004~RAC01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,3.0,4.6,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH004~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,3.0,4.4,Race,Non-Hispanic White,C1,T3,NH004,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH004~RAC02~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.4,4.5,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH004~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.0,4.0,,,3.0,5.2,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH004~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH004~RAC03~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH004~RAC04~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH004~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH004~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.0,1.0,,,0.3,3.0,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH004~RAC07~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.7,0.7,,,0.2,2.2,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH004~OVR01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.2,4.9,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH004~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.0,4.0,,,3.3,4.8,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH004~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),5.2,5.2,,,4.1,6.7,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH004~GEN01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.9,4.9,,,3.7,6.5,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH004~GEN02~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.2,4.1,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH004~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.1,3.9,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH004~AGE02~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH004~AGE04~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.2,0.8,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH004~AGE05~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.1,6.8,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH004~AGE06~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),13.3,13.3,,,11.0,16.1,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH004~AGE07~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),5.5,5.5,,,4.5,6.7,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH004~AGE08~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,11.0,17.9,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH004~RAC01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.7,5.5,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH004~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.1,4.1,,,3.4,5.0,Race,Non-Hispanic White,C1,T3,NH004,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH004~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,2.7,4.9,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH004~RAC02~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.3,4.2,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH004~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH004~RAC03~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH004~RAC04~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH004~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH004~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH004~RAC07~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH004~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.5,3.5,,,2.8,4.3,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH004~OVR01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.8,4.5,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH004~GEN01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.4,4.4,,,3.3,5.8,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH004~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.7,4.7,,,3.8,5.7,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH004~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.9,3.5,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH004~GEN02~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.0,3.6,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH004~AGE02~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.1,2.5,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH004~AGE04~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.3,1.2,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH004~AGE05~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.5,5.2,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH004~AGE06~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),11.9,11.9,,,9.3,15.1,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH004~AGE07~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.7,4.7,,,3.7,5.9,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH004~AGE08~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),14.9,14.9,,,12.4,17.9,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH004~RAC01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.1,4.1,,,3.2,5.4,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH004~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.7,3.7,,,2.9,4.8,Race,Non-Hispanic White,C1,T3,NH004,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH004~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.4,3.4,,,2.5,4.6,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH004~RAC02~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.0,3.9,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH004~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH004~RAC03~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH004~RAC04~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH004~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH004~RAC07~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,0.8,3.3,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH004~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.1,4.8,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH004~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.8,3.7,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH004~OVR01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.8,3.9,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH004~GEN01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.4,5.1,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH004~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.4,4.4,,,3.6,5.2,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH004~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,2.0,2.7,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH004~GEN02~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,2.1,3.0,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH004~AGE02~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.2,0.2,,,0.0,1.8,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH004~AGE04~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.3,1.1,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH004~AGE05~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.5,3.9,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH004~AGE06~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),11.5,11.5,,,10.1,13.1,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH004~AGE07~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.4,4.4,,,3.8,5.2,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH004~AGE08~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),13.8,13.8,,,11.4,16.5,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH004~RAC01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.8,4.3,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH004~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.5,3.8,Race,Non-Hispanic White,C1,T3,NH004,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH004~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.5,3.5,,,2.6,4.5,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH004~RAC02~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.4,4.4,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH004~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH004~RAC03~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH004~RAC04~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH004~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH004~RAC07~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.7,4.7,,,2.8,7.9,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH004~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),5.3,5.3,,,3.1,9.0,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH004~OVR01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.5,3.9,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH004~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.5,3.7,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH004~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.6,4.6,,,3.8,5.5,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH004~GEN01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.7,5.7,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH004~GEN02~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.3,2.5,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH004~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,1.2,2.3,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH004~AGE02~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.2,0.2,,,0.0,1.2,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH004~AGE04~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.8,0.8,,,0.4,1.6,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH004~AGE05~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,2.9,4.9,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH004~AGE06~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,7.0,10.0,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH004~AGE07~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.4,5.1,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH004~AGE08~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),10.7,10.7,,,8.5,13.3,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH004~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.5,3.9,Race,Non-Hispanic White,C1,T3,NH004,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH004~RAC01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.9,4.6,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH004~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.4,4.0,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH004~RAC02~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.1,3.9,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH004~RAC03~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH004~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH004~RAC04~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH004~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH004~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,0.7,4.4,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH004~RAC07~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.4,1.4,,,0.6,3.5,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH004~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.5,3.4,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH004~OVR01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.6,3.8,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH004~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.7,3.7,,,3.0,4.4,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH004~GEN01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,3.1,4.7,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH004~GEN02~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,1.9,3.4,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH004~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.7,3.1,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH004~AGE02~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.1,0.1,,,0.0,0.4,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH004~AGE04~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.3,1.2,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH004~AGE05~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.1,3.8,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH004~AGE06~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),10.7,10.7,,,8.2,13.8,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH004~AGE07~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,3.7,5.0,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH004~AGE08~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),10.5,10.5,,,8.3,13.3,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH004~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.5,3.7,Race,Non-Hispanic White,C1,T3,NH004,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH004~RAC01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,2.9,4.6,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH004~RAC02~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.8,2.9,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH004~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.8,3.2,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH004~RAC03~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.2,1.2,,,0.7,1.9,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH004~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.4,1.4,,,0.9,2.1,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH004~RAC04~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.1,3.0,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH004~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,1.8,4.0,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH004~RAC07~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.2,4.7,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH004~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.4,4.6,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH004~OVR01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.8,4.0,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH004~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.5,3.7,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH004~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.1,5.1,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH004~GEN01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.3,5.4,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH004~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.7,3.1,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH004~GEN02~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,1.9,3.4,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH004~AGE02~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH004~AGE04~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.4,0.8,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH004~AGE05~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.4,3.8,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH004~AGE06~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),11.1,11.1,,,8.9,13.7,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH004~AGE07~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.8,5.5,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH004~AGE08~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),13.2,13.2,,,10.2,16.9,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH004~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.5,4.0,Race,Non-Hispanic White,C1,T3,NH004,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH004~RAC01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.1,4.9,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH004~RAC02~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.2,3.4,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH004~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.3,3.4,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH004~RAC03~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,1.0,2.8,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH004~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,1.0,2.9,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH004~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.1,2.1,,,1.6,2.8,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH004~RAC04~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,1.2,2.4,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH004~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,1.8,4.6,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH004~RAC07~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.6,4.1,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH004~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.6,3.5,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH004~OVR01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.8,4.0,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH004~GEN01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.4,5.3,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH004~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.2,4.7,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH004~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.8,2.8,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH004~GEN02~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,2.0,3.2,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH004~AGE02~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH004~AGE04~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.4,1.0,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH004~AGE05~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.7,4.8,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH004~AGE06~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),9.2,9.2,,,7.3,11.5,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH004~AGE07~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.9,5.6,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH004~AGE08~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),11.7,11.7,,,9.4,14.5,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH004~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.2,3.8,Race,Non-Hispanic White,C1,T3,NH004,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH004~RAC01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.7,4.8,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH004~RAC02~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.4,4.1,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH004~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.5,4.1,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH004~RAC03~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.4,1.4,,,0.6,2.9,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH004~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.4,1.4,,,0.6,3.2,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH004~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.5,3.7,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH004~RAC04~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.6,3.0,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH004~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH004~RAC07~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH004~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.3,3.3,,,2.6,4.1,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH004~OVR01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,3.0,4.7,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH004~GEN01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),5.4,5.4,,,4.0,7.3,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH004~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.9,4.9,,,3.7,6.5,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH004~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.4,2.6,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH004~GEN02~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.6,3.1,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH004~AGE02~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.1,0.1,,,0.0,0.6,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH004~AGE04~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.9,0.9,,,0.6,1.5,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH004~AGE05~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.4,4.4,,,2.8,6.9,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH004~AGE06~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),9.1,9.1,,,7.6,10.8,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH004~AGE07~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),5.1,5.1,,,4.1,6.4,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH004~AGE08~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),10.5,10.5,,,8.2,13.3,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH004~RAC01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.4,4.4,,,3.2,5.9,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH004~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.5,3.5,,,2.6,4.8,Race,Non-Hispanic White,C1,T3,NH004,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH004~RAC02~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.1,3.9,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH004~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.1,3.9,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH004~RAC03~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,0.9,2.5,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH004~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.5,1.5,,,1.0,2.4,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH004~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.6,4.1,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH004~RAC04~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.2,3.5,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH004~RAC07~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.0,6.0,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH004~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,2.2,5.8,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH003~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.9,3.7,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH003~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.7,3.4,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH003~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.7,4.7,,,3.8,5.8,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH003~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.3,5.2,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH003~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.5,2.7,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH003~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.5,2.7,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH003~AGE02~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,0.0,0.3,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH003~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.3,0.3,,,0.1,0.9,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH003~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.7,5.7,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH003~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),9.6,9.6,,,8.2,11.4,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH003~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,3.7,5.0,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH003~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),10.8,10.8,,,8.2,14.2,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH003~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.4,3.4,,,3.0,4.0,Race,Non-Hispanic White,C1,T4,NH003,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH003~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,3.0,4.1,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH003~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.6,3.1,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH003~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,1.1,2.4,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH003~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH003~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH003~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH003~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH003~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH003~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH003~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,3.0,4.4,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH003~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.6,4.2,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH003~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.7,4.7,,,3.7,6.1,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH003~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.2,5.6,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH003~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.8,3.5,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH003~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.9,3.6,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH003~AGE02~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH003~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.7,0.7,,,0.4,1.3,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH003~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,2.7,5.6,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH003~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),11.8,11.8,,,9.0,15.3,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH003~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.8,4.8,,,3.8,5.9,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH003~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),14.8,14.8,,,10.1,21.2,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH003~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.2,4.8,Race,Non-Hispanic White,C1,T4,NH003,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH003~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.0,4.0,,,3.1,5.0,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH003~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.6,3.7,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH003~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.1,4.2,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH003~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH003~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH003~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH003~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH003~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.0,5.0,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH003~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,0.6,3.4,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH003~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.1,4.9,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH003~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.2,4.8,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH003~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),5.1,5.1,,,4.0,6.5,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH003~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.5,5.5,,,4.5,6.8,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH003~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.1,3.6,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH003~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.5,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH003~AGE02~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH003~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.2,0.9,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH003~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.1,4.1,,,2.9,5.8,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH003~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),14.0,14.0,,,11.6,16.8,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH003~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),5.5,5.5,,,4.4,6.7,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH003~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),14.5,14.5,,,11.0,18.8,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH003~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.7,5.8,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH003~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.2,4.2,,,3.3,5.3,Race,Non-Hispanic White,C1,T4,NH003,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH003~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.5,3.3,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH003~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.3,3.0,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH003~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH003~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH003~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH003~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH003~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH003~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH003~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.4,3.4,,,3.0,3.8,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH003~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.8,4.0,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH003~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.7,4.7,,,3.9,5.7,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH003~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.0,5.0,,,4.3,5.8,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH003~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.5,3.1,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH003~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.4,2.8,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH003~AGE02~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.8,0.8,,,0.2,2.7,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH003~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.2,0.2,,,0.1,0.6,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH003~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.2,4.2,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH003~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),12.6,12.6,,,11.1,14.4,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH003~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.8,5.4,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH003~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),13.3,13.3,,,10.6,16.6,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH003~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.0,4.0,,,3.2,4.9,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH003~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,3.1,4.2,Race,Non-Hispanic White,C1,T4,NH003,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH003~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.3,3.0,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH003~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.7,3.4,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH003~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH003~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH003~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH003~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH003~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH003~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,0.5,4.6,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH003~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.3,3.3,,,2.8,3.7,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH003~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.9,3.8,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH003~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.8,4.8,,,4.0,5.6,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH003~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.9,4.9,,,4.1,5.9,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH003~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.7,2.4,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH003~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.6,2.2,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH003~AGE02~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH003~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.2,1.0,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH003~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.8,4.5,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH003~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),11.4,11.4,,,9.3,13.9,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH003~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.9,5.2,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH003~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),11.8,11.8,,,9.2,15.0,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH003~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,3.3,4.4,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH003~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.4,3.4,,,2.9,3.9,Race,Non-Hispanic White,C1,T4,NH003,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH003~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.3,1.3,,,0.9,2.0,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH003~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.4,1.4,,,1.0,2.1,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH003~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH003~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH003~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH003~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH003~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH003~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH003~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.6,3.8,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH003~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.5,3.5,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH003~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.5,4.5,,,3.8,5.4,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH003~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.6,5.7,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH003~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,1.3,2.3,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH003~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,1.4,2.5,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH003~AGE02~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH003~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.5,0.5,,,0.2,1.1,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH003~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.1,4.5,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH003~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),10.6,10.6,,,9.3,12.1,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH003~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,3.6,5.2,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH003~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),13.5,13.5,,,10.5,17.2,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH003~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,3.0,4.7,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH003~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.6,3.8,Race,Non-Hispanic White,C1,T4,NH003,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH003~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.5,2.8,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH003~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.8,2.8,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH003~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH003~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH003~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH003~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH003~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.0,4.7,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH003~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,1.3,5.7,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH003~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.1,3.5,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH003~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.2,3.9,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH003~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,2.7,5.4,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH003~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.7,3.7,,,2.8,4.9,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH003~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.8,1.8,,,1.3,2.6,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH003~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.5,2.9,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH003~AGE02~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH003~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.2,1.1,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH003~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.3,3.6,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH003~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),11.2,11.2,,,8.6,14.3,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH003~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.0,4.0,,,3.1,5.2,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH003~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,10.7,18.5,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH003~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.0,3.8,Race,Non-Hispanic White,C1,T4,NH003,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH003~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.4,4.8,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH003~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,1.4,2.2,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH003~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.5,2.4,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH003~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.0,3.1,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH003~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.1,2.1,,,1.2,3.4,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH003~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,0.9,2.9,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH003~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.4,3.9,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH003~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,1.9,4.3,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH003~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,1.8,4.0,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH003~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.3,3.3,,,2.6,4.2,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH003~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,2.9,4.6,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH003~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.7,5.7,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH003~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.3,4.3,,,3.4,5.3,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH003~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,1.9,4.2,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH003~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.7,3.7,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH003~AGE02~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.2,0.2,,,0.0,1.5,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH003~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.1,1.2,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH003~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.1,4.4,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH003~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),13.0,13.0,,,10.4,16.2,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH003~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.9,4.9,,,3.9,6.2,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH003~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),15.7,15.7,,,12.1,20.2,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH003~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,2.7,4.9,Race,Non-Hispanic White,C1,T4,NH003,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH003~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.5,5.9,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH003~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.0,3.3,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH003~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.0,3.5,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH003~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.0,3.2,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH003~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.1,3.1,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH003~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,0.9,2.4,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH003~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.3,2.9,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH003~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.2,4.7,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH003~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,0.9,4.2,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH003~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.6,3.6,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH003~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.8,4.3,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH003~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.2,4.9,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH003~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,3.4,5.5,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH003~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.2,3.4,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH003~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.9,2.8,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH003~AGE02~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH003~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.3,0.3,,,0.1,0.7,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH003~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,1.9,4.3,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH003~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),11.7,11.7,,,9.3,14.6,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH003~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.9,4.9,,,4.0,5.9,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH003~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),11.9,11.9,,,9.1,15.4,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH003~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.3,3.8,Race,Non-Hispanic White,C1,T4,NH003,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH003~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.0,5.0,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH003~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.3,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH003~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.3,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH003~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.1,2.1,,,1.2,3.7,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH003~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.1,3.5,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH003~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.2,3.5,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH003~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,1.3,2.7,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH003~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.8,4.8,,,2.8,7.9,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH003~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.8,4.8,,,3.1,7.3,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH003~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.2,5.6,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH003~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,2.8,4.7,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH003~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),6.1,6.1,,,4.3,8.6,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH003~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.5,5.5,,,4.0,7.3,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH003~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.3,3.1,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH003~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.6,3.7,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH003~AGE02~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.2,0.2,,,0.0,1.4,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH003~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.7,0.7,,,0.4,1.3,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH003~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,2.5,6.7,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH003~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),12.3,12.3,,,10.2,14.8,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH003~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),5.8,5.8,,,4.3,7.7,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH003~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),15.2,15.2,,,11.9,19.2,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH003~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.2,4.2,,,3.1,5.8,Race,Non-Hispanic White,C1,T4,NH003,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH003~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),5.5,5.5,,,4.0,7.7,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH003~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,1.3,2.6,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH003~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.3,2.6,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH003~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.1,2.1,,,1.2,3.6,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH003~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.1,3.6,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH003~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.6,4.0,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH003~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.2,3.3,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH003~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.5,3.7,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH003~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.6,3.6,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH002~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.8,2.8,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH002~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.7,2.6,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH002~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.4,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH002~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.8,3.1,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH002~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,1.3,2.7,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH002~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.3,2.7,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH002~AGE02~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.7,0.7,,,0.2,2.5,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH002~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.3,0.3,,,0.1,0.8,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH002~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.0,4.1,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH002~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),6.7,6.7,,,5.3,8.4,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH002~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.3,3.5,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH002~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),10.3,10.3,,,8.0,13.2,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH002~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.7,2.9,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH002~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.1,2.1,,,1.6,2.8,Race,Non-Hispanic White,C1,T5,NH002,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH002~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,1.5,4.8,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH002~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.0,3.8,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH002~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH002~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH002~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH002~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH002~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),0.7,0.7,,,0.1,4.4,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH002~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.8,0.8,,,0.1,5.2,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH002~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.7,2.9,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH002~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.9,3.0,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH002~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.3,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH002~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.6,3.1,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH002~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.5,3.0,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH002~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.7,3.0,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH002~AGE02~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.1,0.1,,,0.0,1.0,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH002~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.2,1.1,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH002~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.2,4.0,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH002~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),8.5,8.5,,,6.8,10.5,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH002~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.4,4.1,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH002~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),10.9,10.9,,,7.8,15.1,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH002~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.6,3.0,Race,Non-Hispanic White,C1,T5,NH002,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH002~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.6,3.2,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH002~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.7,3.7,,,2.6,5.1,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH002~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.0,4.6,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH002~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH002~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH002~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH002~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH002~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.2,1.2,,,0.4,4.0,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH002~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.6,1.6,,,0.5,4.9,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH002~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.2,3.2,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH002~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.1,3.2,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH002~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.2,4.0,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH002~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.0,3.7,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH002~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.3,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH002~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.9,3.1,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH002~AGE02~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH002~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.2,1.2,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH002~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.4,3.3,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH002~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),10.2,10.2,,,8.7,12.0,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH002~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,3.0,4.4,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH002~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),12.3,12.3,,,10.1,14.9,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH002~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.4,3.3,Race,Non-Hispanic White,C1,T5,NH002,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH002~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.6,3.6,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH002~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.7,3.7,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH002~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.4,3.2,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH002~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH002~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH002~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH002~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH002~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH002~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH002~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.2,3.0,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH002~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.2,3.0,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH002~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.5,3.7,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH002~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.7,3.7,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH002~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.1,2.1,,,1.7,2.6,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH002~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.8,2.7,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH002~AGE02~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH002~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.2,0.8,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH002~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.6,3.4,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH002~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),9.5,9.5,,,7.8,11.6,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH002~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,3.1,4.2,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH002~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),10.9,10.9,,,8.3,14.0,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH002~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,2.0,2.9,Race,Non-Hispanic White,C1,T5,NH002,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH002~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.3,3.3,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH002~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.6,5.0,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH002~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),4.2,4.2,,,3.2,5.4,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH002~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH002~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH002~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH002~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH002~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH002~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH002~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.9,3.0,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH002~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.8,2.9,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH002~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.2,3.2,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH002~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.3,3.3,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH002~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.4,3.1,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH002~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.3,2.9,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH002~AGE02~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH002~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.5,0.5,,,0.2,1.0,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH002~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,1.5,2.6,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH002~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),9.0,9.0,,,7.0,11.4,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH002~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.5,4.1,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH002~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),11.1,11.1,,,8.3,14.8,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH002~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.5,3.2,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH002~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.4,2.8,Race,Non-Hispanic White,C1,T5,NH002,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH002~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,2.9,4.9,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH002~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),4.1,4.1,,,3.2,5.3,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH002~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH002~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH002~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH002~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH002~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH002~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),5.1,5.1,,,3.3,7.9,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH002~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.6,2.5,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH002~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.5,2.3,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH002~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.7,3.0,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH002~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.8,2.8,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH002~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.6,1.6,,,1.2,2.1,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH002~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,1.3,2.3,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH002~AGE02~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH002~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.2,0.8,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH002~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.4,3.0,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH002~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),6.3,6.3,,,4.9,8.1,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH002~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.1,3.4,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH002~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,6.3,11.2,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH002~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.6,3.0,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH002~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.8,1.8,,,1.4,2.5,Race,Non-Hispanic White,C1,T5,NH002,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH002~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.3,4.3,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH002~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.1,4.2,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH002~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH002~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH002~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH002~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH002~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),0.7,0.7,,,0.2,2.3,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH002~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.2,1.7,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH002~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,2.0,3.2,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH002~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.1,3.6,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH002~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.6,3.5,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH002~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.6,3.7,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH002~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.4,3.8,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH002~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.1,3.4,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH002~AGE02~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH002~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.0,1.0,,,0.5,1.9,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH002~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,1.0,2.2,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH002~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),10.5,10.5,,,7.5,14.4,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH002~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.8,4.8,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH002~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),12.9,12.9,,,9.5,17.4,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH002~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.9,3.2,Race,Non-Hispanic White,C1,T5,NH002,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH002~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.2,3.8,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH002~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.1,4.4,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH002~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.3,3.3,,,2.3,4.6,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH002~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.9,0.9,,,0.5,1.4,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH002~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.0,1.0,,,0.7,1.6,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH002~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.3,3.8,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH002~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,0.8,3.1,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH002~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH002~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH002~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.3,3.0,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH002~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,2.0,2.8,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH002~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.7,3.3,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH002~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.8,3.4,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH002~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,2.0,2.9,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH002~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.2,3.2,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH002~AGE02~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH002~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.3,1.2,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH002~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.7,3.0,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH002~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,7.0,10.1,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH002~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,3.0,4.1,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH002~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),11.1,11.1,,,9.2,13.3,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH002~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.5,3.4,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH002~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,2.0,2.9,Race,Non-Hispanic White,C1,T5,NH002,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH002~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.4,4.7,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH002~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.5,3.5,,,2.5,4.8,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH002~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),0.7,0.7,,,0.3,1.7,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH002~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.7,0.7,,,0.3,1.5,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH002~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,0.9,2.7,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH002~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.2,3.1,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH002~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.9,0.9,,,0.4,2.0,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH002~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.2,1.2,,,0.5,2.6,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH002~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.9,2.5,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH002~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,2.1,2.9,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH002~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.4,3.2,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH002~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,2.2,2.9,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH002~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.4,2.4,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH002~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.7,3.0,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH002~AGE02~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH002~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.2,0.8,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH002~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.4,2.5,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH002~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),8.3,8.3,,,6.7,10.1,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH002~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.9,4.1,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH002~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),10.5,10.5,,,8.2,13.2,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH002~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,1.4,2.2,Race,Non-Hispanic White,C1,T5,NH002,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH002~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.9,3.0,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH002~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,2.8,5.4,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH002~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),4.0,4.0,,,3.0,5.4,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH002~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,1.0,2.8,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH002~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,1.0,3.0,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH002~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.5,2.5,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH002~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.2,3.2,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH002~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.4,4.0,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH002~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.4,3.8,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH002~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.7,3.0,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH002~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.6,2.6,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH002~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.2,3.7,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH002~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.1,3.3,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH002~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.5,1.5,,,1.1,2.1,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH002~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.2,2.6,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH002~AGE02~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH002~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.5,0.5,,,0.3,1.0,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH002~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.4,3.7,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH002~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),6.5,6.5,,,4.9,8.5,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH002~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.3,4.1,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH002~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),8.7,8.7,,,6.7,11.1,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH002~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.5,2.7,Race,Non-Hispanic White,C1,T5,NH002,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH002~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,1.8,3.6,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH002~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.0,4.7,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH002~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.1,4.6,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH002~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.0,1.0,,,0.6,1.6,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH002~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.0,1.0,,,0.6,1.6,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH002~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.1,1.1,,,0.5,2.4,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH002~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.5,1.5,,,0.8,2.9,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH002~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,1.0,2.9,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH002~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,0.9,2.9,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH005~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.9,3.2,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH005~OVR01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.8,2.9,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH005~GEN01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.6,2.8,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH005~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.8,3.1,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH005~GEN02~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.3,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH005~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.9,3.4,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH005~AGE02~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.1,2.6,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH005~AGE04~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.5,0.5,,,0.2,1.1,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH005~AGE05~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.4,3.5,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH005~AGE06~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),8.7,8.7,,,6.9,10.9,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH005~AGE07~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.5,4.2,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH005~AGE08~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),10.6,10.6,,,8.0,13.9,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH005~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.7,3.3,Race,Non-Hispanic White,C1,T6,NH005,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH005~RAC01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.8,3.3,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH005~RAC02~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.5,3.5,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH005~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.3,4.6,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH005~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH005~RAC03~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH005~RAC04~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH005~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH005~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH005~RAC07~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,0.9,3.5,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH005~OVR01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,2.1,2.8,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH005~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.3,3.0,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH005~GEN01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.8,2.8,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH005~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.2,3.2,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH005~GEN02~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.0,3.4,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH005~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.1,3.5,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH005~AGE02~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.1,0.1,,,0.0,1.0,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH005~AGE04~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.9,0.9,,,0.5,1.5,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH005~AGE05~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.2,3.4,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH005~AGE06~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),9.0,9.0,,,7.9,10.4,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH005~AGE07~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.8,3.9,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH005~AGE08~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),12.8,12.8,,,10.5,15.5,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH005~RAC01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,2.1,3.0,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH005~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,2.0,3.0,Race,Non-Hispanic White,C1,T6,NH005,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH005~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),4.0,4.0,,,2.7,5.7,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH005~RAC02~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.3,4.8,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH005~RAC03~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH005~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH005~RAC04~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH005~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH005~RAC07~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH005~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH005~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.2,3.4,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH005~OVR01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.2,3.4,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH005~GEN01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.7,2.9,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH005~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.9,3.1,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH005~GEN02~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.5,4.0,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH005~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.5,3.9,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH005~AGE02~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH005~AGE04~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),1.0,1.0,,,0.5,1.9,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH005~AGE05~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.8,3.5,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH005~AGE06~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),8.8,8.8,,,7.6,10.2,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH005~AGE07~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.9,4.6,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH005~AGE08~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),10.8,10.8,,,9.0,12.9,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH005~RAC01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.2,3.6,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH005~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.4,Race,Non-Hispanic White,C1,T6,NH005,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH005~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),4.1,4.1,,,3.1,5.5,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH005~RAC02~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.6,4.7,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH005~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH005~RAC03~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH005~RAC04~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH005~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH005~RAC07~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH005~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH005~OVR01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.3,3.7,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH005~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.4,3.5,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH005~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.2,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH005~GEN01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.7,3.3,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH005~GEN02~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.5,4.4,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH005~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.5,4.1,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH005~AGE02~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.1,2.5,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH005~AGE04~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.5,0.5,,,0.2,1.2,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH005~AGE05~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.1,3.9,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH005~AGE06~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),9.8,9.8,,,8.1,11.9,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH005~AGE07~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.1,4.9,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH005~AGE08~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,10.8,18.3,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH005~RAC01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.3,4.1,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH005~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.2,3.5,Race,Non-Hispanic White,C1,T6,NH005,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH005~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.0,4.9,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH005~RAC02~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.4,4.5,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH005~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH005~RAC03~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH005~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH005~RAC04~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH005~RAC07~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH005~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH005~OVR01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.6,4.0,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH005~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.5,3.9,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH005~GEN01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.3,3.3,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH005~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.4,3.3,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH005~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.4,3.4,,,2.5,4.7,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH005~GEN02~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.6,5.1,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH005~AGE02~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH005~AGE04~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.7,0.7,,,0.4,1.4,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH005~AGE05~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.0,4.2,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH005~AGE06~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),11.3,11.3,,,8.8,14.6,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH005~AGE07~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,3.4,5.5,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH005~AGE08~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),13.9,13.9,,,9.9,19.2,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH005~RAC01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.7,4.6,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH005~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.3,4.1,Race,Non-Hispanic White,C1,T6,NH005,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH005~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),5.0,5.0,,,3.7,6.6,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH005~RAC02~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.3,6.0,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH005~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH005~RAC03~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH005~RAC04~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH005~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH005~RAC07~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH005~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH005~OVR01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.2,3.0,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH005~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,2.2,2.9,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH005~GEN01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.2,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH005~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,2.0,3.1,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH005~GEN02~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.2,3.3,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH005~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,2.1,3.1,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH005~AGE02~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.3,0.3,,,0.1,1.3,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH005~AGE04~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.3,1.1,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH005~AGE05~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.1,3.1,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH005~AGE06~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),8.2,8.2,,,6.4,10.5,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH005~AGE07~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,3.0,4.1,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH005~AGE08~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),11.7,11.7,,,9.9,13.8,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH005~RAC01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.1,3.3,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH005~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.9,2.8,Race,Non-Hispanic White,C1,T6,NH005,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH005~RAC02~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,3.1,4.6,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH005~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),4.0,4.0,,,3.3,4.9,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH005~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH005~RAC03~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH005~RAC04~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH005~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH005~RAC07~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.3,4.0,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH005~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,1.9,4.6,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH005~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.2,3.2,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH005~OVR01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.3,3.5,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH005~GEN01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.0,3.6,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH005~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.9,3.4,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH005~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.2,3.4,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH005~GEN02~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.4,3.8,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH005~AGE02~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.8,0.8,,,0.2,3.3,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH005~AGE04~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.5,0.5,,,0.3,0.9,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH005~AGE05~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.0,3.7,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH005~AGE06~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),8.9,8.9,,,7.7,10.3,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH005~AGE07~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,3.0,4.7,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH005~AGE08~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),11.5,11.5,,,9.2,14.3,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH005~RAC01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.1,3.3,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH005~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.8,2.8,Race,Non-Hispanic White,C1,T6,NH005,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH005~RAC02~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.5,5.8,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH005~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),4.8,4.8,,,3.6,6.2,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH005~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.2,3.3,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH005~RAC03~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.0,3.1,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH005~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.2,3.4,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH005~RAC04~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.6,2.7,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH005~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.8,3.8,,,2.4,5.9,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH005~RAC07~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.0,5.9,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH005~OVR01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.5,3.3,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH005~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.3,3.0,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH005~GEN01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.8,3.2,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH005~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.7,3.1,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH005~GEN02~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.6,4.2,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH005~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.4,3.6,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH005~AGE02~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.1,1.9,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH005~AGE04~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.2,1.0,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH005~AGE05~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.4,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH005~AGE06~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),9.5,9.5,,,8.2,11.0,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH005~AGE07~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.4,4.5,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH005~AGE08~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),11.2,11.2,,,8.3,15.0,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH005~RAC01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.7,3.8,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH005~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.3,3.1,Race,Non-Hispanic White,C1,T6,NH005,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH005~RAC02~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.2,3.9,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH005~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.3,4.0,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH005~RAC03~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,0.8,3.0,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH005~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,1.0,2.9,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH005~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.3,3.0,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH005~RAC04~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,1.0,2.4,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH005~RAC07~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.3,4.0,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH005~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,1.8,4.4,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH005~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,2.1,2.9,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH005~OVR01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.3,3.2,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH005~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.2,3.5,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH005~GEN01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.4,3.7,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH005~GEN02~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,2.0,3.2,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH005~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.8,2.7,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH005~AGE02~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.3,0.3,,,0.0,1.9,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH005~AGE04~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.8,0.8,,,0.4,1.5,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH005~AGE05~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,1.9,3.5,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH005~AGE06~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),7.5,7.5,,,6.0,9.3,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH005~AGE07~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,3.1,4.2,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH005~AGE08~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),9.7,9.7,,,7.1,13.1,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH005~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.8,2.7,Race,Non-Hispanic White,C1,T6,NH005,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH005~RAC01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.2,3.4,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH005~RAC02~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,2.9,4.9,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH005~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.0,5.0,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH005~RAC03~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),1.0,1.0,,,0.4,2.0,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH005~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),1.0,1.0,,,0.5,2.1,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH005~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.7,3.1,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH005~RAC04~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.3,2.5,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH005~RAC07~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH005~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH005~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.4,3.6,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH005~OVR01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.7,4.1,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH005~GEN01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.2,3.7,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH005~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.1,3.2,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH005~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.3,3.3,,,2.5,4.4,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH005~GEN02~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,2.9,5.0,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH005~AGE02~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.1,0.1,,,0.0,0.6,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH005~AGE04~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.4,0.4,,,0.2,0.8,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH005~AGE05~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.5,4.9,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH005~AGE06~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),9.6,9.6,,,7.5,12.1,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH005~AGE07~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.7,5.5,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH005~AGE08~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),12.9,12.9,,,9.8,16.8,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH005~RAC01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.7,4.7,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH005~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.1,3.7,Race,Non-Hispanic White,C1,T6,NH005,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH005~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),5.0,5.0,,,4.0,6.3,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH005~RAC02~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),5.0,5.0,,,4.0,6.2,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH005~RAC03~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),1.1,1.1,,,0.6,2.0,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH005~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),1.1,1.1,,,0.7,1.9,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH005~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.1,3.0,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH005~RAC04~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,1.0,2.5,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH005~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,1.9,4.8,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH005~RAC07~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,1.8,5.0,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH060~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH060~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH060~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH060~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH060~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH060~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH060~AGE02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH060~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH060~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH060~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH060~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH060~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH060~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH060~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH060~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH060~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH060~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH060~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH060~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH060~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH060~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH060~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH060~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH060~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH060~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH060~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH060~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH060~AGE02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH060~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH060~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH060~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH060~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH060~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH060~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH060~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH060~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH060~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH060~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH060~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH060~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH060~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH060~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH060~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH060~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH060~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH060~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH060~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH060~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH060~AGE02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH060~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH060~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH060~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH060~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH060~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH060~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH060~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH060~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH060~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH060~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH060~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH060~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH060~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH060~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH060~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH060~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH060~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH060~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH060~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH060~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH060~AGE02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH060~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH060~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH060~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH060~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH060~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH060~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH060~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH060~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH060~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH060~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH060~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH060~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH060~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH060~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH060~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH060~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH060~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH060~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH060~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH060~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH060~AGE02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH060~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH060~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH060~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH060~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH060~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH060~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH060~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH060~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH060~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH060~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH060~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH060~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH060~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH060~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH060~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH060~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH060~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH060~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH060~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH060~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH060~AGE02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH060~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH060~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH060~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH060~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH060~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH060~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH060~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH060~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH060~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH060~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH060~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH060~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH060~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH060~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH060~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH060~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH060~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH060~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH060~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH060~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH060~AGE02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH060~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH060~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH060~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH060~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH060~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH060~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH060~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH060~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH060~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH060~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH060~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH060~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH060~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH060~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH060~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH060~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH060~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH060~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH060~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH060~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH060~AGE02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH060~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH060~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH060~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH060~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH060~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH060~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH060~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH060~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH060~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH060~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH060~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH060~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH060~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH060~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH060~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),21.9,21.9,,,19.3,24.9,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH060~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),20.0,20.0,,,18.0,22.1,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH060~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),25.9,25.9,,,23.7,28.3,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH060~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),24.1,24.1,,,22.0,26.3,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH060~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),18.2,18.2,,,14.3,22.9,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH060~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),16.3,16.3,,,12.9,20.3,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH060~AGE02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),0.7,0.7,,,0.1,4.5,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH060~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),7.0,7.0,,,5.0,9.9,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH060~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),32.1,32.1,,,27.6,37.0,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH060~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),38.5,38.5,,,33.3,43.9,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH060~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),29.5,29.5,,,26.3,32.8,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH060~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),8.1,8.1,,,5.0,12.7,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH060~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),21.8,21.8,,,18.8,25.2,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH060~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),24.6,24.6,,,21.1,28.4,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH060~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),24.3,24.3,,,21.6,27.3,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH060~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),14.4,14.4,,,10.3,19.7,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH060~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),14.8,14.8,,,10.0,21.4,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH060~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),24.6,24.6,,,22.3,27.1,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH060~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),20.9,20.9,,,18.4,23.7,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH060~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),21.3,21.3,,,15.9,28.0,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH060~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),21.3,21.3,,,14.7,29.9,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH060~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),19.7,19.7,,,17.6,22.1,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH060~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),21.4,21.4,,,19.2,23.9,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH060~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),22.7,22.7,,,18.7,27.2,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH060~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),20.9,20.9,,,17.4,24.8,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH060~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),20.2,20.2,,,17.0,23.8,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH060~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),18.7,18.7,,,15.3,22.7,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH060~AGE02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH060~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),5.8,5.8,,,4.2,7.9,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH060~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),31.7,31.7,,,26.1,37.8,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH060~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),36.8,36.8,,,29.2,45.1,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH060~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),28.4,28.4,,,25.2,31.9,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH060~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH060~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),20.4,20.4,,,17.4,23.8,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH060~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),26.2,26.2,,,22.7,30.0,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH060~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),26.5,26.5,,,23.4,29.9,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH060~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),21.3,21.3,,,17.1,26.3,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH060~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),20.3,20.3,,,16.5,24.7,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH060~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),21.2,21.2,,,16.8,26.2,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH060~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),24.4,24.4,,,20.5,28.7,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH060~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Crude,Percent (%),22.9,22.9,,,17.6,29.2,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH060~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (20+); NHANES,Age-Standardized,Percent (%),23.4,23.4,,,19.6,27.6,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH061~OVR01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH061~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH061~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH061~GEN01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH061~GEN02~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH061~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH061~AGE02~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH061~AGE04~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH061~AGE05~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH061~AGE06~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH061~AGE07~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH061~AGE08~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH061~RAC01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH061~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH061~RAC02~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH061~RAC03~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH061~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH061~RAC04~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH061~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH061~RAC07~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH061~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH061~OVR01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH061~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH061~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH061~GEN01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH061~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH061~GEN02~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH061~AGE02~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH061~AGE04~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH061~AGE05~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH061~AGE06~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH061~AGE07~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH061~AGE08~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH061~RAC01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH061~RAC02~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH061~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH061~RAC03~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH061~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH061~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH061~RAC04~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH061~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH061~RAC07~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH061~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH061~OVR01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH061~GEN01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH061~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH061~GEN02~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH061~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH061~AGE02~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH061~AGE04~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH061~AGE05~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH061~AGE06~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH061~AGE07~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH061~AGE08~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH061~RAC01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH061~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH061~RAC02~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH061~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH061~RAC03~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH061~RAC04~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH061~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH061~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH061~RAC07~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH061~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH061~OVR01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH061~GEN01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH061~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH061~GEN02~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH061~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH061~AGE02~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH061~AGE04~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH061~AGE05~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH061~AGE06~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH061~AGE07~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH061~AGE08~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH061~RAC01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH061~RAC02~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH061~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH061~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH061~RAC03~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH061~RAC04~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH061~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH061~RAC07~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH061~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH061~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH061~OVR01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH061~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH061~GEN01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH061~GEN02~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH061~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH061~AGE02~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH061~AGE04~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH061~AGE05~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH061~AGE06~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH061~AGE07~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH061~AGE08~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH061~RAC01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH061~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH061~RAC02~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH061~RAC03~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH061~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH061~RAC04~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH061~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH061~RAC07~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH061~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH061~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH061~OVR01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH061~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH061~GEN01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH061~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH061~GEN02~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH061~AGE02~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH061~AGE04~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH061~AGE05~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH061~AGE06~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH061~AGE07~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH061~AGE08~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH061~RAC01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH061~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH061~RAC02~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH061~RAC03~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH061~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH061~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH061~RAC04~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH061~RAC07~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH061~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH061~OVR01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH061~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH061~GEN01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH061~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH061~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH061~GEN02~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH061~AGE02~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH061~AGE04~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH061~AGE05~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH061~AGE06~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH061~AGE07~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH061~AGE08~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH061~RAC01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH061~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH061~RAC02~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH061~RAC03~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH061~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH061~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH061~RAC04~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH061~RAC07~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH061~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH061~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH061~OVR01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH061~GEN01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH061~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH061~GEN02~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH061~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH061~AGE02~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH061~AGE04~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH061~AGE05~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH061~AGE06~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH061~AGE07~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH061~AGE08~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH061~RAC01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH061~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH061~RAC02~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH061~RAC03~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH061~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH061~RAC04~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH061~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH061~RAC07~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH061~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH061~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),32.0,32.0,,,25.9,38.8,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH061~OVR01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),49.8,49.8,,,44.8,54.8,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH061~GEN01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),54.6,54.6,,,47.0,62.0,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH061~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),30.9,30.9,,,26.2,36.0,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH061~GEN02~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),43.4,43.4,,,37.4,49.5,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH061~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH061~AGE02~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH061~AGE04~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH061~AGE05~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),49.1,49.1,,,42.3,56.0,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH061~AGE06~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),61.4,61.4,,,53.1,69.0,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH061~AGE07~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),50.7,50.7,,,45.1,56.2,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH061~AGE08~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH061~RAC01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),55.2,55.2,,,49.4,60.9,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH061~RAC02~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),39.4,39.4,,,28.9,50.9,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH061~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),22.9,22.9,,,16.0,31.5,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH061~RAC03~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH061~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH061~RAC04~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),29.2,29.2,,,21.3,38.6,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH061~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),19.4,19.4,,,15.1,24.6,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH061~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),30.6,30.6,,,19.5,44.6,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH061~RAC07~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH061~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),30.1,30.1,,,22.7,38.8,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH061~OVR01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),45.8,45.8,,,37.5,54.3,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH061~GEN01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),51.8,51.8,,,40.0,63.4,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH061~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH061~GEN02~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),39.3,39.3,,,30.7,48.6,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH061~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),24.0,24.0,,,19.3,29.6,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH061~AGE02~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH061~AGE04~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH061~AGE05~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),46.5,46.5,,,37.6,55.7,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH061~AGE06~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),53.9,53.9,,,42.6,64.9,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH061~AGE07~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),47.5,47.5,,,39.1,56.1,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH061~AGE08~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH061~RAC01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH061~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),19.6,19.6,,,15.0,25.1,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH061~RAC02~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),31.0,31.0,,,24.5,38.3,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH061~RAC03~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH061~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),26.7,26.7,,,18.2,37.4,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH061~RAC04~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),38.5,38.5,,,28.4,49.7,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH061~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),24.3,24.3,,,18.4,31.4,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH061~RAC07~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),47.8,47.8,,,36.4,59.4,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH061~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (20+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),27.9,27.9,,,23.0,33.4,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH063~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.7,3.7,,,2.7,5.1,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH063~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.6,5.0,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH063~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.0,4.0,,,2.3,6.6,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH063~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,2.3,6.4,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH063~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.4,3.4,,,2.4,4.9,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH063~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.3,5.0,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH063~AGE02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH063~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.2,4.7,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH063~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),5.0,5.0,,,3.2,7.6,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH063~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH063~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),4.0,4.0,,,2.8,5.5,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH063~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH063~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.1,5.2,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH063~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH063~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH063~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH063~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH063~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH063~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH063~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH063~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH063~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.5,4.1,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH063~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.5,4.1,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH063~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,1.9,5.0,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH063~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,1.8,4.9,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH063~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.4,3.4,,,2.2,5.1,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH063~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.2,5.2,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH063~AGE02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH063~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.2,3.9,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH063~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),5.5,5.5,,,3.8,7.8,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH063~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.2,4.8,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH063~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),4.0,4.0,,,3.0,5.3,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH063~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.1,5.4,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH063~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.5,4.3,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH063~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH063~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH063~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH063~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH063~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH063~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH063~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH063~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH063~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.3,3.3,,,2.4,4.4,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH063~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.4,4.4,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH063~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,1.6,5.1,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH063~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,1.6,5.2,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH063~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.5,5.1,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH063~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.5,3.5,,,2.5,4.9,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH063~AGE02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH063~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.0,5.8,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH063~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.0,6.3,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH063~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),4.1,4.1,,,2.6,6.5,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH063~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.1,4.9,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH063~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH063~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,2.6,5.3,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH063~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.3,3.3,,,2.2,4.8,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH063~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.2,4.6,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH063~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH063~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH063~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH063~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH063~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),0.0,0.0,,,,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH063~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH063~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.7,4.0,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH063~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,1.8,4.0,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH063~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,1.9,4.9,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH063~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,1.9,4.7,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH063~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.2,4.4,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH063~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.1,4.4,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH063~AGE02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH063~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH063~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH063~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,0.9,2.7,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH063~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.0,4.6,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH063~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH063~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.4,4.0,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH063~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.8,1.8,,,0.8,4.0,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH063~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,0.8,4.3,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH063~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH063~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH063~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH063~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH063~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH063~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH063~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.2,3.6,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH063~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.2,3.6,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH063~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,1.6,4.8,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH063~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,1.6,4.9,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH063~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.1,3.8,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH063~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.0,3.7,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH063~AGE02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH063~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,0.9,3.6,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH063~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),4.1,4.1,,,2.9,5.9,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH063~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH063~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.8,4.7,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH063~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,2.7,7.8,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH063~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.3,4.3,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH063~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.7,3.7,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH063~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.8,3.7,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH063~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH063~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH063~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH063~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH063~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH063~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH063~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.0,4.3,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH063~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.0,4.3,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH063~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.7,4.1,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH063~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,1.7,4.1,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH063~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.0,4.7,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH063~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.2,4.8,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH063~AGE02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH063~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,1.8,4.0,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH063~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH063~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.1,4.3,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH063~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,2.4,5.6,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH063~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH063~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.1,5.2,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH063~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,1.7,4.6,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH063~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,1.7,4.5,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH063~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH063~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH063~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH063~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH063~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH063~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH063~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.7,3.1,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH063~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.7,3.2,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH063~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.1,2.1,,,1.3,3.6,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH063~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.3,3.7,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH063~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.7,3.6,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH063~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.7,3.6,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH063~AGE02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH063~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.0,3.1,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH063~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,2.6,5.7,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH063~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,1.0,2.8,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH063~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.2,4.1,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH063~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),0.9,0.9,,,0.3,3.0,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH063~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.5,3.9,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH063~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,1.4,4.6,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH063~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.4,4.6,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH063~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.3,3.3,,,1.8,6.0,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH063~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,1.8,6.0,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH063~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.3,1.3,,,0.6,2.9,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH063~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.4,1.4,,,0.7,2.9,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH063~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.5,3.5,,,2.1,5.9,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH063~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.0,5.9,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH063~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.8,3.0,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH063~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.9,2.9,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH063~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.6,3.6,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH063~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.5,3.5,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH063~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.5,3.5,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH063~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.6,3.5,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH063~AGE02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH063~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.0,1.0,,,0.5,2.0,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH063~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),4.4,4.4,,,2.9,6.7,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH063~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.3,1.3,,,0.4,4.1,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH063~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.2,3.8,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH063~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),0.8,0.8,,,0.2,3.3,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH063~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.2,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH063~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.2,4.3,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH063~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.1,4.3,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH063~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.6,1.6,,,0.5,4.6,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH063~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,0.5,4.6,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH063~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.5,4.5,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH063~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.5,4.3,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH063~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.1,1.1,,,0.4,3.2,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH063~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.2,1.2,,,0.4,3.5,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH063~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.5,3.3,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH063~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.1,2.1,,,1.4,3.2,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH063~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,1.8,4.3,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH063~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,1.8,4.2,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH063~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.5,1.5,,,0.8,3.0,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH063~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,0.9,3.1,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH063~AGE02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH063~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.2,4.2,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH063~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,1.5,5.3,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH063~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.0,3.9,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH063~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.6,3.9,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH063~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.1,2.5,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH063~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.2,3.8,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH063~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,1.5,4.6,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH063~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,1.5,4.7,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH063~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,0.7,4.7,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH063~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.8,1.8,,,0.7,4.9,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH063~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.2,2.8,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH063~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,1.0,2.9,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH063~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH063~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH063~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.4,3.3,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH063~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.4,3.3,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH063~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.8,1.8,,,0.9,3.5,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH063~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,0.8,3.3,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH063~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.6,3.9,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH063~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,1.7,4.1,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH063~AGE02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH063~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,0.8,3.7,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH063~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,1.5,5.2,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH063~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.1,4.0,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH063~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.5,3.6,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH063~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,0.7,5.1,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH063~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.2,3.7,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH063~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.2,4.7,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH063~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.2,4.6,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH063~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.3,1.3,,,0.4,4.2,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH063~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.3,1.3,,,0.4,4.0,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH063~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,1.6,5.1,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH063~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,1.5,4.9,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH063~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,0.5,4.8,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH063~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of severe hypercholesterolemia (LDL-C =190) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.6,1.6,,,0.5,4.5,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH064~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH064~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH064~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH064~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH064~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH064~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH064~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH064~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH064~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH064~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH065~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum triglycerides among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH065~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum triglycerides among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH065~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum triglycerides among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH065~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum triglycerides among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH065~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum triglycerides among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH065~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum triglycerides among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH065~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum triglycerides among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH065~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum triglycerides among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH065~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum triglycerides among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH065~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum triglycerides among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH066~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),63.0,63.0,,,59.9,66.0,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH066~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),64.2,64.2,,,61.3,67.1,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH066~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),62.6,62.6,,,59.6,65.5,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH066~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),60.0,60.0,,,56.9,63.0,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH066~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),65.9,65.9,,,61.6,69.9,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH066~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),66.0,66.0,,,61.7,70.1,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH066~AGE02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),27.7,27.7,,,22.8,33.2,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH066~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),51.7,51.7,,,46.5,56.8,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH066~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),77.6,77.6,,,74.4,80.4,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH066~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),88.6,88.6,,,85.6,91.0,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH066~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),74.2,74.2,,,71.4,76.8,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH066~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),87.9,87.9,,,84.7,90.5,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH066~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),67.6,67.6,,,63.2,71.6,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH066~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),55.1,55.1,,,51.1,59.1,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH066~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),58.1,58.1,,,54.2,62.0,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH066~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH066~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH066~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH066~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH066~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),49.4,49.4,,,42.8,56.1,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH066~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),52.7,52.7,,,47.1,58.3,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH066~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),63.9,63.9,,,60.9,66.9,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH066~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),64.3,64.3,,,62.0,66.5,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH066~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),60.8,60.8,,,57.1,64.4,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH066~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),62.1,62.1,,,59.7,64.4,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH066~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),66.7,66.7,,,63.9,69.3,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH066~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),67.0,67.0,,,63.9,70.0,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH066~AGE02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),21.9,21.9,,,17.5,27.1,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH066~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),53.9,53.9,,,51.2,56.6,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH066~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),77.4,77.4,,,73.8,80.7,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH066~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),88.3,88.3,,,84.5,91.2,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH066~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),75.3,75.3,,,72.4,78.0,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH066~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),86.5,86.5,,,82.2,89.8,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH066~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),68.2,68.2,,,64.7,71.4,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH066~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),60.9,60.9,,,55.8,65.8,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH066~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),58.2,58.2,,,52.8,63.3,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH066~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH066~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH066~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH066~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH066~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),60.0,60.0,,,50.4,68.8,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH066~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),63.8,63.8,,,56.7,70.4,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH066~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),66.0,66.0,,,63.3,68.5,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH066~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),66.7,66.7,,,63.7,69.5,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH066~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),63.2,63.2,,,60.4,65.9,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH066~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),62.7,62.7,,,59.8,65.6,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH066~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),68.8,68.8,,,65.8,71.7,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH066~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),70.4,70.4,,,67.0,73.6,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH066~AGE02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),26.2,26.2,,,20.7,32.6,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH066~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),53.4,53.4,,,48.6,58.1,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH066~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),80.1,80.1,,,76.9,82.9,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH066~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),92.2,92.2,,,91.1,93.2,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH066~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),77.4,77.4,,,75.0,79.7,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH066~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),92.4,92.4,,,90.7,93.7,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH066~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),70.7,70.7,,,66.7,74.3,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH066~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),64.2,64.2,,,61.6,66.8,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH066~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),62.8,62.8,,,59.8,65.6,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH066~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH066~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH066~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH066~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH066~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),64.1,64.1,,,56.2,71.2,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH066~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),61.3,61.3,,,53.2,68.9,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH066~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),67.8,67.8,,,65.4,70.0,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH066~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),68.8,68.8,,,66.1,71.3,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH066~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),64.6,64.6,,,61.7,67.3,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH066~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),64.4,64.4,,,60.9,67.7,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH066~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),73.0,73.0,,,70.6,75.3,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH066~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),71.2,71.2,,,68.7,73.6,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH066~AGE02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),29.9,29.9,,,25.2,35.0,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH066~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),57.2,57.2,,,53.0,61.4,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH066~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),80.9,80.9,,,77.8,83.7,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH066~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),89.8,89.8,,,87.1,92.0,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH066~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),79.1,79.1,,,76.4,81.5,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH066~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),90.1,90.1,,,85.5,93.3,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH066~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),73.0,73.0,,,70.2,75.7,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH066~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),64.9,64.9,,,62.2,67.5,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH066~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),66.1,66.1,,,63.0,69.1,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH066~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH066~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH066~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH066~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH066~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),66.7,66.7,,,57.8,74.6,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH066~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),68.2,68.2,,,58.7,76.5,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH066~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),68.7,68.7,,,66.5,70.9,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH066~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),67.6,67.6,,,65.5,69.7,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH066~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),64.0,64.0,,,61.3,66.6,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH066~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),64.1,64.1,,,61.0,67.0,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH066~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),73.1,73.1,,,70.5,75.6,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH066~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),71.2,71.2,,,68.7,73.6,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH066~AGE02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),29.3,29.3,,,24.2,35.0,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH066~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),55.5,55.5,,,51.1,59.8,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH066~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),80.4,80.4,,,77.6,82.9,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH066~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),93.3,93.3,,,91.6,94.7,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH066~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),78.9,78.9,,,77.0,80.7,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH066~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),93.4,93.4,,,90.9,95.2,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH066~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),72.3,72.3,,,69.2,75.3,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH066~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),69.3,69.3,,,66.5,72.0,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH066~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),68.4,68.4,,,65.5,71.2,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH066~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH066~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH066~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH066~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH066~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),63.6,63.6,,,54.5,71.9,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH066~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),64.8,64.8,,,57.4,71.6,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH066~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),67.8,67.8,,,65.9,69.6,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH066~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),69.3,69.3,,,67.1,71.4,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH066~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),65.6,65.6,,,63.4,67.8,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH066~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),66.3,66.3,,,63.4,69.1,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH066~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),72.2,72.2,,,69.8,74.4,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH066~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),70.0,70.0,,,67.6,72.2,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH066~AGE02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),29.5,29.5,,,24.5,35.2,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH066~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),56.8,56.8,,,53.4,60.2,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH066~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),81.0,81.0,,,77.6,84.0,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH066~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),91.2,91.2,,,89.4,92.8,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH066~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),79.7,79.7,,,77.0,82.0,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH066~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),90.1,90.1,,,86.7,92.7,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH066~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),73.9,73.9,,,71.9,75.9,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH066~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),65.9,65.9,,,62.0,69.6,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH066~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),65.1,65.1,,,61.1,68.8,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH066~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH066~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH066~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH066~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH066~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),66.7,66.7,,,60.5,72.3,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH066~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),68.9,68.9,,,63.2,74.0,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH066~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),69.3,69.3,,,67.3,71.3,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH066~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),71.0,71.0,,,68.2,73.7,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH066~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),67.8,67.8,,,64.9,70.7,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH066~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),66.9,66.9,,,65.0,68.8,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH066~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),71.6,71.6,,,68.8,74.2,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH066~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),74.0,74.0,,,70.6,77.1,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH066~AGE02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),34.0,34.0,,,26.6,42.2,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH066~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),58.8,58.8,,,55.1,62.4,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH066~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),81.6,81.6,,,78.4,84.5,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH066~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),92.7,92.7,,,90.6,94.4,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH066~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),80.9,80.9,,,78.5,83.0,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH066~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),91.8,91.8,,,89.8,93.4,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH066~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),75.2,75.2,,,72.2,78.0,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH066~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),71.6,71.6,,,65.3,77.2,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH066~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),71.8,71.8,,,66.6,76.5,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH066~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),70.5,70.5,,,66.9,73.9,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH066~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),69.3,69.3,,,64.9,73.4,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH066~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),53.8,53.8,,,49.6,57.8,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH066~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),59.0,59.0,,,55.9,62.0,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH066~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),65.7,65.7,,,59.7,71.4,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH066~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),66.5,66.5,,,61.7,71.0,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH066~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),72.9,72.9,,,71.4,74.3,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH066~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),74.6,74.6,,,73.0,76.3,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH066~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),69.9,69.9,,,67.2,72.6,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH066~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),71.0,71.0,,,67.9,74.0,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH066~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),75.9,75.9,,,74.3,77.4,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH066~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),78.1,78.1,,,76.4,79.7,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH066~AGE02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),37.2,37.2,,,30.8,44.0,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH066~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),63.5,63.5,,,61.2,65.8,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH066~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),85.3,85.3,,,83.6,86.9,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH066~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),93.3,93.3,,,91.3,94.9,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH066~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),83.7,83.7,,,82.9,84.6,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH066~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),95.5,95.5,,,92.5,97.3,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH066~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),78.4,78.4,,,76.3,80.3,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH066~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),72.8,72.8,,,68.1,77.0,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH066~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),72.7,72.7,,,69.1,76.0,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH066~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),74.9,74.9,,,70.5,78.8,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH066~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),74.9,74.9,,,70.7,78.6,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH066~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),64.7,64.7,,,61.8,67.4,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH066~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),60.3,60.3,,,56.7,63.7,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH066~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),73.8,73.8,,,69.8,77.3,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH066~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),72.9,72.9,,,68.4,76.9,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH066~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),74.6,74.6,,,72.5,76.6,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH066~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),76.4,76.4,,,74.2,78.5,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH066~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),72.1,72.1,,,69.2,74.9,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH066~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),73.3,73.3,,,69.9,76.5,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH066~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),77.2,77.2,,,75.4,78.8,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH066~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),79.3,79.3,,,77.7,80.8,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH066~AGE02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),42.9,42.9,,,37.1,48.9,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH066~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),64.4,64.4,,,61.0,67.6,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH066~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),85.1,85.1,,,82.4,87.5,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH066~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),94.2,94.2,,,92.6,95.5,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH066~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),85.2,85.2,,,83.1,87.1,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH066~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),93.8,93.8,,,90.6,96.0,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH066~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),80.2,80.2,,,77.0,83.0,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH066~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),74.5,74.5,,,71.4,77.3,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH066~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),74.5,74.5,,,71.4,77.3,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH066~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),75.3,75.3,,,69.1,80.6,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH066~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),75.7,75.7,,,69.8,80.7,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH066~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),62.8,62.8,,,58.2,67.2,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH066~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),65.8,65.8,,,62.1,69.2,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH066~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),75.3,75.3,,,70.0,79.9,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH066~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),75.4,75.4,,,70.4,79.7,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH066~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),74.4,74.4,,,71.6,77.0,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH066~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),76.3,76.3,,,73.4,79.0,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH066~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),72.6,72.6,,,69.1,76.0,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH066~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),71.4,71.4,,,67.8,74.7,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH066~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),79.8,79.8,,,77.3,82.0,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH066~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),77.5,77.5,,,75.2,79.7,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH066~AGE02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),41.9,41.9,,,36.1,47.9,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH066~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),65.9,65.9,,,60.5,70.8,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH066~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),84.7,84.7,,,81.3,87.6,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH066~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),93.3,93.3,,,91.1,95.0,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH066~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),84.8,84.8,,,81.8,87.4,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH066~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),93.3,93.3,,,90.2,95.5,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH066~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),79.8,79.8,,,76.9,82.5,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH066~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),72.1,72.1,,,69.1,74.9,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH066~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),72.1,72.1,,,68.3,75.6,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH066~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),76.7,76.7,,,71.4,81.2,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH066~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),77.1,77.1,,,71.9,81.5,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH066~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),65.3,65.3,,,58.7,71.3,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH066~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),67.6,67.6,,,62.2,72.5,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH066~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),76.3,76.3,,,72.0,80.2,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH066~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),76.1,76.1,,,71.5,80.2,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH067~OVR01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),203.0,203.0,,,200.0,205.0,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH067~GEN01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),202.0,202.0,,,200.0,204.0,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH067~GEN02~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),203.0,203.0,,,201.0,206.0,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH067~AGE02~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),176.0,176.0,,,171.0,182.0,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH067~AGE04~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),196.0,196.0,,,193.0,200.0,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH067~AGE05~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),215.0,215.0,,,212.0,217.0,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH067~AGE06~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),216.0,216.0,,,214.0,218.0,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH067~AGE07~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),210.0,210.0,,,207.0,214.0,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH067~AGE08~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),209.0,209.0,,,207.0,211.0,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH067~RAC01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),205.0,205.0,,,202.0,208.0,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH067~RAC02~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),194.0,194.0,,,191.0,197.0,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH067~RAC03~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH067~RAC04~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH067~RAC07~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),204.0,204.0,,,195.0,213.0,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH067~OVR01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),202.0,202.0,,,199.0,204.0,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH067~GEN01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),202.0,202.0,,,198.0,206.0,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH067~GEN02~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),202.0,202.0,,,200.0,204.0,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH067~AGE02~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),173.0,173.0,,,167.0,178.0,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH067~AGE04~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),197.0,197.0,,,194.0,200.0,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH067~AGE05~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),214.0,214.0,,,210.0,217.0,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH067~AGE06~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),208.0,208.0,,,205.0,212.0,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH067~AGE07~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),209.0,209.0,,,206.0,212.0,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH067~AGE08~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),208.0,208.0,,,203.0,213.0,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH067~RAC01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),203.0,203.0,,,200.0,206.0,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH067~RAC02~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),197.0,197.0,,,192.0,202.0,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH067~RAC03~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH067~RAC04~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH067~RAC07~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),211.0,211.0,,,204.0,218.0,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH067~OVR01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),202.0,202.0,,,200.0,203.0,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH067~GEN01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),201.0,201.0,,,199.0,202.0,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH067~GEN02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),202.0,202.0,,,200.0,205.0,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH067~AGE02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),173.0,173.0,,,169.0,177.0,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH067~AGE04~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),199.0,199.0,,,197.0,201.0,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH067~AGE05~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),210.0,210.0,,,207.0,213.0,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH067~AGE06~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),206.0,206.0,,,204.0,208.0,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH067~AGE07~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),208.0,208.0,,,205.0,210.0,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH067~AGE08~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),204.0,204.0,,,200.0,208.0,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH067~RAC01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),203.0,203.0,,,201.0,205.0,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH067~RAC02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),195.0,195.0,,,193.0,198.0,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH067~RAC03~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH067~RAC04~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH067~RAC07~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),196.0,196.0,,,190.0,202.0,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH067~OVR01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),199.0,199.0,,,197.0,200.0,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH067~GEN01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),196.0,196.0,,,194.0,198.0,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH067~GEN02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),201.0,201.0,,,199.0,203.0,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH067~AGE02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),174.0,174.0,,,170.0,177.0,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH067~AGE04~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),196.0,196.0,,,193.0,199.0,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH067~AGE05~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),208.0,208.0,,,206.0,211.0,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH067~AGE06~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),197.0,197.0,,,194.0,200.0,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH067~AGE07~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),203.0,203.0,,,202.0,205.0,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH067~AGE08~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),192.0,192.0,,,187.0,198.0,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH067~RAC01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),200.0,200.0,,,198.0,201.0,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH067~RAC02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),190.0,190.0,,,188.0,192.0,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH067~RAC03~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH067~RAC04~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH067~RAC07~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),200.0,200.0,,,194.0,206.0,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH067~OVR01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),197.0,197.0,,,196.0,199.0,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH067~GEN01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),195.0,195.0,,,192.0,197.0,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH067~GEN02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),200.0,200.0,,,197.0,202.0,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH067~AGE02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),176.0,176.0,,,170.0,182.0,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH067~AGE04~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),194.0,194.0,,,192.0,197.0,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH067~AGE05~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),206.0,206.0,,,203.0,209.0,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH067~AGE06~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),194.0,194.0,,,192.0,197.0,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH067~AGE07~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),202.0,202.0,,,200.0,204.0,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH067~AGE08~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),194.0,194.0,,,191.0,197.0,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH067~RAC01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),198.0,198.0,,,196.0,200.0,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH067~RAC02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),192.0,192.0,,,189.0,196.0,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH067~RAC03~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH067~RAC04~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH067~RAC07~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),198.0,198.0,,,192.0,203.0,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH067~OVR01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),196.0,196.0,,,194.0,198.0,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH067~GEN01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),194.0,194.0,,,192.0,196.0,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH067~GEN02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),198.0,198.0,,,196.0,200.0,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH067~AGE02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),172.0,172.0,,,168.0,176.0,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH067~AGE04~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),193.0,193.0,,,191.0,194.0,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH067~AGE05~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),207.0,207.0,,,203.0,211.0,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH067~AGE06~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),193.0,193.0,,,189.0,197.0,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH067~AGE07~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),202.0,202.0,,,199.0,204.0,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH067~AGE08~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),189.0,189.0,,,186.0,193.0,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH067~RAC01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),197.0,197.0,,,195.0,199.0,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH067~RAC02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),190.0,190.0,,,187.0,193.0,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH067~RAC03~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH067~RAC04~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH067~RAC07~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),194.0,194.0,,,186.0,201.0,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH067~OVR01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),195.0,195.0,,,193.0,197.0,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH067~GEN01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),191.0,191.0,,,189.0,193.0,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH067~GEN02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),199.0,199.0,,,197.0,202.0,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH067~AGE02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),174.0,174.0,,,171.0,178.0,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH067~AGE04~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),191.0,191.0,,,189.0,192.0,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH067~AGE05~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),206.0,206.0,,,203.0,209.0,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH067~AGE06~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),193.0,193.0,,,189.0,197.0,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH067~AGE07~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),201.0,201.0,,,198.0,203.0,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH067~AGE08~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),190.0,190.0,,,185.0,194.0,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH067~RAC01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),197.0,197.0,,,194.0,200.0,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH067~RAC02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),189.0,189.0,,,187.0,191.0,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH067~RAC03~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),191.0,191.0,,,188.0,194.0,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH067~RAC04~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),194.0,194.0,,,191.0,197.0,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH067~RAC07~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),191.0,191.0,,,187.0,194.0,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH067~OVR01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),189.0,189.0,,,188.0,191.0,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH067~GEN01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),186.0,186.0,,,184.0,188.0,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH067~GEN02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),192.0,192.0,,,191.0,194.0,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH067~AGE02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),170.0,170.0,,,166.0,174.0,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH067~AGE04~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),187.0,187.0,,,185.0,190.0,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH067~AGE05~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),199.0,199.0,,,196.0,201.0,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH067~AGE06~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),185.0,185.0,,,181.0,188.0,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH067~AGE07~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),194.0,194.0,,,193.0,195.0,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH067~AGE08~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),182.0,182.0,,,177.0,187.0,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH067~RAC01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),190.0,190.0,,,188.0,192.0,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH067~RAC02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),183.0,183.0,,,180.0,186.0,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH067~RAC03~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),191.0,191.0,,,187.0,194.0,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH067~RAC04~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),192.0,192.0,,,188.0,195.0,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH067~RAC07~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),187.0,187.0,,,185.0,190.0,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH067~OVR01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),192.0,192.0,,,190.0,195.0,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH067~GEN01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),189.0,189.0,,,186.0,193.0,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH067~GEN02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),195.0,195.0,,,192.0,198.0,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH067~AGE02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),168.0,168.0,,,164.0,171.0,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH067~AGE04~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),186.0,186.0,,,184.0,189.0,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH067~AGE05~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),205.0,205.0,,,200.0,209.0,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH067~AGE06~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),191.0,191.0,,,188.0,194.0,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH067~AGE07~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),198.0,198.0,,,195.0,201.0,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH067~AGE08~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),187.0,187.0,,,185.0,189.0,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH067~RAC01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),194.0,194.0,,,191.0,197.0,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH067~RAC02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),185.0,185.0,,,182.0,189.0,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH067~RAC03~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),191.0,191.0,,,186.0,195.0,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH067~RAC04~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),190.0,190.0,,,188.0,193.0,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH067~RAC07~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),192.0,192.0,,,187.0,196.0,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH067~OVR01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),189.0,189.0,,,185.0,192.0,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH067~GEN01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),185.0,185.0,,,181.0,189.0,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH067~GEN02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),192.0,192.0,,,189.0,196.0,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH067~AGE02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),168.0,168.0,,,164.0,172.0,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH067~AGE04~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),186.0,186.0,,,182.0,189.0,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH067~AGE05~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),199.0,199.0,,,194.0,203.0,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH067~AGE06~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),185.0,185.0,,,181.0,190.0,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH067~AGE07~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),193.0,193.0,,,190.0,197.0,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH067~AGE08~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),181.0,181.0,,,176.0,186.0,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH067~RAC01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),189.0,189.0,,,185.0,194.0,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH067~RAC02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),185.0,185.0,,,182.0,189.0,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH067~RAC03~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),192.0,192.0,,,187.0,197.0,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH067~RAC04~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),188.0,188.0,,,184.0,193.0,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH067~RAC07~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),191.0,191.0,,,186.0,195.0,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH068~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US children/adolescents (12-19); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH068,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH068~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US children/adolescents (12-19); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH068,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH068~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US children/adolescents (12-19); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH068,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH068~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US children/adolescents (12-19); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH068,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH068~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US children/adolescents (12-19); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH068,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH068~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US children/adolescents (12-19); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH068,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH068~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US children/adolescents (12-19); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH068,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH068~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US children/adolescents (12-19); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH068,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH068~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US children/adolescents (12-19); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH068,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH068~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US children/adolescents (12-19); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH068,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH070~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),8.8,8.8,,,7.7,10.0,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH070~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),8.3,8.3,,,7.3,9.5,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH070~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),8.8,8.8,,,7.5,10.4,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH070~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.7,9.7,,,8.2,11.4,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH070~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),7.9,7.9,,,6.6,9.3,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH070~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),8.0,8.0,,,6.8,9.4,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH070~AGE01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),0.1,0.1,,,0.0,0.2,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
NHANES~1999-2000~59~NH070~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),3.2,3.2,,,2.2,4.7,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH070~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.7,13.7,,,11.5,16.4,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH070~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),20.1,20.1,,,17.1,23.5,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH070~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.1,12.1,,,10.5,13.9,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH070~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),18.5,18.5,,,13.8,24.3,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH070~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),7.5,7.5,,,6.4,8.9,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH070~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),7.3,7.3,,,6.2,8.6,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH070~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),14.9,14.9,,,13.1,16.8,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH070~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.0,12.0,,,10.4,13.9,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH070~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH070~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH070~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH070~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH070~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.1,15.1,,,8.5,25.3,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH070~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH070~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.6,9.6,,,8.5,10.8,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH070~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.2,9.2,,,8.2,10.3,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH070~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.5,10.5,,,9.0,12.3,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH070~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.9,9.9,,,8.5,11.5,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH070~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),8.7,8.7,,,7.6,10.0,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH070~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),8.6,8.6,,,7.5,9.7,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH070~AGE01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),1.0,1.0,,,0.4,2.4,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
NHANES~2001-2002~59~NH070~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),4.4,4.4,,,3.2,5.9,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH070~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.8,12.8,,,10.5,15.6,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH070~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),22.4,22.4,,,21.0,23.9,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH070~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.6,12.6,,,11.4,13.9,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH070~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),21.9,21.9,,,18.4,25.7,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH070~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),8.1,8.1,,,7.4,9.0,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH070~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),7.9,7.9,,,7.0,8.8,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH070~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.5,12.5,,,10.2,15.3,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH070~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),14.4,14.4,,,12.4,16.6,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH070~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH070~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH070~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH070~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH070~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.9,16.9,,,10.0,27.2,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH070~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),14.1,14.1,,,8.4,22.7,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH070~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.5,10.5,,,9.5,11.6,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH070~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.5,10.5,,,9.4,11.8,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH070~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.1,11.1,,,9.7,12.6,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH070~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),11.4,11.4,,,10.2,12.8,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH070~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.7,9.7,,,8.6,10.9,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH070~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.0,10.0,,,8.8,11.4,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH070~AGE01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),1.2,1.2,,,0.6,2.4,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH070~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),4.1,4.1,,,3.2,5.3,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH070~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.1,15.1,,,13.1,17.2,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH070~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),24.4,24.4,,,20.9,28.2,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH070~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),14.6,14.6,,,13.2,16.3,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH070~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),20.6,20.6,,,17.3,24.2,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH070~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.8,9.8,,,8.5,11.2,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH070~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.1,9.1,,,7.9,10.3,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH070~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),14.4,14.4,,,12.2,16.9,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH070~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.9,12.9,,,11.0,15.0,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH070~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH070~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH070~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH070~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH070~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.0,15.0,,,10.4,21.0,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH070~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.6,16.6,,,11.5,23.2,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH070~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.0,10.0,,,9.1,11.0,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH070~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.2,10.2,,,9.0,11.4,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH070~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.2,10.2,,,9.0,11.5,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH070~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.0,10.0,,,8.6,11.6,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH070~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.8,9.8,,,8.5,11.3,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH070~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.3,10.3,,,8.8,12.0,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH070~AGE01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),0.3,0.3,,,0.1,1.2,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH070~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),5.2,5.2,,,4.0,6.6,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH070~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.1,13.1,,,11.0,15.5,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH070~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),23.3,23.3,,,21.0,25.7,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH070~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.8,13.8,,,12.4,15.4,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH070~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),21.1,21.1,,,18.1,24.4,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH070~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),8.2,8.2,,,7.1,9.3,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH070~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.0,9.0,,,7.6,10.7,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH070~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.0,15.0,,,12.6,17.7,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH070~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.8,16.8,,,15.0,18.8,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH070~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH070~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH070~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH070~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH070~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),11.4,11.4,,,7.9,16.2,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH070~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.9,9.9,,,7.1,13.7,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH070~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.1,12.1,,,10.7,13.7,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH070~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),11.8,11.8,,,10.4,13.4,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH070~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.7,12.7,,,11.4,14.2,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH070~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),12.9,12.9,,,11.5,14.5,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH070~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.5,11.5,,,9.6,13.8,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH070~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),11.0,11.0,,,9.2,13.0,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH070~AGE01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),1.0,1.0,,,0.8,1.4,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH070~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),4.6,4.6,,,3.8,5.7,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH070~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.4,16.4,,,14.0,19.1,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH070~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),28.4,28.4,,,24.5,32.6,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH070~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.3,16.3,,,14.3,18.5,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH070~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),27.1,27.1,,,23.2,31.4,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH070~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.1,11.1,,,8.9,13.7,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH070~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.1,10.1,,,8.2,12.5,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH070~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),18.2,18.2,,,16.2,20.5,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH070~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),19.6,19.6,,,18.0,21.2,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH070~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH070~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH070~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH070~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH070~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.6,12.6,,,8.2,18.8,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH070~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),13.3,13.3,,,9.6,18.3,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH070~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.9,11.9,,,10.7,13.2,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH070~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),11.4,11.4,,,10.2,12.7,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH070~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.1,13.1,,,11.4,15.1,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH070~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),13.0,13.0,,,11.2,14.9,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH070~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.8,10.8,,,9.7,11.9,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH070~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.0,10.0,,,8.9,11.1,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH070~AGE01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),0.9,0.9,,,0.3,2.6,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH070~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),4.3,4.3,,,3.3,5.5,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH070~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.9,15.9,,,13.6,18.5,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH070~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),28.0,28.0,,,24.9,31.3,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH070~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.1,16.1,,,14.4,17.8,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH070~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),27.9,27.9,,,24.3,31.8,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH070~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.4,9.4,,,8.1,10.9,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH070~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.7,10.7,,,9.1,12.6,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH070~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.7,15.7,,,13.6,18.1,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH070~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.9,16.9,,,15.4,18.5,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH070~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH070~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH070~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH070~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH070~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.3,13.3,,,10.2,17.0,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH070~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.3,16.3,,,12.9,20.3,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH070~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),11.5,11.5,,,10.4,12.8,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH070~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.2,12.2,,,10.9,13.7,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH070~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),12.3,12.3,,,10.6,14.4,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH070~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.7,12.7,,,10.7,15.1,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH070~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,9.4,12.4,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH070~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.7,11.7,,,10.2,13.5,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH070~AGE01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),1.0,1.0,,,0.5,1.9,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH070~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),5.6,5.6,,,4.3,7.1,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH070~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.2,16.2,,,14.2,18.5,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH070~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),25.9,25.9,,,23.2,28.8,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH070~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.7,16.7,,,15.0,18.4,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH070~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),26.9,26.9,,,23.0,31.1,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH070~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),8.9,8.9,,,7.9,10.1,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH070~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.4,10.4,,,8.9,12.0,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH070~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),17.8,17.8,,,14.4,21.7,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH070~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),18.7,18.7,,,15.6,22.2,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH070~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.3,13.3,,,10.3,17.0,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH070~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),14.2,14.2,,,11.5,17.3,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH070~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),14.2,14.2,,,11.8,17.1,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH070~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),17.6,17.6,,,15.0,20.6,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH070~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.6,16.6,,,12.7,21.3,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH070~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.6,15.6,,,11.3,21.3,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH070~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.1,13.1,,,12.0,14.2,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH070~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),12.2,12.2,,,11.2,13.3,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH070~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.8,13.8,,,12.3,15.5,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH070~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),13.2,13.2,,,11.8,14.8,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH070~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),11.4,11.4,,,10.3,12.5,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH070~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.4,12.4,,,11.2,13.6,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH070~AGE01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),1.4,1.4,,,0.5,3.8,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH070~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),5.4,5.4,,,4.6,6.2,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH070~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),17.7,17.7,,,15.2,20.5,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH070~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),27.5,27.5,,,25.1,30.1,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH070~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),17.8,17.8,,,16.3,19.4,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH070~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),28.3,28.3,,,24.1,33.0,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH070~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.6,10.6,,,9.3,12.2,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH070~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.4,12.4,,,11.0,14.0,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH070~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.1,16.1,,,14.4,18.0,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH070~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.5,16.5,,,14.3,19.0,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH070~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.5,15.5,,,12.6,18.8,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH070~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.8,15.8,,,13.7,18.1,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH070~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.8,16.8,,,15.1,18.7,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH070~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.2,13.2,,,11.5,14.9,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH070~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.9,13.9,,,11.3,17.1,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH070~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.0,15.0,,,12.4,18.1,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH070~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),14.7,14.7,,,12.9,16.7,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH070~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),13.6,13.6,,,12.0,15.4,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH070~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.5,15.5,,,13.2,18.1,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH070~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.5,16.5,,,14.1,19.1,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH070~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),11.9,11.9,,,10.3,13.7,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH070~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.1,13.1,,,11.2,15.3,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH070~AGE01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),2.0,2.0,,,0.9,4.3,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH070~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),6.4,6.4,,,5.1,8.1,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH070~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),19.2,19.2,,,16.3,22.4,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH070~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),28.5,28.5,,,25.3,31.9,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH070~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),19.7,19.7,,,17.4,22.1,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH070~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),26.0,26.0,,,22.1,30.2,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH070~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.6,13.6,,,11.7,15.8,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH070~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),11.5,11.5,,,9.8,13.5,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH070~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),18.0,18.0,,,15.8,20.4,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH070~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),17.7,17.7,,,15.2,20.5,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH070~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),14.7,14.7,,,11.3,18.9,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH070~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.3,15.3,,,12.7,18.2,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH070~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.9,16.9,,,13.2,21.2,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH070~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),19.9,19.9,,,16.8,23.4,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH070~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.0,15.0,,,12.0,18.7,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH070~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.1,15.1,,,12.1,18.7,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH070~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),14.9,14.9,,,13.8,16.0,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH070~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),13.6,13.6,,,12.5,14.9,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH070~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.0,16.0,,,14.2,17.9,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH070~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),14.9,14.9,,,13.3,16.7,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH070~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.9,13.9,,,11.9,16.1,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH070~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),12.6,12.6,,,10.5,15.0,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH070~AGE01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),1.9,1.9,,,1.0,3.4,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH070~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),5.7,5.7,,,4.4,7.3,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH070~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),19.3,19.3,,,16.6,22.4,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH070~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),30.9,30.9,,,27.6,34.4,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH070~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),20.2,20.2,,,18.7,21.8,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH070~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),33.6,33.6,,,30.1,37.2,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH070~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),12.1,12.1,,,10.6,13.7,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH070~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),14.2,14.2,,,12.8,15.7,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH070~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.9,16.9,,,14.8,19.2,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH070~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.9,16.9,,,14.9,19.1,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH070~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),17.4,17.4,,,15.2,19.9,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH070~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),17.7,17.7,,,15.2,20.5,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH070~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),14.6,14.6,,,12.8,16.6,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH070~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),17.3,17.3,,,15.6,19.1,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH070~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),17.0,17.0,,,14.6,19.6,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH070~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),17.0,17.0,,,15.2,19.0,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH073~OVR01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3635.0,3635.0,,,3572.0,3699.0,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH073~GEN01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),4283.0,4283.0,,,4180.0,4387.0,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH073~GEN02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3034.0,3034.0,,,2963.0,3104.0,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH073~AGE01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3865.0,3865.0,,,3701.0,4030.0,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH073~AGE04~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3929.0,3929.0,,,3812.0,4047.0,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH073~AGE05~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3540.0,3540.0,,,3430.0,3650.0,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH073~AGE06~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2987.0,2987.0,,,2885.0,3088.0,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH073~AGE07~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3469.0,3469.0,,,3388.0,3549.0,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH073~AGE08~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2740.0,2740.0,,,2636.0,2844.0,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH073~RAC01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3679.0,3679.0,,,3593.0,3765.0,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH073~RAC02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3350.0,3350.0,,,3139.0,3561.0,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH073~RAC03~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH073~RAC04~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH073~RAC07~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3820.0,3820.0,,,3481.0,4159.0,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH073~OVR01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3701.0,3701.0,,,3601.0,3802.0,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH073~GEN01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),4382.0,4382.0,,,4262.0,4501.0,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH073~GEN02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3071.0,3071.0,,,2969.0,3172.0,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH073~AGE01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3784.0,3784.0,,,3622.0,3946.0,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH073~AGE04~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),4058.0,4058.0,,,3946.0,4170.0,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH073~AGE05~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3608.0,3608.0,,,3461.0,3755.0,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH073~AGE06~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3065.0,3065.0,,,2911.0,3219.0,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH073~AGE07~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3603.0,3603.0,,,3491.0,3714.0,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH073~AGE08~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2815.0,2815.0,,,2713.0,2918.0,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH073~RAC01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3769.0,3769.0,,,3650.0,3887.0,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH073~RAC02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3504.0,3504.0,,,3327.0,3681.0,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH073~RAC03~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH073~RAC04~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH073~RAC07~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3715.0,3715.0,,,3471.0,3960.0,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH073~OVR01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3599.0,3599.0,,,3481.0,3718.0,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH073~GEN01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),4243.0,4243.0,,,4074.0,4411.0,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH073~GEN02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3021.0,3021.0,,,2935.0,3108.0,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH073~AGE01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3793.0,3793.0,,,3501.0,4085.0,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH073~AGE04~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3842.0,3842.0,,,3712.0,3972.0,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH073~AGE05~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3589.0,3589.0,,,3419.0,3759.0,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH073~AGE06~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2917.0,2917.0,,,2806.0,3028.0,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH073~AGE07~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3520.0,3520.0,,,3387.0,3653.0,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH073~AGE08~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2738.0,2738.0,,,2573.0,2904.0,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH073~RAC01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3653.0,3653.0,,,3512.0,3794.0,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH073~RAC02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3419.0,3419.0,,,3251.0,3588.0,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH073~RAC03~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH073~RAC04~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH073~RAC07~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3719.0,3719.0,,,3280.0,4158.0,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH073~OVR01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3594.0,3594.0,,,3538.0,3651.0,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH073~GEN01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),4255.0,4255.0,,,4168.0,4341.0,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH073~GEN02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2976.0,2976.0,,,2921.0,3031.0,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH073~AGE01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3749.0,3749.0,,,3562.0,3936.0,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH073~AGE04~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3777.0,3777.0,,,3689.0,3865.0,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH073~AGE05~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3640.0,3640.0,,,3543.0,3737.0,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH073~AGE06~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2992.0,2992.0,,,2880.0,3104.0,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH073~AGE07~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3507.0,3507.0,,,3438.0,3576.0,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH073~AGE08~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2741.0,2741.0,,,2593.0,2889.0,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH073~RAC01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3631.0,3631.0,,,3565.0,3697.0,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH073~RAC02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3352.0,3352.0,,,3235.0,3469.0,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH073~RAC03~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH073~RAC04~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH073~RAC07~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3994.0,3994.0,,,3668.0,4319.0,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH073~OVR01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3618.0,3618.0,,,3566.0,3670.0,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH073~GEN01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),4255.0,4255.0,,,4168.0,4342.0,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH073~GEN02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3002.0,3002.0,,,2931.0,3072.0,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH073~AGE01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),4081.0,4081.0,,,3816.0,4346.0,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH073~AGE04~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3833.0,3833.0,,,3701.0,3965.0,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH073~AGE05~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3507.0,3507.0,,,3368.0,3646.0,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH073~AGE06~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3048.0,3048.0,,,2949.0,3147.0,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH073~AGE07~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3474.0,3474.0,,,3389.0,3558.0,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH073~AGE08~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2861.0,2861.0,,,2726.0,2995.0,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH073~RAC01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3607.0,3607.0,,,3532.0,3682.0,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH073~RAC02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3544.0,3544.0,,,3413.0,3675.0,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH073~RAC03~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3841.0,3841.0,,,3606.0,4076.0,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH073~RAC04~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3666.0,3666.0,,,3518.0,3814.0,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH073~RAC07~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3728.0,3728.0,,,3528.0,3928.0,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH073~OVR01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3534.0,3534.0,,,3472.0,3595.0,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH073~GEN01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),4097.0,4097.0,,,3997.0,4196.0,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH073~GEN02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3002.0,3002.0,,,2953.0,3051.0,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH073~AGE01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3796.0,3796.0,,,3575.0,4017.0,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH073~AGE04~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3770.0,3770.0,,,3709.0,3830.0,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH073~AGE05~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3469.0,3469.0,,,3332.0,3607.0,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH073~AGE06~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3014.0,3014.0,,,2925.0,3103.0,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH073~AGE07~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3401.0,3401.0,,,3323.0,3479.0,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH073~AGE08~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2935.0,2935.0,,,2767.0,3102.0,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH073~RAC01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3506.0,3506.0,,,3444.0,3568.0,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH073~RAC02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3535.0,3535.0,,,3387.0,3682.0,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH073~RAC03~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3654.0,3654.0,,,3412.0,3896.0,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH073~RAC04~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3615.0,3615.0,,,3476.0,3753.0,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH073~RAC07~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3605.0,3605.0,,,3415.0,3796.0,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH073~OVR01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3535.0,3535.0,,,3454.0,3616.0,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH073~GEN01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),4095.0,4095.0,,,3966.0,4224.0,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH073~GEN02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3013.0,3013.0,,,2938.0,3088.0,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH073~AGE01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3733.0,3733.0,,,3518.0,3948.0,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH073~AGE04~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3834.0,3834.0,,,3685.0,3982.0,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH073~AGE05~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3524.0,3524.0,,,3426.0,3623.0,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH073~AGE06~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2947.0,2947.0,,,2817.0,3076.0,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH073~AGE07~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3403.0,3403.0,,,3314.0,3491.0,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH073~AGE08~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2733.0,2733.0,,,2552.0,2915.0,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH073~RAC01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3515.0,3515.0,,,3408.0,3622.0,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH073~RAC02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3364.0,3364.0,,,3245.0,3483.0,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH073~RAC03~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3831.0,3831.0,,,3605.0,4058.0,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH073~RAC04~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3582.0,3582.0,,,3453.0,3711.0,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH073~RAC07~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3791.0,3791.0,,,3521.0,4061.0,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH073~OVR01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3531.0,3531.0,,,3453.0,3609.0,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH073~GEN01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),4115.0,4115.0,,,3998.0,4232.0,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH073~GEN02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),2988.0,2988.0,,,2896.0,3079.0,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH073~AGE01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3621.0,3621.0,,,3448.0,3794.0,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH073~AGE04~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3789.0,3789.0,,,3680.0,3899.0,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH073~AGE05~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3467.0,3467.0,,,3319.0,3615.0,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH073~AGE06~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3156.0,3156.0,,,3010.0,3303.0,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH073~AGE07~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3406.0,3406.0,,,3303.0,3509.0,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH073~AGE08~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3042.0,3042.0,,,2887.0,3196.0,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH073~RAC01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3523.0,3523.0,,,3400.0,3646.0,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH073~RAC02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3394.0,3394.0,,,3275.0,3513.0,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH073~RAC03~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3568.0,3568.0,,,3355.0,3782.0,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH073~RAC04~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3620.0,3620.0,,,3467.0,3773.0,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH073~RAC07~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),3591.0,3591.0,,,3373.0,3809.0,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH074~OVR01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake among US children/adolescents (2-17); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Overall,Overall,C2,T12,NH074,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH074~OVR01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake among US children/adolescents (2-17); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Overall,Overall,C2,T12,NH074,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH074~OVR01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake among US children/adolescents (2-17); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Overall,Overall,C2,T12,NH074,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH074~OVR01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake among US children/adolescents (2-17); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Overall,Overall,C2,T12,NH074,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH074~OVR01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake among US children/adolescents (2-17); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Overall,Overall,C2,T12,NH074,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH074~OVR01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake among US children/adolescents (2-17); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Overall,Overall,C2,T12,NH074,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH074~OVR01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake among US children/adolescents (2-17); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Overall,Overall,C2,T12,NH074,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH074~OVR01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake among US children/adolescents (2-17); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Overall,Overall,C2,T12,NH074,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH074~OVR01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake among US children/adolescents (2-17); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Overall,Overall,C2,T12,NH074,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH074~OVR01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Nutrition,Mean dietary sodium intake among US children/adolescents (2-17); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Overall,Overall,C2,T12,NH074,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH071~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),30.4,30.4,,,27.5,33.4,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH071~OVR01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.0,30.0,,,27.3,33.0,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH071~GEN01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),26.5,26.5,,,23.7,29.5,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH071~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),26.9,26.9,,,24.0,30.1,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH071~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),33.5,33.5,,,30.1,37.1,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH071~GEN02~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.3,33.3,,,30.0,36.7,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH071~AGE02~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),19.3,19.3,,,14.8,24.9,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH071~AGE04~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),28.6,28.6,,,25.4,32.1,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH071~AGE05~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.6,35.6,,,30.6,40.8,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH071~AGE06~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.8,30.8,,,27.0,34.9,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH071~AGE07~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.5,32.5,,,28.9,36.3,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH071~AGE08~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),23.2,23.2,,,18.9,28.1,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH071~RAC01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),28.3,28.3,,,24.9,31.9,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH071~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),28.3,28.3,,,24.8,32.0,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH071~RAC02~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),39.4,39.4,,,36.2,42.7,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH071~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),39.8,39.8,,,36.5,43.1,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH071~RAC03~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH071~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH071~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH071~RAC04~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH071~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),30.0,30.0,,,19.1,43.7,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH071~RAC07~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH071~OVR01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.2,30.2,,,28.0,32.4,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH071~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),30.2,30.2,,,28.0,32.5,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH071~GEN01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),27.2,27.2,,,25.1,29.3,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH071~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),27.1,27.1,,,25.1,29.3,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH071~GEN02~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.9,32.9,,,30.1,35.9,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH071~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),33.0,33.0,,,30.1,36.0,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH071~AGE02~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),24.9,24.9,,,19.5,31.3,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH071~AGE04~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),28.2,28.2,,,25.5,31.1,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH071~AGE05~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.2,35.2,,,31.8,38.8,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH071~AGE06~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),28.1,28.1,,,25.6,30.7,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH071~AGE07~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.3,32.3,,,29.5,35.2,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH071~AGE08~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),18.9,18.9,,,14.7,24.0,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH071~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),29.8,29.8,,,27.3,32.3,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH071~RAC01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.1,30.1,,,27.7,32.5,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH071~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),38.7,38.7,,,35.2,42.3,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH071~RAC02~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),38.0,38.0,,,34.3,41.9,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH071~RAC03~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH071~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH071~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH071~RAC04~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH071~RAC07~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH071~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH071~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.1,32.1,,,29.8,34.5,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH071~OVR01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.2,32.2,,,29.9,34.6,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH071~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),30.8,30.8,,,28.3,33.4,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH071~GEN01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.8,30.8,,,28.4,33.4,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH071~GEN02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.5,33.5,,,30.3,36.8,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH071~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),33.4,33.4,,,30.2,36.7,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH071~AGE02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),25.4,25.4,,,21.3,30.0,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH071~AGE04~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.0,32.0,,,29.2,35.0,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH071~AGE05~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.7,35.7,,,31.6,39.9,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH071~AGE06~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),29.7,29.7,,,26.5,33.2,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH071~AGE07~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),34.3,34.3,,,32.1,36.7,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH071~AGE08~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),23.5,23.5,,,19.5,28.1,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH071~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),30.5,30.5,,,28.1,33.1,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH071~RAC01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.9,30.9,,,28.5,33.4,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH071~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),45.1,45.1,,,41.0,49.1,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH071~RAC02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),45.1,45.1,,,40.9,49.2,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH071~RAC03~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH071~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH071~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH071~RAC04~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH071~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),18.9,18.9,,,12.4,27.8,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH071~RAC07~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),19.0,19.0,,,11.5,29.7,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH071~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),34.1,34.1,,,31.5,36.8,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH071~OVR01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),34.3,34.3,,,31.5,37.1,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH071~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,28.9,36.8,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH071~GEN01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.9,32.9,,,28.9,37.2,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH071~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),35.4,35.4,,,32.8,38.0,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH071~GEN02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.5,35.5,,,32.9,38.3,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH071~AGE02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),25.1,25.1,,,18.3,33.3,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH071~AGE04~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.0,33.0,,,29.1,37.3,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH071~AGE05~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),40.3,40.3,,,35.8,44.8,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH071~AGE06~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.4,30.4,,,27.5,33.5,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH071~AGE07~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),36.5,36.5,,,33.6,39.4,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH071~AGE08~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),24.7,24.7,,,20.5,29.5,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH071~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,29.6,35.9,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH071~RAC01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.2,33.2,,,30.1,36.5,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH071~RAC02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),45.3,45.3,,,41.9,48.7,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH071~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),45.8,45.8,,,42.6,49.0,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH071~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH071~RAC03~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH071~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH071~RAC04~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH071~RAC07~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),26.2,26.2,,,18.4,35.8,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH071~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),25.6,25.6,,,18.6,34.2,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH071~OVR01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.7,33.7,,,31.5,36.0,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH071~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),33.6,33.6,,,31.4,35.8,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH071~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.0,32.0,,,29.4,34.8,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH071~GEN01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.0,32.0,,,29.2,34.9,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH071~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),35.2,35.2,,,32.8,37.6,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH071~GEN02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.2,35.2,,,33.0,37.5,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH071~AGE02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),26.5,26.5,,,19.8,34.5,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH071~AGE04~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.8,32.8,,,29.2,36.6,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH071~AGE05~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),37.3,37.3,,,34.2,40.6,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH071~AGE06~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),31.9,31.9,,,29.0,35.0,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH071~AGE07~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.6,35.6,,,33.3,38.1,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH071~AGE08~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),26.2,26.2,,,22.5,30.3,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH071~RAC01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.6,32.6,,,29.3,36.1,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH071~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.2,32.2,,,28.7,35.9,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH071~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),43.7,43.7,,,39.8,47.7,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH071~RAC02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),43.6,43.6,,,39.6,47.6,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH071~RAC03~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH071~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH071~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH071~RAC04~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH071~RAC07~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),19.4,19.4,,,11.5,30.8,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH071~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),19.1,19.1,,,11.3,30.5,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH071~OVR01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.8,35.8,,,34.0,37.7,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH071~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),35.7,35.7,,,33.9,37.5,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH071~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),35.2,35.2,,,31.9,38.7,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH071~GEN01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.3,35.3,,,31.9,38.8,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH071~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),36.0,36.0,,,34.3,37.7,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH071~GEN02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),36.3,36.3,,,34.5,38.2,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH071~AGE02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),23.8,23.8,,,17.9,30.9,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH071~AGE04~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.0,35.0,,,32.5,37.6,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH071~AGE05~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),39.0,39.0,,,36.2,41.9,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH071~AGE06~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),37.4,37.4,,,34.3,40.7,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH071~AGE07~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),38.4,38.4,,,36.6,40.2,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH071~AGE08~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),28.8,28.8,,,24.9,33.1,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH071~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),34.2,34.2,,,31.9,36.5,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH071~RAC01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),34.7,34.7,,,32.4,37.1,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH071~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),49.8,49.8,,,45.3,54.4,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH071~RAC02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),49.9,49.9,,,45.1,54.8,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH071~RAC03~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH071~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH071~RAC04~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH071~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH071~RAC07~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),19.8,19.8,,,15.8,24.4,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH071~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),19.5,19.5,,,15.5,24.2,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH071~OVR01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.1,35.1,,,32.4,37.9,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH071~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),34.9,34.9,,,32.2,37.7,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH071~GEN01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.7,33.7,,,31.1,36.4,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH071~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),33.5,33.5,,,30.9,36.3,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH071~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),36.1,36.1,,,32.8,39.5,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH071~GEN02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),36.4,36.4,,,33.0,39.9,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH071~AGE02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),25.4,25.4,,,20.7,30.7,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH071~AGE04~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),34.2,34.2,,,31.2,37.3,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH071~AGE05~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),39.4,39.4,,,34.8,44.2,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH071~AGE06~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.4,33.4,,,29.5,37.6,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH071~AGE07~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),37.0,37.0,,,34.1,40.0,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH071~AGE08~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),28.7,28.7,,,24.4,33.4,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH071~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.6,32.6,,,29.3,36.2,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH071~RAC01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.3,33.3,,,29.9,36.9,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH071~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),47.8,47.8,,,44.5,51.2,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH071~RAC02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),47.8,47.8,,,44.4,51.2,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH071~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),10.7,10.7,,,8.2,13.8,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH071~RAC03~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),10.8,10.8,,,8.3,13.9,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH071~RAC04~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),42.0,42.0,,,38.4,45.7,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH071~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),42.5,42.5,,,39.2,45.9,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH071~RAC07~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),18.7,18.7,,,14.3,24.1,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH071~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),19.0,19.0,,,14.5,24.4,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH071~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),37.8,37.8,,,35.9,39.6,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH071~OVR01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),37.9,37.9,,,36.2,39.6,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH071~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),35.0,35.0,,,33.0,37.2,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH071~GEN01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.2,35.2,,,33.2,37.2,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH071~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),40.3,40.3,,,37.7,43.0,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH071~GEN02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),40.4,40.4,,,37.8,43.0,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH071~AGE02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),25.6,25.6,,,21.3,30.5,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH071~AGE04~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),39.1,39.1,,,36.5,41.8,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH071~AGE05~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),41.1,41.1,,,37.0,45.4,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH071~AGE06~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.9,35.9,,,32.0,40.0,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH071~AGE07~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),40.2,40.2,,,37.9,42.6,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH071~AGE08~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),29.3,29.3,,,25.1,33.9,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH071~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),36.4,36.4,,,34.2,38.7,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH071~RAC01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),37.1,37.1,,,35.0,39.1,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH071~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),47.8,47.8,,,43.6,52.0,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH071~RAC02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),47.8,47.8,,,43.7,51.9,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH071~RAC03~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),12.9,12.9,,,10.7,15.6,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH071~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),12.8,12.8,,,10.5,15.5,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH071~RAC04~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),42.9,42.9,,,38.8,47.2,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH071~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),42.8,42.8,,,38.7,47.0,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH071~RAC07~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),21.3,21.3,,,17.0,26.4,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH071~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),20.9,20.9,,,16.8,25.7,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH071~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),39.6,39.6,,,36.5,42.9,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH071~OVR01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),39.8,39.8,,,36.8,42.9,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH071~GEN01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),38.0,38.0,,,33.7,42.4,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH071~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),37.9,37.9,,,33.5,42.5,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH071~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),41.3,41.3,,,38.2,44.4,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH071~GEN02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),41.5,41.5,,,38.5,44.5,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH071~AGE02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.1,30.1,,,24.5,36.3,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH071~AGE04~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),39.3,39.3,,,35.1,43.8,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH071~AGE05~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),43.0,43.0,,,38.3,47.9,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH071~AGE06~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),39.1,39.1,,,35.3,43.0,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH071~AGE07~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),42.0,42.0,,,38.5,45.5,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH071~AGE08~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.0,32.0,,,26.2,38.4,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH071~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),38.0,38.0,,,34.5,41.7,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH071~RAC01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),38.7,38.7,,,35.5,42.0,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH071~RAC02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),46.8,46.8,,,42.4,51.2,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH071~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),46.8,46.8,,,42.4,51.3,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH071~RAC03~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),12.9,12.9,,,10.9,15.3,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH071~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),12.8,12.8,,,10.8,15.2,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH071~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),47.1,47.1,,,43.0,51.3,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH071~RAC04~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),46.9,46.9,,,42.9,50.9,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH071~RAC07~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),27.7,27.7,,,21.5,35.0,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH071~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),27.7,27.7,,,21.3,35.1,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH071~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),42.6,42.6,,,39.3,46.1,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH071~OVR01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),42.7,42.7,,,39.3,46.1,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH071~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),43.0,43.0,,,37.8,48.3,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH071~GEN01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),43.0,43.0,,,37.9,48.2,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH071~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),42.3,42.3,,,38.7,46.0,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH071~GEN02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),42.4,42.4,,,38.7,46.2,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH071~AGE02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),34.2,34.2,,,26.0,43.5,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH071~AGE04~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),43.3,43.3,,,39.7,47.0,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH071~AGE05~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),45.0,45.0,,,40.9,49.2,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH071~AGE06~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),41.3,41.3,,,36.3,46.5,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH071~AGE07~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),43.8,43.8,,,41.0,46.6,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH071~AGE08~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),36.7,36.7,,,31.6,42.1,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH071~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),42.5,42.5,,,37.7,47.3,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH071~RAC01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),42.9,42.9,,,38.2,47.8,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH071~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),49.8,49.8,,,46.9,52.8,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH071~RAC02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),49.5,49.5,,,46.6,52.4,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH071~RAC03~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),17.6,17.6,,,15.4,20.0,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH071~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),17.5,17.5,,,15.3,19.9,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH071~RAC04~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),45.0,45.0,,,41.9,48.3,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH071~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),45.0,45.0,,,42.1,47.8,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH071~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),30.2,30.2,,,25.5,35.4,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH071~RAC07~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.4,30.4,,,25.6,35.6,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH072~OVR01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US children/adolescents (2-19); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH072~OVR01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US children/adolescents (2-19); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH072~OVR01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US children/adolescents (2-19); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH072~OVR01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US children/adolescents (2-19); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH072~OVR01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US children/adolescents (2-19); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH072~OVR01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US children/adolescents (2-19); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH072~OVR01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US children/adolescents (2-19); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH072~OVR01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US children/adolescents (2-19); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH072~OVR01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US children/adolescents (2-19); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH072~OVR01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Obesity,Prevalence of obesity among US children/adolescents (2-19); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH075~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T15,NH075,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH075~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T15,NH075,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH075~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T15,NH075,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH075~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T15,NH075,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH075~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T15,NH075,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH075~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T15,NH075,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH075~AGE02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T15,NH075,Crude,BOC03,AGE02,59,
NHANES~1999-2000~59~NH075~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T15,NH075,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH075~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T15,NH075,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH075~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T15,NH075,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH075~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T15,NH075,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH075~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T15,NH075,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH075~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T15,NH075,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH075~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T15,NH075,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH075~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T15,NH075,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH075~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T15,NH075,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH075~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH075~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH075~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH075,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH075~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH075,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH075~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T15,NH075,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH075~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T15,NH075,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH075~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T15,NH075,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH075~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Overall,Overall,C2,T15,NH075,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH075~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T15,NH075,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH075~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Male,C2,T15,NH075,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH075~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T15,NH075,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH075~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Gender,Female,C2,T15,NH075,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH075~AGE02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,20-24,C2,T15,NH075,Crude,BOC03,AGE02,59,
NHANES~2001-2002~59~NH075~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,25-44,C2,T15,NH075,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH075~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,45-64,C2,T15,NH075,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH075~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,65+,C2,T15,NH075,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH075~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,35+,C2,T15,NH075,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH075~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T15,NH075,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH075~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T15,NH075,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH075~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic White,C2,T15,NH075,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH075~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T15,NH075,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH075~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Black,C2,T15,NH075,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH075~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH075~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH075~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH075,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH075~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH075,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH075~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T15,NH075,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH075~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T15,NH075,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH075~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),31.4,31.4,,,28.7,34.2,Overall,Overall,C2,T15,NH075,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH075~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),31.3,31.3,,,28.6,34.2,Overall,Overall,C2,T15,NH075,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH075~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),38.7,38.7,,,34.7,42.9,Gender,Male,C2,T15,NH075,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH075~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),39.2,39.2,,,35.2,43.4,Gender,Male,C2,T15,NH075,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH075~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),24.2,24.2,,,21.5,27.1,Gender,Female,C2,T15,NH075,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH075~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),24.5,24.5,,,21.9,27.3,Gender,Female,C2,T15,NH075,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH075~AGE02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),41.1,41.1,,,35.7,46.7,Age,20-24,C2,T15,NH075,Crude,BOC03,AGE02,59,
NHANES~2003-2004~59~NH075~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),36.4,36.4,,,32.0,40.9,Age,25-44,C2,T15,NH075,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH075~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),32.3,32.3,,,29.1,35.7,Age,45-64,C2,T15,NH075,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH075~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.5,12.5,,,10.8,14.3,Age,65+,C2,T15,NH075,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH075~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),28.5,28.5,,,25.8,31.3,Age,35+,C2,T15,NH075,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH075~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),8.5,8.5,,,7.0,10.3,Age,75+,C2,T15,NH075,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH075~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),32.5,32.5,,,29.5,35.6,Race,Non-Hispanic White,C2,T15,NH075,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH075~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),31.6,31.6,,,28.5,34.9,Race,Non-Hispanic White,C2,T15,NH075,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH075~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),34.7,34.7,,,29.2,40.6,Race,Non-Hispanic Black,C2,T15,NH075,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH075~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),35.3,35.3,,,29.7,41.3,Race,Non-Hispanic Black,C2,T15,NH075,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH075~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH075~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH075~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH075,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH075~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH075,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH075~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),28.7,28.7,,,21.4,37.1,Race,Other,C2,T15,NH075,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH075~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),30.1,30.1,,,22.3,39.3,Race,Other,C2,T15,NH075,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH075~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),29.0,29.0,,,26.7,31.4,Overall,Overall,C2,T15,NH075,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH075~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.0,29.0,,,26.9,31.2,Overall,Overall,C2,T15,NH075,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH075~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),35.4,35.4,,,32.4,38.5,Gender,Male,C2,T15,NH075,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH075~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),35.1,35.1,,,32.1,38.3,Gender,Male,C2,T15,NH075,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH075~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),23.0,23.0,,,20.9,25.2,Gender,Female,C2,T15,NH075,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH075~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),23.2,23.2,,,20.9,25.6,Gender,Female,C2,T15,NH075,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH075~AGE02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),41.3,41.3,,,34.6,48.3,Age,20-24,C2,T15,NH075,Crude,BOC03,AGE02,59,
NHANES~2005-2006~59~NH075~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),32.9,32.9,,,29.2,36.8,Age,25-44,C2,T15,NH075,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH075~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),28.3,28.3,,,24.5,32.5,Age,45-64,C2,T15,NH075,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH075~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),14.3,14.3,,,11.7,17.4,Age,65+,C2,T15,NH075,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH075~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),27.1,27.1,,,24.6,29.7,Age,35+,C2,T15,NH075,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH075~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),9.7,9.7,,,7.4,12.6,Age,75+,C2,T15,NH075,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH075~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),31.2,31.2,,,27.7,35.0,Race,Non-Hispanic White,C2,T15,NH075,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH075~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),30.2,30.2,,,27.2,33.4,Race,Non-Hispanic White,C2,T15,NH075,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH075~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),29.8,29.8,,,24.6,35.4,Race,Non-Hispanic Black,C2,T15,NH075,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH075~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),30.0,30.0,,,24.9,35.6,Race,Non-Hispanic Black,C2,T15,NH075,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH075~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH075~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH075~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH075,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH075~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH075,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH075~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),27.5,27.5,,,18.4,39.1,Race,Other,C2,T15,NH075,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH075~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),26.4,26.4,,,18.2,36.5,Race,Other,C2,T15,NH075,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH075~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),28.3,28.3,,,25.2,31.6,Overall,Overall,C2,T15,NH075,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH075~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),28.1,28.1,,,25.2,31.2,Overall,Overall,C2,T15,NH075,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH075~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),34.2,34.2,,,30.6,37.9,Gender,Male,C2,T15,NH075,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH075~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),34.0,34.0,,,30.3,37.9,Gender,Male,C2,T15,NH075,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH075~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),22.4,22.4,,,20.0,25.1,Gender,Female,C2,T15,NH075,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH075~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),22.8,22.8,,,20.1,25.7,Gender,Female,C2,T15,NH075,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH075~AGE02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),35.0,35.0,,,28.9,41.6,Age,20-24,C2,T15,NH075,Crude,BOC03,AGE02,59,
NHANES~2007-2008~59~NH075~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),33.7,33.7,,,30.3,37.2,Age,25-44,C2,T15,NH075,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH075~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,23.5,32.8,Age,45-64,C2,T15,NH075,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH075~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.1,12.1,,,10.7,13.5,Age,65+,C2,T15,NH075,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH075~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),24.8,24.8,,,21.9,28.1,Age,35+,C2,T15,NH075,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH075~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),9.5,9.5,,,7.6,11.9,Age,75+,C2,T15,NH075,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH075~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),30.1,30.1,,,25.7,34.8,Race,Non-Hispanic White,C2,T15,NH075,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH075~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),28.8,28.8,,,24.6,33.3,Race,Non-Hispanic White,C2,T15,NH075,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH075~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),33.2,33.2,,,30.1,36.4,Race,Non-Hispanic Black,C2,T15,NH075,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH075~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),33.9,33.9,,,30.6,37.3,Race,Non-Hispanic Black,C2,T15,NH075,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH075~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH075~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH075~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T15,NH075,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH075~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T15,NH075,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH075~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),20.1,20.1,,,14.3,27.5,Race,Other,C2,T15,NH075,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH075~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),20.7,20.7,,,14.6,28.5,Race,Other,C2,T15,NH075,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH075~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.6,25.6,,,24.2,27.1,Overall,Overall,C2,T15,NH075,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH075~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),25.9,25.9,,,24.4,27.6,Overall,Overall,C2,T15,NH075,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH075~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),30.4,30.4,,,28.1,32.8,Gender,Male,C2,T15,NH075,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH075~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),30.3,30.3,,,28.2,32.6,Gender,Male,C2,T15,NH075,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH075~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),21.2,21.2,,,19.5,23.0,Gender,Female,C2,T15,NH075,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH075~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),21.8,21.8,,,20.0,23.7,Gender,Female,C2,T15,NH075,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH075~AGE02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),36.1,36.1,,,29.4,43.4,Age,20-24,C2,T15,NH075,Crude,BOC03,AGE02,59,
NHANES~2009-2010~59~NH075~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),30.1,30.1,,,27.4,33.0,Age,25-44,C2,T15,NH075,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH075~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.3,25.3,,,23.4,27.3,Age,45-64,C2,T15,NH075,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH075~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),11.1,11.1,,,9.4,12.9,Age,65+,C2,T15,NH075,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH075~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),22.6,22.6,,,21.2,24.1,Age,35+,C2,T15,NH075,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH075~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),8.0,8.0,,,6.3,10.2,Age,75+,C2,T15,NH075,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH075~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.5,25.5,,,23.8,27.3,Race,Non-Hispanic White,C2,T15,NH075,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH075~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),26.9,26.9,,,25.0,29.0,Race,Non-Hispanic White,C2,T15,NH075,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH075~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),34.4,34.4,,,28.4,40.9,Race,Non-Hispanic Black,C2,T15,NH075,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH075~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),33.8,33.8,,,28.1,40.1,Race,Non-Hispanic Black,C2,T15,NH075,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH075~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH075~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH075,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH075~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T15,NH075,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH075~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T15,NH075,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH075~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),20.9,20.9,,,14.2,29.7,Race,Other,C2,T15,NH075,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH075~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),20.1,20.1,,,13.5,28.8,Race,Other,C2,T15,NH075,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH075~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),24.7,24.7,,,22.2,27.5,Overall,Overall,C2,T15,NH075,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH075~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),25.1,25.1,,,22.4,28.0,Overall,Overall,C2,T15,NH075,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH075~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),31.4,31.4,,,27.5,35.6,Gender,Male,C2,T15,NH075,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH075~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),31.3,31.3,,,27.5,35.4,Gender,Male,C2,T15,NH075,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH075~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),18.7,18.7,,,16.0,21.7,Gender,Female,C2,T15,NH075,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH075~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),19.2,19.2,,,16.4,22.3,Gender,Female,C2,T15,NH075,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH075~AGE02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.1,25.1,,,19.2,32.1,Age,20-24,C2,T15,NH075,Crude,BOC03,AGE02,59,
NHANES~2011-2012~59~NH075~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.8,29.8,,,26.9,33.0,Age,25-44,C2,T15,NH075,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH075~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.8,25.8,,,22.3,29.7,Age,45-64,C2,T15,NH075,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH075~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.0,12.0,,,9.1,15.6,Age,65+,C2,T15,NH075,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH075~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),23.3,23.3,,,20.8,26.0,Age,35+,C2,T15,NH075,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH075~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),6.1,6.1,,,4.1,9.0,Age,75+,C2,T15,NH075,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH075~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.2,25.2,,,22.0,28.7,Race,Non-Hispanic White,C2,T15,NH075,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH075~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),26.4,26.4,,,22.8,30.2,Race,Non-Hispanic White,C2,T15,NH075,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH075~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),29.8,29.8,,,24.7,35.5,Race,Non-Hispanic Black,C2,T15,NH075,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH075~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),30.1,30.1,,,24.8,36.0,Race,Non-Hispanic Black,C2,T15,NH075,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH075~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),11.4,11.4,,,9.4,13.9,Race,Non-Hispanic Asian,C2,T15,NH075,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH075~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),11.9,11.9,,,9.9,14.3,Race,Non-Hispanic Asian,C2,T15,NH075,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH075~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),19.6,19.6,,,17.2,22.4,Race,Hispanic,C2,T15,NH075,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH075~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),20.2,20.2,,,17.2,23.5,Race,Hispanic,C2,T15,NH075,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH075~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),21.0,21.0,,,14.9,28.8,Race,Other,C2,T15,NH075,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH075~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),20.9,20.9,,,14.6,29.1,Race,Other,C2,T15,NH075,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH075~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.9,25.9,,,23.2,28.9,Overall,Overall,C2,T15,NH075,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH075~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),26.5,26.5,,,23.8,29.5,Overall,Overall,C2,T15,NH075,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH075~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),30.8,30.8,,,27.5,34.2,Gender,Male,C2,T15,NH075,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH075~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),30.3,30.3,,,27.1,33.8,Gender,Male,C2,T15,NH075,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH075~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),22.6,22.6,,,19.6,25.8,Gender,Female,C2,T15,NH075,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH075~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),21.9,21.9,,,19.0,25.1,Gender,Female,C2,T15,NH075,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH075~AGE02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),34.7,34.7,,,29.7,40.1,Age,20-24,C2,T15,NH075,Crude,BOC03,AGE02,59,
NHANES~2013-2014~59~NH075~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.5,29.5,,,26.9,32.2,Age,25-44,C2,T15,NH075,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH075~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),27.2,27.2,,,22.5,32.5,Age,45-64,C2,T15,NH075,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH075~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.0,12.0,,,9.8,14.5,Age,65+,C2,T15,NH075,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH075~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),23.8,23.8,,,20.7,27.1,Age,35+,C2,T15,NH075,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH075~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),7.1,7.1,,,5.0,10.1,Age,75+,C2,T15,NH075,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH075~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),28.6,28.6,,,24.6,33.1,Race,Non-Hispanic White,C2,T15,NH075,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH075~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),26.8,26.8,,,22.9,31.2,Race,Non-Hispanic White,C2,T15,NH075,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH075~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),35.1,35.1,,,31.6,38.7,Race,Non-Hispanic Black,C2,T15,NH075,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH075~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),35.3,35.3,,,32.2,38.5,Race,Non-Hispanic Black,C2,T15,NH075,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH075~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),12.4,12.4,,,9.5,16.0,Race,Non-Hispanic Asian,C2,T15,NH075,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH075~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.6,12.6,,,9.7,16.1,Race,Non-Hispanic Asian,C2,T15,NH075,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH075~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),17.3,17.3,,,14.2,21.0,Race,Hispanic,C2,T15,NH075,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH075~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),17.0,17.0,,,14.3,20.0,Race,Hispanic,C2,T15,NH075,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH075~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),21.2,21.2,,,18.0,24.7,Race,Other,C2,T15,NH075,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH075~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),20.6,20.6,,,17.5,24.1,Race,Other,C2,T15,NH075,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH075~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),25.4,25.4,,,22.9,28.1,Overall,Overall,C2,T15,NH075,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH075~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),24.8,24.8,,,22.5,27.3,Overall,Overall,C2,T15,NH075,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH075~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),31.4,31.4,,,28.1,35.0,Gender,Male,C2,T15,NH075,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH075~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),31.0,31.0,,,27.8,34.4,Gender,Male,C2,T15,NH075,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH075~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),19.1,19.1,,,17.2,21.2,Gender,Female,C2,T15,NH075,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH075~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),19.7,19.7,,,17.7,22.0,Gender,Female,C2,T15,NH075,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH075~AGE02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),31.8,31.8,,,24.3,40.4,Age,20-24,C2,T15,NH075,Crude,BOC03,AGE02,59,
NHANES~2015-2016~59~NH075~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),28.8,28.8,,,25.4,32.4,Age,25-44,C2,T15,NH075,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH075~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),26.1,26.1,,,22.7,29.8,Age,45-64,C2,T15,NH075,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH075~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.6,12.6,,,9.9,15.8,Age,65+,C2,T15,NH075,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH075~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),23.0,23.0,,,20.6,25.5,Age,35+,C2,T15,NH075,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH075~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),8.8,8.8,,,6.6,11.7,Age,75+,C2,T15,NH075,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH075~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.0,25.0,,,21.7,28.6,Race,Non-Hispanic White,C2,T15,NH075,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH075~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),26.6,26.6,,,22.9,30.5,Race,Non-Hispanic White,C2,T15,NH075,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH075~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),33.6,33.6,,,30.2,37.1,Race,Non-Hispanic Black,C2,T15,NH075,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH075~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),33.8,33.8,,,30.4,37.4,Race,Non-Hispanic Black,C2,T15,NH075,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH075~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),12.0,12.0,,,9.1,15.8,Race,Non-Hispanic Asian,C2,T15,NH075,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH075~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.1,12.1,,,9.2,15.6,Race,Non-Hispanic Asian,C2,T15,NH075,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH075~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),19.6,19.6,,,17.6,21.8,Race,Hispanic,C2,T15,NH075,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH075~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),19.1,19.1,,,17.0,21.4,Race,Hispanic,C2,T15,NH075,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH075~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),21.1,21.1,,,16.2,27.1,Race,Other,C2,T15,NH075,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH075~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),21.0,21.0,,,16.0,26.9,Race,Other,C2,T15,NH075,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH075~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),24.0,24.0,,,21.5,26.6,Overall,Overall,C2,T15,NH075,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH075~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),24.7,24.7,,,22.1,27.5,Overall,Overall,C2,T15,NH075,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH075~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),29.9,29.9,,,26.6,33.5,Gender,Male,C2,T15,NH075,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH075~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.4,29.4,,,26.2,32.9,Gender,Male,C2,T15,NH075,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH075~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),18.9,18.9,,,16.5,21.6,Gender,Female,C2,T15,NH075,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH075~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),19.8,19.8,,,17.3,22.5,Gender,Female,C2,T15,NH075,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH075~AGE02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),26.2,26.2,,,19.3,34.5,Age,20-24,C2,T15,NH075,Crude,BOC03,AGE02,59,
NHANES~2017-2018~59~NH075~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),31.0,31.0,,,27.2,35.1,Age,25-44,C2,T15,NH075,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH075~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),22.5,22.5,,,18.9,26.6,Age,45-64,C2,T15,NH075,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH075~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),13.5,13.5,,,11.3,16.1,Age,65+,C2,T15,NH075,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH075~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),21.7,21.7,,,19.1,24.5,Age,35+,C2,T15,NH075,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH075~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),7.3,7.3,,,5.6,9.5,Age,75+,C2,T15,NH075,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH075~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),24.5,24.5,,,21.2,28.0,Race,Non-Hispanic White,C2,T15,NH075,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH075~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),26.2,26.2,,,22.5,30.4,Race,Non-Hispanic White,C2,T15,NH075,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH075~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),32.9,32.9,,,28.5,37.7,Race,Non-Hispanic Black,C2,T15,NH075,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH075~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),33.0,33.0,,,28.6,37.7,Race,Non-Hispanic Black,C2,T15,NH075,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH075~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),10.3,10.3,,,7.6,13.8,Race,Non-Hispanic Asian,C2,T15,NH075,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH075~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),10.3,10.3,,,7.6,13.8,Race,Non-Hispanic Asian,C2,T15,NH075,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH075~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),16.7,16.7,,,13.1,21.0,Race,Hispanic,C2,T15,NH075,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH075~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),15.7,15.7,,,12.3,19.8,Race,Hispanic,C2,T15,NH075,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH075~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),22.3,22.3,,,17.6,27.8,Race,Other,C2,T15,NH075,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH075~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),22.0,22.0,,,17.6,27.2,Race,Other,C2,T15,NH075,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH020~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.5,28.5,,,25.7,31.4,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH020~OVR01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),27.4,27.4,,,24.5,30.5,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH020~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.1,28.1,,,24.2,32.4,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH020~GEN01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),26.1,26.1,,,22.5,30.0,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH020~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.4,28.4,,,26.2,30.7,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH020~GEN02~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),28.7,28.7,,,25.5,32.0,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH020~AGE01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
NHANES~1999-2000~59~NH020~AGE04~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),12.2,12.2,,,9.3,16.0,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH020~AGE05~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),37.9,37.9,,,33.6,42.3,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH020~AGE06~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),70.4,70.4,,,66.2,74.3,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH020~AGE07~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),38.1,38.1,,,34.5,41.8,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH020~AGE08~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),77.8,77.8,,,73.1,81.8,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH020~RAC01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),28.0,28.0,,,24.2,32.1,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH020~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.0,27.0,,,23.6,30.7,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH020~RAC02~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),33.1,33.1,,,31.4,34.9,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH020~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),38.7,38.7,,,36.6,40.7,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH020~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH020~RAC03~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH020~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH020~RAC04~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH020~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.9,28.9,,,18.7,41.8,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH020~RAC07~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),25.3,25.3,,,15.9,37.7,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH020~OVR01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),27.2,27.2,,,24.9,29.7,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH020~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.9,27.9,,,26.2,29.7,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH020~GEN01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),24.7,24.7,,,22.1,27.6,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH020~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),26.4,26.4,,,24.1,28.9,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH020~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.9,28.9,,,27.3,30.6,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH020~GEN02~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),29.7,29.7,,,27.1,32.3,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH020~AGE01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),3.3,3.3,,,2.1,5.2,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
NHANES~2001-2002~59~NH020~AGE04~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),10.4,10.4,,,8.9,12.1,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH020~AGE05~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),37.6,37.6,,,33.0,42.5,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH020~AGE06~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),70.4,70.4,,,67.5,73.1,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH020~AGE07~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),37.6,37.6,,,34.4,40.9,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH020~AGE08~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),75.4,75.4,,,72.4,78.1,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH020~RAC01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),27.9,27.9,,,25.5,30.4,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH020~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),26.5,26.5,,,24.6,28.4,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH020~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),40.8,40.8,,,37.8,43.9,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH020~RAC02~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),36.3,36.3,,,31.5,41.4,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH020~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH020~RAC03~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH020~RAC04~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH020~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH020~RAC07~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),22.7,22.7,,,15.8,31.5,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH020~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.9,27.9,,,20.0,37.4,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH020~OVR01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),29.8,29.8,,,27.3,32.4,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH020~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.7,29.7,,,27.6,31.8,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH020~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),30.5,30.5,,,27.6,33.4,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH020~GEN01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),29.5,29.5,,,26.6,32.7,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH020~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.7,28.7,,,26.5,31.0,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH020~GEN02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),30.1,30.1,,,27.4,32.9,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH020~AGE01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),0.9,0.9,,,0.4,2.1,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH020~AGE04~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),12.3,12.3,,,10.7,14.1,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH020~AGE05~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),42.7,42.7,,,38.3,47.1,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH020~AGE06~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),69.7,69.7,,,65.4,73.7,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH020~AGE07~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),41.3,41.3,,,38.1,44.7,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH020~AGE08~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),73.6,73.6,,,67.7,78.8,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH020~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.6,28.6,,,26.1,31.2,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH020~RAC01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),30.7,30.7,,,27.5,34.0,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH020~RAC02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),35.9,35.9,,,32.3,39.6,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH020~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),39.6,39.6,,,36.0,43.2,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH020~RAC03~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH020~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH020~RAC04~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH020~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH020~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),30.5,30.5,,,23.5,38.4,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH020~RAC07~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),27.0,27.0,,,21.1,33.8,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH020~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.0,29.0,,,27.2,30.9,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH020~OVR01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),29.8,29.8,,,27.5,32.2,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH020~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.8,29.8,,,27.2,32.5,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH020~GEN01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),29.2,29.2,,,26.6,32.0,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH020~GEN02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),30.3,30.3,,,27.7,33.1,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH020~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.9,27.9,,,26.3,29.4,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH020~AGE01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),4.0,4.0,,,2.3,6.6,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH020~AGE04~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),11.7,11.7,,,9.2,14.7,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH020~AGE05~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),39.8,39.8,,,35.8,43.9,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH020~AGE06~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),68.6,68.6,,,66.1,70.9,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH020~AGE07~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),39.7,39.7,,,36.7,42.7,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH020~AGE08~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),71.4,71.4,,,68.4,74.3,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH020~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.8,27.8,,,25.7,30.1,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH020~RAC01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),31.0,31.0,,,28.1,34.0,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH020~RAC02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),37.9,37.9,,,33.9,42.1,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH020~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),40.8,40.8,,,37.8,43.8,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH020~RAC03~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH020~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH020~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH020~RAC04~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH020~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),30.0,30.0,,,23.8,37.0,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH020~RAC07~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),26.2,26.2,,,19.6,34.1,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH020~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.6,29.6,,,28.2,30.9,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH020~OVR01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),30.6,30.6,,,28.8,32.4,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH020~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),30.0,30.0,,,28.6,31.5,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH020~GEN01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),29.9,29.9,,,27.9,31.9,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH020~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.9,28.9,,,27.3,30.6,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH020~GEN02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),31.3,31.3,,,28.9,33.7,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH020~AGE01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),2.8,2.8,,,1.9,4.1,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH020~AGE04~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),13.3,13.3,,,11.5,15.2,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH020~AGE05~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),39.7,39.7,,,37.2,42.3,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH020~AGE06~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),70.0,70.0,,,64.9,74.7,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH020~AGE07~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),41.0,41.0,,,39.1,43.0,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH020~AGE08~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),76.1,76.1,,,72.8,79.0,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH020~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.9,28.9,,,27.0,31.0,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH020~RAC01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),32.1,32.1,,,29.9,34.4,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH020~RAC02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),38.5,38.5,,,34.2,42.8,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH020~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),40.5,40.5,,,37.3,43.9,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH020~RAC03~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH020~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH020~RAC04~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH020~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH020~RAC07~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),21.0,21.0,,,15.8,27.4,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH020~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),23.0,23.0,,,19.4,27.0,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH020~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.5,28.5,,,26.8,30.3,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH020~OVR01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),30.2,30.2,,,27.8,32.8,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH020~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.4,29.4,,,27.0,31.9,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH020~GEN01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),29.9,29.9,,,26.9,33.2,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH020~GEN02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),30.5,30.5,,,28.0,33.2,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH020~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.5,27.5,,,25.7,29.3,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH020~AGE01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),2.1,2.1,,,1.1,4.1,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH020~AGE04~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),10.7,10.7,,,9.5,12.1,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH020~AGE05~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),39.5,39.5,,,35.2,43.9,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH020~AGE06~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),71.2,71.2,,,67.5,74.7,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH020~AGE07~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),40.9,40.9,,,37.5,44.4,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH020~AGE08~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),76.6,76.6,,,73.0,79.9,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH020~RAC01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),31.5,31.5,,,28.4,34.8,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH020~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.4,27.4,,,25.1,29.9,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH020~RAC02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),38.7,38.7,,,34.9,42.7,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH020~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),40.3,40.3,,,37.1,43.7,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH020~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH020~RAC03~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH020~RAC04~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH020~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH020~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.5,29.5,,,25.1,34.2,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH020~RAC07~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),24.6,24.6,,,19.3,30.9,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH020~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.8,28.8,,,27.4,30.2,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH020~OVR01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),30.9,30.9,,,28.1,33.8,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH020~GEN01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),30.2,30.2,,,26.5,34.1,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH020~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.4,29.4,,,27.3,31.6,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH020~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.1,28.1,,,26.5,29.8,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH020~GEN02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),31.6,31.6,,,29.2,34.1,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH020~AGE01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),3.0,3.0,,,1.5,5.9,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH020~AGE04~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),12.6,12.6,,,10.1,15.5,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH020~AGE05~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),40.6,40.6,,,37.6,43.6,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH020~AGE06~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),67.4,67.4,,,63.6,70.9,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH020~AGE07~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),41.9,41.9,,,39.4,44.4,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH020~AGE08~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),76.9,76.9,,,73.8,79.8,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH020~RAC01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),32.3,32.3,,,28.9,36.0,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH020~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.6,27.6,,,26.0,29.2,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH020~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),41.7,41.7,,,40.0,43.3,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH020~RAC02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),40.3,40.3,,,37.4,43.3,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH020~RAC03~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),22.5,22.5,,,18.4,27.2,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH020~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),24.3,24.3,,,21.4,27.5,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH020~RAC04~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),20.1,20.1,,,16.2,24.7,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH020~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),25.7,25.7,,,22.6,29.1,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH020~RAC07~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),24.3,24.3,,,20.0,29.2,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH020~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),25.8,25.8,,,22.7,29.3,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH020~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.4,29.4,,,27.7,31.1,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH020~OVR01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),31.6,31.6,,,29.8,33.4,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH020~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),30.6,30.6,,,28.7,32.6,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH020~GEN01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),31.8,31.8,,,30.1,33.7,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH020~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.1,28.1,,,25.8,30.5,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH020~GEN02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),31.4,31.4,,,28.6,34.3,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH020~AGE01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),2.5,2.5,,,1.5,4.1,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH020~AGE04~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),12.9,12.9,,,11.0,15.1,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH020~AGE05~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),41.2,41.2,,,38.2,44.2,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH020~AGE06~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),69.6,69.6,,,66.8,72.3,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH020~AGE07~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),42.7,42.7,,,40.2,45.3,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH020~AGE08~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),75.0,75.0,,,70.4,79.2,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH020~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.5,28.5,,,26.6,30.5,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH020~RAC01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),33.4,33.4,,,30.9,36.0,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH020~RAC02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),40.1,40.1,,,37.6,42.7,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH020~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),40.6,40.6,,,37.7,43.6,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH020~RAC03~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),24.9,24.9,,,20.9,29.4,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH020~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),25.6,25.6,,,22.8,28.7,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH020~RAC04~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),20.8,20.8,,,18.0,24.0,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH020~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),26.1,26.1,,,23.7,28.6,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH020~RAC07~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),24.7,24.7,,,20.9,28.9,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH020~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.5,27.5,,,24.4,30.8,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH020~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.1,29.1,,,27.1,31.0,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH020~OVR01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),32.1,32.1,,,29.7,34.5,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH020~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),30.2,30.2,,,27.4,33.0,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH020~GEN01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),31.8,31.8,,,28.9,34.8,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH020~GEN02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),32.4,32.4,,,29.9,35.0,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH020~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.8,27.8,,,25.7,29.9,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH020~AGE01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),2.1,2.1,,,1.3,3.4,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH020~AGE04~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),12.6,12.6,,,10.1,15.7,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH020~AGE05~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),40.4,40.4,,,37.0,43.9,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH020~AGE06~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),66.1,66.1,,,60.6,71.1,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH020~AGE07~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),43.1,43.1,,,39.8,46.3,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH020~AGE08~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),72.0,72.0,,,66.7,76.6,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH020~RAC01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),33.3,33.3,,,30.2,36.6,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH020~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.8,27.8,,,25.1,30.6,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH020~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),40.3,40.3,,,36.5,44.3,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH020~RAC02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),40.1,40.1,,,36.1,44.3,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH020~RAC03~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),24.6,24.6,,,19.7,30.3,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH020~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),25.0,25.0,,,21.9,28.5,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH020~RAC04~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),23.0,23.0,,,18.8,27.8,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH020~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.7,27.7,,,25.0,30.6,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH020~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.4,28.4,,,24.7,32.5,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH020~RAC07~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),28.6,28.6,,,23.7,34.1,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH020~OVR01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),33.7,33.7,,,30.6,36.9,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH020~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),30.7,30.7,,,28.0,33.5,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH020~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),32.8,32.8,,,29.2,36.6,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH020~GEN01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),34.6,34.6,,,30.9,38.6,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH020~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.5,28.5,,,26.1,31.0,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH020~GEN02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),32.8,32.8,,,29.7,36.1,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH020~AGE01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),2.2,2.2,,,1.2,4.0,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH020~AGE04~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),12.5,12.5,,,10.6,14.8,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH020~AGE05~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),45.0,45.0,,,39.8,50.3,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH020~AGE06~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),68.4,68.4,,,64.3,72.3,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH020~AGE07~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),45.3,45.3,,,41.5,49.2,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH020~AGE08~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),77.7,77.7,,,73.4,81.4,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH020~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.0,29.0,,,25.0,33.2,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH020~RAC01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),34.5,34.5,,,30.2,39.1,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH020~RAC02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),42.9,42.9,,,39.2,46.7,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH020~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),42.6,42.6,,,39.5,45.7,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH020~RAC03~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),32.2,32.2,,,29.6,34.9,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH020~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),31.9,31.9,,,29.3,34.7,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH020~RAC04~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),24.9,24.9,,,21.5,28.7,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH020~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.0,29.0,,,25.8,32.4,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH020~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),31.8,31.8,,,28.6,35.2,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH020~RAC07~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of hypertension (BP =140/90) among US adults (18+); NHANES,Crude,Percent (%),32.0,32.0,,,27.7,36.8,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH021~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),69.1,69.1,,,64.7,73.2,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH021~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),63.7,63.7,,,57.0,70.0,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH021~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),66.4,66.4,,,61.7,70.7,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH021~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),63.6,63.6,,,57.7,69.1,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH021~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),60.1,60.1,,,48.9,70.4,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH021~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),71.6,71.6,,,66.4,76.2,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH021~AGE01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
NHANES~1999-2000~59~NH021~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),60.8,60.8,,,47.4,72.7,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH021~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),74.9,74.9,,,67.9,80.8,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH021~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),68.1,68.1,,,64.5,71.5,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH021~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),70.6,70.6,,,66.5,74.4,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH021~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),66.5,66.5,,,62.8,70.0,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH021~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),69.6,69.6,,,66.2,72.9,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH021~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),64.9,64.9,,,57.9,71.4,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH021~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),66.0,66.0,,,53.3,76.8,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH021~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),74.4,74.4,,,65.4,81.7,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH021~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH021~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH021~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH021~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH021~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH021~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH021~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),70.5,70.5,,,67.5,73.4,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH021~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),62.8,62.8,,,59.2,66.3,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH021~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),64.7,64.7,,,61.9,67.4,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH021~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),55.9,55.9,,,52.6,59.1,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH021~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),75.2,75.2,,,68.8,80.7,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH021~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),74.5,74.5,,,67.8,80.3,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH021~AGE01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
NHANES~2001-2002~59~NH021~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),58.1,58.1,,,50.4,65.5,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH021~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),72.2,72.2,,,67.6,76.4,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH021~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),74.2,74.2,,,71.0,77.2,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH021~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),71.7,71.7,,,68.3,74.8,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH021~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),72.8,72.8,,,68.2,76.9,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH021~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),61.1,61.1,,,54.2,67.5,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH021~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),70.2,70.2,,,66.2,73.9,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH021~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.5,78.5,,,74.3,82.2,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH021~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),75.5,75.5,,,69.4,80.6,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH021~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH021~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH021~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH021~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH021~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH021~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH021~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),67.5,67.5,,,61.2,73.2,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH021~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),75.4,75.4,,,71.8,78.8,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH021~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),76.3,76.3,,,71.0,81.0,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH021~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),68.1,68.1,,,61.9,73.7,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH021~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),74.6,74.6,,,69.6,79.0,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH021~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),68.0,68.0,,,56.3,77.8,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH021~AGE01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH021~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),67.2,67.2,,,58.8,74.7,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH021~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),75.0,75.0,,,68.9,80.3,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH021~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),79.5,79.5,,,75.2,83.1,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH021~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.0,77.0,,,73.6,80.1,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH021~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),74.3,74.3,,,68.6,79.3,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH021~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),75.4,75.4,,,71.0,79.4,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH021~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),68.2,68.2,,,58.4,76.6,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH021~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),66.1,66.1,,,55.9,74.9,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH021~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),74.7,74.7,,,67.8,80.5,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH021~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH021~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH021~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH021~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH021~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH021~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH021~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.0,78.0,,,74.6,81.0,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH021~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),68.3,68.3,,,63.7,72.6,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH021~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),72.5,72.5,,,67.7,76.9,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH021~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),63.7,63.7,,,59.0,68.1,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH021~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),83.2,83.2,,,79.2,86.5,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH021~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),83.0,83.0,,,73.4,89.6,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH021~AGE01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH021~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),60.5,60.5,,,52.4,68.0,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH021~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),81.0,81.0,,,76.7,84.6,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH021~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),82.5,82.5,,,78.8,85.6,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH021~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.1,80.1,,,76.9,82.9,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH021~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.4,77.4,,,71.4,82.5,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH021~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.4,78.4,,,74.6,81.7,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH021~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),66.5,66.5,,,60.8,71.8,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH021~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),72.7,72.7,,,65.4,78.9,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH021~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.6,80.6,,,76.4,84.3,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH021~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH021~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH021~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH021~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH021~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH021~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH021~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),74.0,74.0,,,66.1,80.5,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH021~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),79.7,79.7,,,77.4,81.8,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH021~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),76.0,76.0,,,71.1,80.2,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH021~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),67.7,67.7,,,58.9,75.4,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH021~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),83.1,83.1,,,76.8,87.9,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH021~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),83.1,83.1,,,81.0,85.1,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH021~AGE01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH021~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),73.0,73.0,,,62.2,81.6,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH021~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.4,80.4,,,77.6,82.8,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH021~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),83.4,83.4,,,80.9,85.6,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH021~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),81.1,81.1,,,79.4,82.6,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH021~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),83.4,83.4,,,79.4,86.7,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH021~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.8,80.8,,,78.2,83.3,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH021~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),76.4,76.4,,,65.7,84.6,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH021~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),74.6,74.6,,,66.7,81.2,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH021~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.7,80.7,,,75.1,85.2,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH021~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH021~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH021~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH021~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH021~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH021~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH021~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),81.9,81.9,,,78.9,84.5,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH021~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),73.4,73.4,,,67.6,78.5,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH021~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.5,78.5,,,75.2,81.6,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH021~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),69.0,69.0,,,60.8,76.3,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH021~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),85.1,85.1,,,81.7,88.0,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH021~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),80.3,80.3,,,73.0,86.0,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH021~AGE01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH021~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),66.6,66.6,,,57.8,74.4,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH021~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),84.0,84.0,,,80.3,87.0,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH021~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),85.3,85.3,,,80.9,88.7,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH021~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),83.2,83.2,,,80.2,85.8,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH021~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),84.5,84.5,,,79.2,88.6,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH021~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),72.9,72.9,,,64.4,80.0,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH021~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),81.6,81.6,,,77.5,85.2,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH021~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),86.5,86.5,,,81.7,90.2,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH021~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),81.2,81.2,,,74.1,86.6,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH021~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH021~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH021~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH021~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH021~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH021~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),70.3,70.3,,,57.5,80.6,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH021~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),74.4,74.4,,,69.3,78.9,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH021~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),82.4,82.4,,,78.5,85.7,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH021~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),79.5,79.5,,,75.7,82.8,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH021~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),68.3,68.3,,,62.9,73.3,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH021~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),85.1,85.1,,,80.1,89.1,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH021~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),81.6,81.6,,,74.2,87.2,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH021~AGE01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH021~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),71.1,71.1,,,61.7,79.0,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH021~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),82.9,82.9,,,77.6,87.2,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH021~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),87.6,87.6,,,84.3,90.3,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH021~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),83.7,83.7,,,79.8,86.9,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH021~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),87.6,87.6,,,83.2,91.0,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH021~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),83.1,83.1,,,77.6,87.5,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH021~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),73.3,73.3,,,64.8,80.5,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH021~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),82.0,82.0,,,76.6,86.4,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH021~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),84.3,84.3,,,81.6,86.7,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH021~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),70.9,70.9,,,64.4,76.7,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH021~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),58.6,58.6,,,47.2,69.2,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH021~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.3,80.3,,,75.7,84.2,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH021~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),71.6,71.6,,,60.6,80.6,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH021~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH021~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),72.3,72.3,,,58.7,82.8,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH021~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),84.7,84.7,,,82.2,87.0,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH021~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),80.3,80.3,,,77.1,83.1,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH021~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),81.4,81.4,,,77.6,84.7,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH021~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),76.0,76.0,,,70.7,80.7,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH021~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),88.0,88.0,,,85.0,90.4,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH021~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),86.7,86.7,,,83.5,89.4,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH021~AGE01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH021~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.5,78.5,,,74.3,82.1,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH021~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),84.3,84.3,,,80.9,87.2,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH021~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),88.2,88.2,,,84.8,90.9,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH021~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),85.5,85.5,,,82.7,88.0,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH021~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),87.8,87.8,,,81.1,92.3,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH021~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),86.1,86.1,,,82.5,89.2,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH021~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),83.5,83.5,,,80.2,86.4,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH021~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),79.9,79.9,,,73.3,85.3,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH021~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),85.3,85.3,,,81.4,88.5,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH021~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH021~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.4,77.4,,,68.4,84.4,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH021~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.2,78.2,,,74.8,81.2,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH021~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),73.4,73.4,,,63.2,81.6,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH021~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),72.0,72.0,,,58.3,82.6,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH021~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.3,78.3,,,68.2,85.9,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH021~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),81.8,81.8,,,79.2,84.1,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH021~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),75.9,75.9,,,72.3,79.2,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH021~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),71.7,71.7,,,66.5,76.4,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH021~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.3,78.3,,,74.6,81.7,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH021~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),85.0,85.0,,,81.3,88.1,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH021~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),82.3,82.3,,,76.8,86.7,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH021~AGE01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH021~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),73.8,73.8,,,66.9,79.7,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH021~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),82.2,82.2,,,78.7,85.3,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH021~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),84.7,84.7,,,81.1,87.7,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH021~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),83.2,83.2,,,80.7,85.4,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH021~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),84.0,84.0,,,79.7,87.6,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH021~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),82.6,82.6,,,78.4,86.2,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH021~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),76.4,76.4,,,68.6,82.8,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH021~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),80.4,80.4,,,75.5,84.5,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH021~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),83.9,83.9,,,81.6,85.9,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH021~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH021~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),75.0,75.0,,,65.7,82.5,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH021~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),68.6,68.6,,,60.8,75.6,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH021~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),76.3,76.3,,,69.8,81.8,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH021~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),74.6,74.6,,,64.1,82.9,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH021~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.9,78.9,,,72.4,84.2,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH021~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),69.6,69.6,,,64.4,74.4,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH021~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.4,77.4,,,73.8,80.7,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH021~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),69.3,69.3,,,62.3,75.5,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH021~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),76.4,76.4,,,71.6,80.5,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH021~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.5,78.5,,,73.1,83.1,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH021~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),70.1,70.1,,,62.9,76.4,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH021~AGE01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH021~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),65.0,65.0,,,56.6,72.6,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH021~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),76.7,76.7,,,69.9,82.3,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH021~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),83.2,83.2,,,78.9,86.8,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH021~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),79.0,79.0,,,75.3,82.2,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH021~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.4,80.4,,,74.9,84.9,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH021~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),71.2,71.2,,,61.7,79.1,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH021~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.7,77.7,,,72.3,82.2,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH021~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.7,80.7,,,75.8,84.9,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH021~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),76.4,76.4,,,66.0,84.4,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH021~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),74.9,74.9,,,66.0,82.1,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH021~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),76.7,76.7,,,68.7,83.2,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH021~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),69.8,69.8,,,64.0,75.0,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH021~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),56.6,56.6,,,47.9,64.9,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH021~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.1,80.1,,,73.8,85.2,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH021~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),72.6,72.6,,,61.8,81.3,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH022~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),47.9,47.9,,,41.7,54.1,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH022~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),58.3,58.3,,,52.1,64.2,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH022~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),45.8,45.8,,,39.4,52.4,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH022~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),54.2,54.2,,,47.8,60.5,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH022~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),50.2,50.2,,,41.0,59.3,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH022~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),61.9,61.9,,,55.8,67.7,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH022~AGE01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
NHANES~1999-2000~59~NH022~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),43.0,43.0,,,31.4,55.5,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH022~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),65.5,65.5,,,59.1,71.4,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH022~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),60.2,60.2,,,54.0,66.2,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH022~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),61.2,61.2,,,55.6,66.5,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH022~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),58.2,58.2,,,50.5,65.4,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH022~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),49.7,49.7,,,44.8,54.6,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH022~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),60.2,60.2,,,54.7,65.4,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH022~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),50.7,50.7,,,39.3,62.0,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH022~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),62.7,62.7,,,54.3,70.4,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH022~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH022~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH022~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH022~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH022~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH022~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH022~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),60.2,60.2,,,56.9,63.5,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH022~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),51.0,51.0,,,47.5,54.5,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH022~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),53.7,53.7,,,50.4,57.0,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH022~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),43.9,43.9,,,40.4,47.5,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH022~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),65.5,65.5,,,59.3,71.3,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH022~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),63.0,63.0,,,55.8,69.6,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH022~AGE01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
NHANES~2001-2002~59~NH022~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),42.3,42.3,,,35.4,49.6,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH022~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),61.2,61.2,,,57.0,65.3,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH022~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),67.0,67.0,,,61.9,71.8,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH022~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),61.8,61.8,,,58.1,65.3,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH022~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),65.7,65.7,,,58.9,71.9,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH022~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),48.6,48.6,,,43.6,53.7,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH022~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),60.2,60.2,,,56.4,63.9,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH022~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),60.4,60.4,,,56.6,64.1,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH022~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),65.3,65.3,,,62.2,68.3,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH022~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH022~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH022~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH022~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH022~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH022~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH022~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),64.6,64.6,,,59.9,69.0,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH022~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),54.5,54.5,,,47.2,61.7,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH022~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),53.6,53.6,,,46.1,60.9,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH022~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),63.8,63.8,,,57.4,69.8,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH022~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),65.3,65.3,,,60.9,69.5,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH022~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),58.0,58.0,,,46.5,68.7,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH022~AGE01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH022~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),52.0,52.0,,,40.2,63.6,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH022~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),61.6,61.6,,,54.4,68.4,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH022~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),73.7,73.7,,,69.3,77.6,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH022~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),66.4,66.4,,,61.6,70.8,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH022~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),66.5,66.5,,,60.7,71.9,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH022~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),64.8,64.8,,,59.8,69.6,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH022~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),55.2,55.2,,,44.5,65.4,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH022~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),54.8,54.8,,,46.8,62.6,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH022~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),65.8,65.8,,,58.8,72.2,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH022~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH022~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH022~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH022~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH022~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH022~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH022~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),67.9,67.9,,,63.7,71.8,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH022~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),53.0,53.0,,,48.5,57.4,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH022~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),47.3,47.3,,,43.1,51.5,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH022~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),60.8,60.8,,,55.3,66.0,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH022~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),74.6,74.6,,,70.5,78.3,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH022~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),74.4,74.4,,,66.2,81.2,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH022~AGE01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH022~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),40.6,40.6,,,33.6,47.9,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH022~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),70.2,70.2,,,66.1,74.0,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH022~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.8,77.8,,,74.0,81.2,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH022~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),70.6,70.6,,,67.1,73.9,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH022~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),71.7,71.7,,,66.1,76.7,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH022~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),69.3,69.3,,,64.3,73.9,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH022~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),51.4,51.4,,,43.9,58.8,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH022~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),64.3,64.3,,,57.1,71.0,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH022~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),72.3,72.3,,,67.7,76.5,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH022~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH022~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH022~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH022~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH022~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH022~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH022~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),71.6,71.6,,,69.2,73.8,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH022~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),62.4,62.4,,,56.7,67.8,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH022~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),66.2,66.2,,,61.6,70.6,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH022~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),55.1,55.1,,,48.3,61.7,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH022~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),76.4,76.4,,,74.4,78.3,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH022~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),72.9,72.9,,,66.7,78.3,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH022~AGE01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH022~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),57.3,57.3,,,48.2,66.0,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH022~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),71.0,71.0,,,67.2,74.5,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH022~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.0,80.0,,,77.5,82.2,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH022~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),73.7,73.7,,,71.5,75.9,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH022~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),79.8,79.8,,,76.2,83.0,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH022~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),73.1,73.1,,,70.6,75.4,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH022~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),64.2,64.2,,,56.4,71.3,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH022~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),70.4,70.4,,,64.0,76.0,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH022~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),64.4,64.4,,,57.1,71.0,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH022~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH022~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH022~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH022~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH022~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH022~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH022~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),64.8,64.8,,,58.7,70.5,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH022~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),76.3,76.3,,,72.7,79.6,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH022~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),71.4,71.4,,,67.8,74.8,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH022~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),58.5,58.5,,,51.4,65.2,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH022~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),81.0,81.0,,,76.4,84.8,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH022~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),74.9,74.9,,,66.3,81.9,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH022~AGE01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH022~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),56.0,56.0,,,47.0,64.6,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH022~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.8,77.8,,,72.8,82.0,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH022~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),82.1,82.1,,,78.1,85.4,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH022~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.0,78.0,,,74.6,81.1,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH022~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),81.3,81.3,,,75.5,86.0,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH022~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),65.3,65.3,,,57.7,72.1,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH022~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.1,77.1,,,72.5,81.1,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH022~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),78.0,78.0,,,71.6,83.3,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH022~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),70.1,70.1,,,60.9,78.0,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH022~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH022~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH022~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH022~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH022~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),63.1,63.1,,,50.7,74.1,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH022~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),76.8,76.8,,,66.7,84.6,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH022~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),62.7,62.7,,,57.3,67.8,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH022~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),75.0,75.0,,,70.7,78.8,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH022~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),69.3,69.3,,,65.4,72.9,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH022~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),53.9,53.9,,,48.5,59.2,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH022~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),73.0,73.0,,,64.8,79.9,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH022~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.4,80.4,,,74.9,84.8,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH022~AGE01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH022~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),54.6,54.6,,,46.2,62.7,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH022~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),75.4,75.4,,,68.9,80.9,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH022~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),84.1,84.1,,,80.1,87.5,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH022~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.0,77.0,,,72.7,80.8,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH022~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),83.9,83.9,,,78.0,88.5,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH022~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),65.0,65.0,,,56.6,72.6,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH022~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.2,77.2,,,71.3,82.2,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH022~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),68.0,68.0,,,61.8,73.5,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH022~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),74.4,74.4,,,70.0,78.3,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH022~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),47.4,47.4,,,36.8,58.2,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH022~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),62.8,62.8,,,55.5,69.5,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH022~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),70.1,70.1,,,62.7,76.6,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH022~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),55.5,55.5,,,44.8,65.6,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH022~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),41.9,41.9,,,32.9,51.5,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH022~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),59.3,59.3,,,48.1,69.6,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH022~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),64.6,64.6,,,59.5,69.4,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH022~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),75.4,75.4,,,71.0,79.3,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH022~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),59.6,59.6,,,52.9,66.0,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH022~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),70.4,70.4,,,65.2,75.1,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH022~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),71.8,71.8,,,65.3,77.5,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH022~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.2,80.2,,,75.4,84.2,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH022~AGE01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH022~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),57.5,57.5,,,50.2,64.6,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH022~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),75.8,75.8,,,70.7,80.2,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH022~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),82.6,82.6,,,78.0,86.4,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH022~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),76.8,76.8,,,72.4,80.7,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH022~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.9,80.9,,,74.2,86.2,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH022~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),68.7,68.7,,,60.5,75.9,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH022~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.3,77.3,,,71.2,82.5,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH022~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),62.2,62.2,,,57.9,66.2,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH022~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),75.2,75.2,,,71.2,78.8,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH022~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),46.5,46.5,,,38.8,54.4,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH022~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),65.8,65.8,,,57.3,73.3,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH022~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),66.2,66.2,,,61.0,71.0,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH022~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),57.4,57.4,,,48.4,65.8,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH022~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),57.7,57.7,,,48.0,66.9,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH022~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),68.6,68.6,,,60.2,75.8,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH022~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),63.5,63.5,,,59.0,67.7,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH022~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),73.3,73.3,,,70.4,76.1,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH022~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),67.2,67.2,,,63.1,71.0,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH022~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),55.7,55.7,,,49.0,62.2,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH022~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),79.2,79.2,,,74.7,83.0,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH022~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),75.5,75.5,,,69.3,80.8,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH022~AGE01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH022~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),58.2,58.2,,,50.3,65.8,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH022~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),72.5,72.5,,,68.1,76.6,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH022~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.0,80.0,,,76.3,83.2,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH022~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),75.2,75.2,,,72.3,77.9,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH022~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),80.1,80.1,,,75.3,84.1,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH022~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),64.9,64.9,,,57.8,71.4,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH022~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),74.6,74.6,,,69.8,78.9,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH022~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),68.8,68.8,,,63.2,74.0,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH022~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),74.9,74.9,,,71.6,77.9,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH022~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),68.9,68.9,,,59.3,77.2,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH022~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),58.2,58.2,,,45.5,70.0,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH022~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),55.2,55.2,,,48.0,62.2,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH022~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),67.2,67.2,,,62.0,72.1,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH022~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),68.9,68.9,,,61.9,75.2,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH022~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),57.8,57.8,,,45.4,69.3,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH022~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),55.8,55.8,,,50.3,61.2,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH022~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),69.0,69.0,,,65.8,71.9,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH022~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),66.1,66.1,,,60.7,71.1,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH022~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),52.9,52.9,,,45.2,60.5,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH022~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),62.5,62.5,,,55.2,69.3,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH022~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),71.9,71.9,,,66.9,76.5,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH022~AGE01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH022~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),47.0,47.0,,,38.5,55.6,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH022~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),66.8,66.8,,,61.1,72.1,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH022~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),79.2,79.2,,,74.3,83.4,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH022~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),70.9,70.9,,,67.7,73.9,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH022~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),77.6,77.6,,,71.2,82.9,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH022~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),69.4,69.4,,,64.4,73.9,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH022~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),55.4,55.4,,,45.5,65.0,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH022~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),71.3,71.3,,,66.1,76.0,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH022~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),63.4,63.4,,,55.3,70.9,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH022~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),68.4,68.4,,,61.2,74.8,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH022~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),58.0,58.0,,,48.9,66.6,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH022~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),48.5,48.5,,,39.1,58.0,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH022~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),61.2,61.2,,,56.4,65.9,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH022~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),72.0,72.0,,,66.2,77.1,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH022~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),58.1,58.1,,,49.9,65.9,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH023~OVR01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),31.0,31.0,,,26.2,36.4,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH023~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),26.9,26.9,,,22.3,32.0,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH023~GEN01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),32.7,32.7,,,26.3,39.8,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH023~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),27.8,27.8,,,22.0,34.4,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH023~GEN02~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),29.6,29.6,,,24.5,35.2,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH023~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),26.8,26.8,,,20.4,34.3,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH023~AGE01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
NHANES~1999-2000~59~NH023~AGE04~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),28.6,28.6,,,20.0,39.2,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH023~AGE05~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),39.7,39.7,,,34.1,45.7,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH023~AGE06~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),24.5,24.5,,,20.0,29.7,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH023~AGE07~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),32.5,32.5,,,27.5,37.9,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH023~AGE08~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),16.3,16.3,,,12.3,21.4,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH023~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),30.0,30.0,,,25.5,35.1,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH023~RAC01~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),33.7,33.7,,,28.7,39.1,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH023~RAC02~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),28.1,28.1,,,22.3,34.8,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH023~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),21.7,21.7,,,15.4,29.8,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH023~RAC03~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH023~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH023~RAC04~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH023~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH023~RAC07~Crude,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH023~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH023~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),32.9,32.9,,,29.2,36.9,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH023~OVR01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),34.7,34.7,,,31.8,37.8,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH023~GEN01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),33.1,33.1,,,29.3,37.1,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH023~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),27.7,27.7,,,23.7,32.0,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH023~GEN02~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),36.1,36.1,,,32.2,40.2,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH023~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),43.4,43.4,,,36.2,50.9,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH023~AGE01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
NHANES~2001-2002~59~NH023~AGE04~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),28.8,28.8,,,23.5,34.6,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH023~AGE05~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),38.8,38.8,,,34.2,43.6,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH023~AGE06~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),32.2,32.2,,,29.0,35.7,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH023~AGE07~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),35.3,35.3,,,32.2,38.6,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH023~AGE08~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),30.5,30.5,,,24.9,36.7,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH023~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,27.6,38.2,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH023~RAC01~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),35.7,35.7,,,32.1,39.4,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH023~RAC02~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),33.0,33.0,,,29.9,36.2,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH023~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,28.4,37.3,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH023~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH023~RAC03~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH023~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH023~RAC04~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH023~RAC07~Crude,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH023~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH023~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),36.4,36.4,,,29.5,44.0,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH023~OVR01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),39.7,39.7,,,35.4,44.2,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH023~GEN01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),42.4,42.4,,,35.9,49.1,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH023~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),36.8,36.8,,,29.8,44.3,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH023~GEN02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),37.2,37.2,,,33.0,41.6,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH023~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),38.7,38.7,,,28.1,50.6,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH023~AGE01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH023~AGE04~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),42.3,42.3,,,31.1,54.3,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH023~AGE05~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),39.4,39.4,,,33.4,45.8,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH023~AGE06~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),38.9,38.9,,,34.9,43.1,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH023~AGE07~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),40.6,40.6,,,36.4,45.0,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH023~AGE08~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),29.3,29.3,,,24.5,34.7,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH023~RAC01~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),41.3,41.3,,,36.3,46.5,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH023~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),38.6,38.6,,,28.3,49.9,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH023~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),31.1,31.1,,,26.8,35.8,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH023~RAC02~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),37.6,37.6,,,31.9,43.6,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH023~RAC03~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH023~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH023~RAC04~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH023~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH023~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),34.5,34.5,,,23.9,46.9,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH023~RAC07~Crude,2003-2004,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),30.8,30.8,,,23.6,39.1,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH023~OVR01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),43.8,43.8,,,40.6,47.0,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH023~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),36.9,36.9,,,32.8,41.2,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH023~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),33.7,33.7,,,29.4,38.3,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH023~GEN01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),41.4,41.4,,,36.6,46.3,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH023~GEN02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),46.0,46.0,,,43.2,48.9,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH023~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),51.9,51.9,,,41.5,62.1,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH023~AGE01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH023~AGE04~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),31.0,31.0,,,23.9,39.1,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH023~AGE05~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),48.3,48.3,,,43.9,52.7,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH023~AGE06~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),44.5,44.5,,,40.7,48.4,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH023~AGE07~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),45.0,45.0,,,41.9,48.2,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH023~AGE08~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),39.4,39.4,,,33.3,45.9,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH023~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),37.5,37.5,,,31.1,44.4,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH023~RAC01~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),45.2,45.2,,,41.8,48.6,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH023~RAC02~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),42.5,42.5,,,38.8,46.2,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH023~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),38.1,38.1,,,32.6,44.0,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH023~RAC03~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH023~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH023~RAC04~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH023~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH023~RAC07~Crude,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH023~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH023~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),45.7,45.7,,,39.8,51.7,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH023~OVR01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),48.3,48.3,,,45.2,51.4,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH023~GEN01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),45.9,45.9,,,41.5,50.4,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH023~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),40.2,40.2,,,34.1,46.6,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH023~GEN02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),50.4,50.4,,,47.6,53.2,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH023~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),54.0,54.0,,,45.9,62.0,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH023~AGE01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH023~AGE04~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),47.8,47.8,,,39.3,56.5,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH023~AGE05~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),49.5,49.5,,,44.7,54.4,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH023~AGE06~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),48.0,48.0,,,43.8,52.1,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH023~AGE07~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),49.4,49.4,,,46.4,52.3,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH023~AGE08~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),43.0,43.0,,,38.2,47.9,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH023~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),49.9,49.9,,,43.4,56.4,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH023~RAC01~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),50.7,50.7,,,47.3,54.1,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH023~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),39.7,39.7,,,32.6,47.2,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH023~RAC02~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),43.4,43.4,,,38.8,48.2,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH023~RAC03~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH023~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH023~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH023~RAC04~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH023~RAC07~Crude,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH023~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),20.2,20.2,,,13.8,28.5,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH023~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),45.9,45.9,,,40.5,51.4,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH023~OVR01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),53.4,53.4,,,50.0,56.7,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH023~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),39.6,39.6,,,33.1,46.5,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH023~GEN01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),49.2,49.2,,,45.0,53.6,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH023~GEN02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),57.3,57.3,,,53.0,61.4,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH023~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),56.0,56.0,,,48.6,63.2,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH023~AGE01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH023~AGE04~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),36.0,36.0,,,27.9,45.0,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH023~AGE05~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),57.1,57.1,,,52.5,61.6,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH023~AGE06~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),55.1,55.1,,,50.6,59.6,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH023~AGE07~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),54.5,54.5,,,51.2,57.8,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH023~AGE08~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),50.2,50.2,,,44.0,56.4,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH023~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),49.1,49.1,,,42.5,55.7,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH023~RAC01~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),56.4,56.4,,,52.4,60.3,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH023~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),43.1,43.1,,,33.9,52.8,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH023~RAC02~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),47.4,47.4,,,41.6,53.3,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH023~RAC03~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH023~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH023~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH023~RAC04~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH023~RAC07~Crude,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),51.1,51.1,,,39.0,63.1,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH023~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH023~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),46.3,46.3,,,40.1,52.6,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH023~OVR01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),51.9,51.9,,,47.1,56.6,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH023~GEN01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),49.0,49.0,,,44.5,53.4,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH023~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),38.7,38.7,,,33.2,44.5,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH023~GEN02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),54.6,54.6,,,48.5,60.4,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH023~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),55.6,55.6,,,46.5,64.2,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH023~AGE01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH023~AGE04~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),45.9,45.9,,,35.6,56.7,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH023~AGE05~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),56.2,56.2,,,49.6,62.7,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH023~AGE06~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),50.2,50.2,,,45.1,55.3,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH023~AGE07~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),53.1,53.1,,,48.4,57.8,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH023~AGE08~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),41.9,41.9,,,33.6,50.7,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH023~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),50.0,50.0,,,40.8,59.1,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH023~RAC01~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),53.9,53.9,,,47.7,60.0,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH023~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),44.7,44.7,,,38.0,51.7,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH023~RAC02~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),48.4,48.4,,,42.8,54.1,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH023~RAC03~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),45.4,45.4,,,38.2,52.9,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH023~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),34.7,34.7,,,24.8,46.1,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH023~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),40.4,40.4,,,30.0,51.7,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH023~RAC04~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),45.9,45.9,,,38.7,53.3,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH023~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),32.4,32.4,,,24.7,41.1,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH023~RAC07~Crude,2011-2012,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),46.0,46.0,,,35.5,56.8,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH023~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),49.3,49.3,,,44.0,54.6,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH023~OVR01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),54.0,54.0,,,48.9,59.0,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH023~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),44.4,44.4,,,37.8,51.3,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH023~GEN01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),51.0,51.0,,,44.3,57.7,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH023~GEN02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),56.9,56.9,,,52.1,61.6,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH023~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),56.6,56.6,,,50.0,62.9,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH023~AGE01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH023~AGE04~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),46.3,46.3,,,39.9,52.9,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH023~AGE05~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),57.0,57.0,,,49.7,64.0,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH023~AGE06~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),54.2,54.2,,,49.3,59.0,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH023~AGE07~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),54.9,54.9,,,49.7,60.0,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH023~AGE08~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),47.4,47.4,,,38.9,56.1,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH023~RAC01~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),57.4,57.4,,,50.0,64.6,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH023~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),55.6,55.6,,,47.1,63.7,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH023~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),39.4,39.4,,,33.9,45.2,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH023~RAC02~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),46.6,46.6,,,40.5,52.8,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH023~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),33.7,33.7,,,25.3,43.3,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH023~RAC03~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),41.5,41.5,,,35.1,48.2,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH023~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),41.4,41.4,,,34.8,48.3,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH023~RAC04~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),47.6,47.6,,,42.5,52.9,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH023~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH023~RAC07~Crude,2013-2014,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),42.9,42.9,,,33.8,52.5,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH023~OVR01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),48.5,48.5,,,44.4,52.5,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH023~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),42.8,42.8,,,38.3,47.4,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH023~GEN01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),45.1,45.1,,,39.9,50.5,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH023~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),34.7,34.7,,,30.7,39.0,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH023~GEN02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),51.6,51.6,,,46.3,56.8,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH023~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),56.6,56.6,,,49.1,63.9,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH023~AGE01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH023~AGE04~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),41.6,41.6,,,35.6,47.8,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH023~AGE05~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),53.7,53.7,,,48.1,59.1,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH023~AGE06~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),45.8,45.8,,,39.7,52.1,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH023~AGE07~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),49.8,49.8,,,45.8,53.8,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH023~AGE08~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),38.2,38.2,,,32.0,44.9,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH023~RAC01~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),50.9,50.9,,,45.3,56.4,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH023~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),45.8,45.8,,,39.0,52.7,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH023~RAC02~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),44.3,44.3,,,41.2,47.4,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH023~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),40.6,40.6,,,36.5,44.9,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH023~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),28.7,28.7,,,21.9,36.6,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH023~RAC03~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),38.2,38.2,,,30.4,46.6,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH023~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),37.4,37.4,,,29.9,45.7,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH023~RAC04~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),44.0,44.0,,,38.0,50.3,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH023~RAC07~Crude,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),42.2,42.2,,,34.7,50.0,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH023~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),35.0,35.0,,,24.3,47.6,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH023~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),37.3,37.3,,,31.4,43.6,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH023~OVR01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),43.9,43.9,,,40.6,47.3,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH023~GEN01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),44.1,44.1,,,38.9,49.3,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH023~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),36.3,36.3,,,29.8,43.4,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH023~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),40.6,40.6,,,33.0,48.7,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH023~GEN02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),43.8,43.8,,,40.1,47.5,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH023~AGE01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH023~AGE04~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),34.1,34.1,,,25.5,43.8,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH023~AGE05~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),46.2,46.2,,,42.4,50.0,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH023~AGE06~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),44.8,44.8,,,39.8,50.0,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH023~AGE07~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),44.8,44.8,,,41.8,47.8,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH023~AGE08~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),36.4,36.4,,,30.5,42.8,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH023~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),38.5,38.5,,,28.9,49.0,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH023~RAC01~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),45.6,45.6,,,40.6,50.6,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH023~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),35.1,35.1,,,27.8,43.1,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH023~RAC02~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),37.9,37.9,,,32.9,43.2,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH023~RAC03~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),43.7,43.7,,,38.3,49.2,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH023~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),39.7,39.7,,,31.7,48.3,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH023~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),31.8,31.8,,,22.5,42.9,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH023~RAC04~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),36.4,36.4,,,30.5,42.6,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH023~RAC07~Crude,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Crude,Percent (%),50.8,50.8,,,44.9,56.8,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH023~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,Healthy People 2030,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =140/90); NHANES,Age-Standardized,Percent (%),42.1,42.1,,,34.8,49.9,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH024~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),31.1,31.1,,,29.2,33.0,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH024~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),31.1,31.1,,,29.3,33.0,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH024~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),40.0,40.0,,,37.1,43.0,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH024~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),39.4,39.4,,,36.5,42.5,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH024~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),22.3,22.3,,,20.4,24.4,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH024~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),22.5,22.5,,,20.6,24.5,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH024~AGE01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),27.7,27.7,,,23.1,32.9,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
NHANES~1999-2000~59~NH024~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),33.7,33.7,,,30.2,37.4,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH024~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),34.2,34.2,,,31.9,36.6,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH024~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),21.2,21.2,,,17.6,25.4,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH024~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),31.4,31.4,,,29.0,33.9,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH024~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),16.8,16.8,,,13.2,21.3,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH024~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),31.5,31.5,,,29.0,34.1,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH024~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),31.3,31.3,,,28.7,33.9,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH024~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.6,29.6,,,26.9,32.4,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH024~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),31.2,31.2,,,28.6,34.0,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH024~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH024~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH024~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH024~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH024~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),30.6,30.6,,,23.3,39.1,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH024~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),30.1,30.1,,,23.1,38.3,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH024~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.8,29.8,,,28.1,31.6,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH024~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),30.1,30.1,,,28.3,32.0,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH024~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),38.2,38.2,,,35.3,41.1,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH024~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),38.9,38.9,,,35.7,42.3,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH024~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),21.5,21.5,,,19.6,23.6,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH024~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),21.4,21.4,,,19.4,23.5,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH024~AGE01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),27.8,27.8,,,24.4,31.5,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
NHANES~2001-2002~59~NH024~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),32.9,32.9,,,29.9,36.1,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH024~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),32.9,32.9,,,30.2,35.6,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH024~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),18.7,18.7,,,15.9,21.9,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH024~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),30.4,30.4,,,28.4,32.5,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH024~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),16.2,16.2,,,13.3,19.6,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH024~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),30.1,30.1,,,28.0,32.2,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH024~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),30.2,30.2,,,28.1,32.3,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH024~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),29.4,29.4,,,24.6,34.9,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH024~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.9,27.9,,,23.6,32.7,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH024~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH024~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH024~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH024~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH024~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),40.8,40.8,,,32.5,49.6,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH024~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),42.2,42.2,,,33.2,51.8,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH024~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.2,28.2,,,26.4,30.1,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH024~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.4,28.4,,,26.5,30.4,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH024~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),34.1,34.1,,,31.2,37.1,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH024~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),33.7,33.7,,,30.9,36.6,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH024~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),22.8,22.8,,,21.0,24.7,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH024~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),22.5,22.5,,,21.0,24.1,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH024~AGE01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),24.4,24.4,,,20.9,28.2,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH024~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),30.7,30.7,,,26.8,35.0,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH024~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),32.4,32.4,,,29.2,35.7,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH024~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),18.2,18.2,,,14.9,22.0,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH024~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),29.0,29.0,,,26.9,31.2,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH024~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),17.0,17.0,,,14.4,20.0,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH024~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.3,28.3,,,25.6,31.2,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH024~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.5,28.5,,,25.7,31.5,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH024~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.1,28.1,,,26.1,30.3,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH024~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),26.9,26.9,,,24.7,29.1,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH024~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH024~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH024~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH024~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH024~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),33.5,33.5,,,26.2,41.6,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH024~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,25.9,40.3,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH024~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.1,28.1,,,25.8,30.6,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH024~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.3,28.3,,,25.7,31.0,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH024~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),34.6,34.6,,,32.1,37.2,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH024~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),34.4,34.4,,,32.2,36.6,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH024~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),22.0,22.0,,,18.4,26.1,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH024~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),21.6,21.6,,,18.1,25.5,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH024~AGE01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.5,28.5,,,22.7,35.1,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH024~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),31.6,31.6,,,28.2,35.3,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH024~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),29.9,29.9,,,26.0,34.0,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH024~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),17.4,17.4,,,15.8,19.2,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH024~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),27.7,27.7,,,25.0,30.4,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH024~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),18.0,18.0,,,15.7,20.6,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH024~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.1,29.1,,,26.0,32.4,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH024~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.9,28.9,,,25.7,32.5,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH024~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),27.6,27.6,,,24.4,31.1,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH024~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),26.7,26.7,,,23.7,29.9,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH024~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH024~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH024~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH024~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH024~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),18.5,18.5,,,13.8,24.3,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH024~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),18.1,18.1,,,13.4,23.8,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH024~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),27.0,27.0,,,25.2,28.8,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH024~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.0,27.0,,,25.1,28.9,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH024~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),33.8,33.8,,,31.5,36.1,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH024~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),33.6,33.6,,,31.3,36.1,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH024~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),20.5,20.5,,,18.4,22.8,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH024~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),20.2,20.2,,,18.0,22.5,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH024~AGE01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),25.2,25.2,,,20.4,30.7,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH024~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.8,28.8,,,25.4,32.5,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH024~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),29.7,29.7,,,27.1,32.4,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH024~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),18.5,18.5,,,15.2,22.4,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH024~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),27.2,27.2,,,25.8,28.7,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH024~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),15.9,15.9,,,13.2,19.1,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH024~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),26.9,26.9,,,24.4,29.5,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH024~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.0,27.0,,,24.3,29.9,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH024~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),24.5,24.5,,,22.4,26.7,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH024~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),23.9,23.9,,,21.8,26.1,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH024~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH024~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH024~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH024~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH024~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),27.5,27.5,,,21.1,34.8,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH024~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.4,27.4,,,21.4,34.4,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH024~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),25.8,25.8,,,23.8,27.8,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH024~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),25.9,25.9,,,24.0,28.0,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH024~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),32.5,32.5,,,30.2,34.9,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH024~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,30.4,35.0,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH024~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),19.2,19.2,,,17.2,21.4,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH024~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),18.9,18.9,,,16.9,21.2,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH024~AGE01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),22.2,22.2,,,17.7,27.5,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH024~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),29.7,29.7,,,26.6,32.9,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH024~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.0,28.0,,,24.9,31.4,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH024~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),15.6,15.6,,,13.3,18.2,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH024~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),25.6,25.6,,,23.4,27.9,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH024~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),13.9,13.9,,,11.8,16.3,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH024~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),25.2,25.2,,,23.0,27.6,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH024~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),25.7,25.7,,,23.4,28.1,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH024~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),26.7,26.7,,,23.7,29.9,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH024~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),26.1,26.1,,,22.7,29.7,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH024~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH024~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH024~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH024~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH024~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),26.3,26.3,,,20.4,33.2,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH024~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),25.5,25.5,,,19.8,32.3,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH024~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),28.1,28.1,,,26.0,30.3,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH024~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.0,28.0,,,25.8,30.2,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH024~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),33.7,33.7,,,31.5,35.9,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH024~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),33.5,33.5,,,31.3,35.8,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH024~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),22.6,22.6,,,20.2,25.2,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH024~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),22.2,22.2,,,19.4,25.1,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH024~AGE01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),25.7,25.7,,,21.4,30.4,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH024~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),30.4,30.4,,,27.7,33.2,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH024~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),31.0,31.0,,,27.2,35.1,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH024~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),18.7,18.7,,,14.6,23.7,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH024~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.0,28.0,,,25.8,30.3,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH024~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),13.3,13.3,,,11.3,15.6,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH024~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.4,29.4,,,26.5,32.4,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH024~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.9,28.9,,,26.1,31.8,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH024~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),25.7,25.7,,,22.0,29.6,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH024~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),25.2,25.2,,,21.9,28.9,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH024~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),24.7,24.7,,,21.0,28.8,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH024~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),24.9,24.9,,,21.3,28.8,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH024~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),25.7,25.7,,,23.3,28.2,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH024~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),25.5,25.5,,,23.4,27.7,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH024~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),27.8,27.8,,,24.0,31.9,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH024~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.9,27.9,,,24.1,32.0,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH024~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),23.9,23.9,,,22.6,25.2,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH024~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),24.0,24.0,,,22.7,25.3,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH024~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.7,29.7,,,27.4,32.1,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH024~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),29.5,29.5,,,27.3,31.7,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH024~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),18.5,18.5,,,16.9,20.3,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH024~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),18.2,18.2,,,16.6,19.9,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH024~AGE01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),23.7,23.7,,,20.8,26.9,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH024~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),24.6,24.6,,,21.1,28.3,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH024~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),26.2,26.2,,,24.0,28.6,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH024~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),18.2,18.2,,,16.2,20.4,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH024~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),24.1,24.1,,,22.3,26.0,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH024~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),13.6,13.6,,,10.7,17.0,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH024~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),23.2,23.2,,,21.5,25.1,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH024~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),23.2,23.2,,,21.4,25.2,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH024~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),24.6,24.6,,,22.5,26.9,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH024~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),24.4,24.4,,,22.2,26.7,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH024~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),21.9,21.9,,,18.9,25.2,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH024~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),21.7,21.7,,,18.8,25.0,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH024~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),26.4,26.4,,,24.2,28.7,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH024~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),26.5,26.5,,,24.4,28.6,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH024~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),23.4,23.4,,,20.1,27.2,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH024~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),22.9,22.9,,,19.6,26.6,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH024~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.0,29.0,,,26.5,31.5,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH024~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.5,28.5,,,26.0,31.0,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH024~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),33.3,33.3,,,30.6,36.1,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH024~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),33.9,33.9,,,31.3,36.7,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH024~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),23.8,23.8,,,21.5,26.4,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH024~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),23.7,23.7,,,21.2,26.3,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH024~AGE01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.4,28.4,,,24.4,32.8,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH024~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),30.7,30.7,,,27.0,34.8,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH024~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),31.3,31.3,,,28.4,34.4,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH024~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),19.8,19.8,,,17.2,22.6,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH024~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.1,28.1,,,25.7,30.6,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH024~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),21.7,21.7,,,18.4,25.4,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH024~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),29.4,29.4,,,25.7,33.3,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH024~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),28.4,28.4,,,25.0,32.2,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH024~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),26.0,26.0,,,23.4,28.7,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH024~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),25.9,25.9,,,23.4,28.5,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH024~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),27.3,27.3,,,23.4,31.6,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH024~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.3,27.3,,,23.3,31.7,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH024~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),32.5,32.5,,,29.5,35.7,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH024~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),31.9,31.9,,,29.1,34.7,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH024~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),25.1,25.1,,,21.5,29.0,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH024~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),25.2,25.2,,,21.4,29.5,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH024~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),26.5,26.5,,,24.4,28.7,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH024~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.0,27.0,,,24.9,29.3,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH024~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),32.6,32.6,,,29.0,36.3,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH024~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),31.9,31.9,,,28.4,35.7,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH024~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),21.3,21.3,,,19.3,23.4,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH024~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),21.2,21.2,,,19.1,23.6,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH024~AGE01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),23.0,23.0,,,18.3,28.6,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH024~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),31.8,31.8,,,28.7,35.2,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH024~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),26.6,26.6,,,21.2,32.9,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH024~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),19.4,19.4,,,16.5,22.8,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH024~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),25.9,25.9,,,22.9,29.1,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH024~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),14.1,14.1,,,11.2,17.7,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH024~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),26.5,26.5,,,24.1,29.1,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH024~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.4,27.4,,,24.9,30.0,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH024~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),24.2,24.2,,,20.2,28.8,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH024~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),24.4,24.4,,,20.3,29.0,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH024~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),24.5,24.5,,,21.8,27.4,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH024~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),24.6,24.6,,,21.8,27.6,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH024~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),27.8,27.8,,,25.3,30.5,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH024~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),27.4,27.4,,,24.9,30.0,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH024~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Crude,Percent (%),26.8,26.8,,,22.9,31.1,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH024~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 130/80-139/89) among US adults (18+); NHANES,Age-Standardized,Percent (%),26.5,26.5,,,22.8,30.6,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH030~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),47.0,47.0,,,44.2,49.8,Overall,Overall,C2,T9,NH030,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH030~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),45.8,45.8,,,43.0,48.7,Overall,Overall,C2,T9,NH030,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH030~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),49.6,49.6,,,46.1,53.0,Gender,Male,C2,T9,NH030,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH030~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),51.7,51.7,,,48.1,55.4,Gender,Male,C2,T9,NH030,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH030~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),41.9,41.9,,,39.0,44.9,Gender,Female,C2,T9,NH030,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH030~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),42.1,42.1,,,38.4,45.9,Gender,Female,C2,T9,NH030,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH030~AGE01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),15.2,15.2,,,9.7,22.9,Age,18-24,C2,T9,NH030,Crude,BOC03,AGE01,59,
NHANES~1999-2000~59~NH030~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),31.6,31.6,,,27.4,36.1,Age,25-44,C2,T9,NH030,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH030~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),61.4,61.4,,,56.8,65.7,Age,45-64,C2,T9,NH030,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH030~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),82.2,82.2,,,77.3,86.2,Age,65+,C2,T9,NH030,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH030~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),58.3,58.3,,,54.7,61.8,Age,35+,C2,T9,NH030,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH030~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),86.1,86.1,,,79.7,90.8,Age,75+,C2,T9,NH030,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH030~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),46.6,46.6,,,42.8,50.5,Race,Non-Hispanic White,C2,T9,NH030,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH030~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),45.8,45.8,,,41.9,49.7,Race,Non-Hispanic White,C2,T9,NH030,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH030~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),53.7,53.7,,,49.2,58.1,Race,Non-Hispanic Black,C2,T9,NH030,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH030~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),58.1,58.1,,,54.4,61.7,Race,Non-Hispanic Black,C2,T9,NH030,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH030~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH030~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH030~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH030,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH030~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH030,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH030~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),49.4,49.4,,,37.9,60.9,Race,Other,C2,T9,NH030,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH030~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),46.5,46.5,,,36.2,57.0,Race,Other,C2,T9,NH030,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH030~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),45.5,45.5,,,43.0,48.1,Overall,Overall,C2,T9,NH030,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH030~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),46.0,46.0,,,43.5,48.5,Overall,Overall,C2,T9,NH030,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH030~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),50.2,50.2,,,46.1,54.2,Gender,Male,C2,T9,NH030,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH030~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),48.9,48.9,,,45.1,52.8,Gender,Male,C2,T9,NH030,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH030~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),42.3,42.3,,,39.2,45.4,Gender,Female,C2,T9,NH030,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH030~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),41.4,41.4,,,39.0,43.8,Gender,Female,C2,T9,NH030,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH030~AGE01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),17.5,17.5,,,14.2,21.3,Age,18-24,C2,T9,NH030,Crude,BOC03,AGE01,59,
NHANES~2001-2002~59~NH030~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),31.1,31.1,,,27.6,34.9,Age,25-44,C2,T9,NH030,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH030~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),58.2,58.2,,,54.1,62.2,Age,45-64,C2,T9,NH030,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH030~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),81.1,81.1,,,77.3,84.3,Age,65+,C2,T9,NH030,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH030~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),56.7,56.7,,,53.3,60.0,Age,35+,C2,T9,NH030,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH030~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),85.7,85.7,,,82.6,88.3,Age,75+,C2,T9,NH030,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH030~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),44.6,44.6,,,41.6,47.6,Race,Non-Hispanic White,C2,T9,NH030,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH030~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),46.1,46.1,,,43.2,49.0,Race,Non-Hispanic White,C2,T9,NH030,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH030~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),55.5,55.5,,,51.9,59.1,Race,Non-Hispanic Black,C2,T9,NH030,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH030~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),59.1,59.1,,,55.5,62.6,Race,Non-Hispanic Black,C2,T9,NH030,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH030~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH030~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH030~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH030,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH030~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH030,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH030~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),57.0,57.0,,,47.2,66.2,Race,Other,C2,T9,NH030,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH030~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),52.8,52.8,,,42.2,63.2,Race,Other,C2,T9,NH030,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH030~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),45.1,45.1,,,42.3,47.9,Overall,Overall,C2,T9,NH030,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH030~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),44.8,44.8,,,42.1,47.4,Overall,Overall,C2,T9,NH030,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH030~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),48.3,48.3,,,44.8,51.9,Gender,Male,C2,T9,NH030,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH030~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),49.0,49.0,,,45.7,52.4,Gender,Male,C2,T9,NH030,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH030~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),41.8,41.8,,,39.1,44.6,Gender,Female,C2,T9,NH030,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH030~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),40.2,40.2,,,38.0,42.5,Gender,Female,C2,T9,NH030,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH030~AGE01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),11.1,11.1,,,8.9,13.8,Age,18-24,C2,T9,NH030,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH030~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),28.6,28.6,,,25.8,31.6,Age,25-44,C2,T9,NH030,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH030~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),61.1,61.1,,,55.9,66.0,Age,45-64,C2,T9,NH030,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH030~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),80.1,80.1,,,77.1,82.9,Age,65+,C2,T9,NH030,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH030~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),58.1,58.1,,,54.4,61.6,Age,35+,C2,T9,NH030,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH030~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),82.7,82.7,,,77.1,87.1,Age,75+,C2,T9,NH030,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH030~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),43.6,43.6,,,40.8,46.4,Race,Non-Hispanic White,C2,T9,NH030,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH030~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),45.9,45.9,,,42.7,49.1,Race,Non-Hispanic White,C2,T9,NH030,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH030~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),51.4,51.4,,,46.4,56.3,Race,Non-Hispanic Black,C2,T9,NH030,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH030~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),54.4,54.4,,,49.2,59.5,Race,Non-Hispanic Black,C2,T9,NH030,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH030~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH030~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH030~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH030,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH030~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH030,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH030~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),43.9,43.9,,,38.4,49.6,Race,Other,C2,T9,NH030,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH030~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),47.0,47.0,,,39.3,54.9,Race,Other,C2,T9,NH030,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH030~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),44.8,44.8,,,43.3,46.4,Overall,Overall,C2,T9,NH030,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH030~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),43.8,43.8,,,41.5,46.0,Overall,Overall,C2,T9,NH030,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH030~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),47.7,47.7,,,45.6,49.9,Gender,Male,C2,T9,NH030,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH030~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),48.0,48.0,,,45.2,50.8,Gender,Male,C2,T9,NH030,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH030~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),42.0,42.0,,,39.6,44.4,Gender,Female,C2,T9,NH030,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH030~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),39.0,39.0,,,36.6,41.5,Gender,Female,C2,T9,NH030,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH030~AGE01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),12.0,12.0,,,8.4,16.9,Age,18-24,C2,T9,NH030,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH030~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),28.2,28.2,,,24.3,32.5,Age,25-44,C2,T9,NH030,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH030~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),58.7,58.7,,,55.5,61.8,Age,45-64,C2,T9,NH030,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH030~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),77.6,77.6,,,74.1,80.7,Age,65+,C2,T9,NH030,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH030~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),56.5,56.5,,,54.2,58.8,Age,35+,C2,T9,NH030,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH030~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),79.5,79.5,,,76.0,82.6,Age,75+,C2,T9,NH030,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH030~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),46.9,46.9,,,44.8,49.0,Race,Non-Hispanic White,C2,T9,NH030,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH030~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),43.4,43.4,,,40.6,46.3,Race,Non-Hispanic White,C2,T9,NH030,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH030~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),51.2,51.2,,,48.5,53.9,Race,Non-Hispanic Black,C2,T9,NH030,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH030~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),53.7,53.7,,,52.0,55.4,Race,Non-Hispanic Black,C2,T9,NH030,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH030~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH030~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH030~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH030,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH030~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH030,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH030~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),37.6,37.6,,,32.7,42.7,Race,Other,C2,T9,NH030,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH030~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),34.1,34.1,,,28.4,40.3,Race,Other,C2,T9,NH030,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH030~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),44.3,44.3,,,42.1,46.6,Overall,Overall,C2,T9,NH030,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH030~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),43.2,43.2,,,41.4,45.0,Overall,Overall,C2,T9,NH030,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH030~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),46.8,46.8,,,44.7,48.9,Gender,Male,C2,T9,NH030,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH030~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),46.8,46.8,,,44.2,49.5,Gender,Male,C2,T9,NH030,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH030~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),42.0,42.0,,,39.3,44.7,Gender,Female,C2,T9,NH030,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH030~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),39.4,39.4,,,37.2,41.6,Gender,Female,C2,T9,NH030,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH030~AGE01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),11.5,11.5,,,9.3,14.1,Age,18-24,C2,T9,NH030,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH030~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),27.9,27.9,,,24.7,31.2,Age,25-44,C2,T9,NH030,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH030~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),56.1,56.1,,,53.1,59.2,Age,45-64,C2,T9,NH030,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH030~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),80.0,80.0,,,76.2,83.3,Age,65+,C2,T9,NH030,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH030~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),56.1,56.1,,,53.8,58.4,Age,35+,C2,T9,NH030,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH030~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),85.4,85.4,,,83.3,87.3,Age,75+,C2,T9,NH030,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH030~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),46.1,46.1,,,43.1,49.1,Race,Non-Hispanic White,C2,T9,NH030,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH030~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),42.7,42.7,,,39.9,45.6,Race,Non-Hispanic White,C2,T9,NH030,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH030~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),50.3,50.3,,,45.3,55.4,Race,Non-Hispanic Black,C2,T9,NH030,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH030~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),52.1,52.1,,,48.1,56.0,Race,Non-Hispanic Black,C2,T9,NH030,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH030~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH030~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH030~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH030,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH030~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH030,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH030~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),37.2,37.2,,,30.0,45.0,Race,Other,C2,T9,NH030,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH030~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),39.0,39.0,,,33.1,45.3,Race,Other,C2,T9,NH030,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH030~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),43.8,43.8,,,41.1,46.5,Overall,Overall,C2,T9,NH030,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH030~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),42.0,42.0,,,39.7,44.4,Overall,Overall,C2,T9,NH030,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH030~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),45.5,45.5,,,42.2,48.8,Gender,Male,C2,T9,NH030,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH030~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),46.0,46.0,,,42.5,49.6,Gender,Male,C2,T9,NH030,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH030~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),41.5,41.5,,,38.7,44.4,Gender,Female,C2,T9,NH030,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH030~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),38.3,38.3,,,36.3,40.4,Gender,Female,C2,T9,NH030,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH030~AGE01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),9.5,9.5,,,6.8,13.2,Age,18-24,C2,T9,NH030,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH030~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),26.6,26.6,,,24.3,29.0,Age,25-44,C2,T9,NH030,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH030~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),55.2,55.2,,,49.8,60.4,Age,45-64,C2,T9,NH030,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH030~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),79.7,79.7,,,76.3,82.7,Age,65+,C2,T9,NH030,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH030~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),55.8,55.8,,,52.0,59.5,Age,35+,C2,T9,NH030,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH030~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),83.4,83.4,,,79.8,86.5,Age,75+,C2,T9,NH030,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH030~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),44.7,44.7,,,41.4,48.0,Race,Non-Hispanic White,C2,T9,NH030,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH030~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),40.6,40.6,,,37.8,43.5,Race,Non-Hispanic White,C2,T9,NH030,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH030~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),54.3,54.3,,,50.3,58.3,Race,Non-Hispanic Black,C2,T9,NH030,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH030~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),55.5,55.5,,,52.8,58.2,Race,Non-Hispanic Black,C2,T9,NH030,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH030~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH030~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH030,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH030~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH030,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH030~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH030,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH030~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),39.8,39.8,,,33.3,46.6,Race,Other,C2,T9,NH030,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH030~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),44.0,44.0,,,38.0,50.1,Race,Other,C2,T9,NH030,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH030~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),44.0,44.0,,,42.3,45.7,Overall,Overall,C2,T9,NH030,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH030~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),46.1,46.1,,,42.9,49.4,Overall,Overall,C2,T9,NH030,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH030~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),48.6,48.6,,,44.5,52.7,Gender,Male,C2,T9,NH030,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH030~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),47.8,47.8,,,45.2,50.4,Gender,Male,C2,T9,NH030,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH030~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),43.7,43.7,,,40.2,47.3,Gender,Female,C2,T9,NH030,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH030~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),39.9,39.9,,,37.7,42.2,Gender,Female,C2,T9,NH030,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH030~AGE01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),13.8,13.8,,,10.6,17.7,Age,18-24,C2,T9,NH030,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH030~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),29.8,29.8,,,25.8,34.0,Age,25-44,C2,T9,NH030,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH030~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),57.7,57.7,,,55.1,60.2,Age,45-64,C2,T9,NH030,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH030~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),78.1,78.1,,,75.3,80.7,Age,65+,C2,T9,NH030,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH030~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),58.1,58.1,,,55.6,60.6,Age,35+,C2,T9,NH030,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH030~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),84.9,84.9,,,81.4,87.9,Age,75+,C2,T9,NH030,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH030~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),43.4,43.4,,,41.2,45.6,Race,Non-Hispanic White,C2,T9,NH030,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH030~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),48.0,48.0,,,44.0,52.1,Race,Non-Hispanic White,C2,T9,NH030,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH030~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),54.4,54.4,,,50.8,58.1,Race,Non-Hispanic Black,C2,T9,NH030,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH030~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),55.6,55.6,,,52.1,59.0,Race,Non-Hispanic Black,C2,T9,NH030,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH030~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),38.3,38.3,,,34.7,42.1,Race,Non-Hispanic Asian,C2,T9,NH030,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH030~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),36.5,36.5,,,31.4,42.0,Race,Non-Hispanic Asian,C2,T9,NH030,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH030~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),39.9,39.9,,,36.5,43.4,Race,Hispanic,C2,T9,NH030,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH030~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),34.3,34.3,,,30.1,38.9,Race,Hispanic,C2,T9,NH030,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH030~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),38.8,38.8,,,33.2,44.7,Race,Other,C2,T9,NH030,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH030~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),40.4,40.4,,,35.9,45.1,Race,Other,C2,T9,NH030,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH030~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),44.0,44.0,,,42.2,45.8,Overall,Overall,C2,T9,NH030,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH030~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),41.7,41.7,,,40.1,43.4,Overall,Overall,C2,T9,NH030,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH030~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),45.2,45.2,,,42.7,47.8,Gender,Male,C2,T9,NH030,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH030~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),46.4,46.4,,,43.8,49.1,Gender,Male,C2,T9,NH030,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH030~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),41.7,41.7,,,39.2,44.3,Gender,Female,C2,T9,NH030,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH030~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),38.2,38.2,,,36.1,40.4,Gender,Female,C2,T9,NH030,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH030~AGE01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),11.9,11.9,,,9.8,14.5,Age,18-24,C2,T9,NH030,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH030~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),25.2,25.2,,,22.9,27.6,Age,25-44,C2,T9,NH030,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH030~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),56.2,56.2,,,53.0,59.4,Age,45-64,C2,T9,NH030,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH030~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),79.1,79.1,,,76.7,81.3,Age,65+,C2,T9,NH030,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH030~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),56.2,56.2,,,53.7,58.7,Age,35+,C2,T9,NH030,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH030~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),80.9,80.9,,,77.1,84.2,Age,75+,C2,T9,NH030,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH030~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),40.4,40.4,,,38.0,42.8,Race,Non-Hispanic White,C2,T9,NH030,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH030~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),45.5,45.5,,,42.7,48.4,Race,Non-Hispanic White,C2,T9,NH030,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH030~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),53.9,53.9,,,51.3,56.4,Race,Non-Hispanic Black,C2,T9,NH030,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH030~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),54.2,54.2,,,52.0,56.5,Race,Non-Hispanic Black,C2,T9,NH030,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH030~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),36.1,36.1,,,33.0,39.2,Race,Non-Hispanic Asian,C2,T9,NH030,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH030~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),35.4,35.4,,,31.3,39.9,Race,Non-Hispanic Asian,C2,T9,NH030,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH030~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),33.5,33.5,,,30.5,36.7,Race,Hispanic,C2,T9,NH030,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH030~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),39.1,39.1,,,36.7,41.5,Race,Hispanic,C2,T9,NH030,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH030~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),39.7,39.7,,,35.5,44.1,Race,Other,C2,T9,NH030,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH030~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),37.2,37.2,,,32.7,41.9,Race,Other,C2,T9,NH030,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH030~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),43.6,43.6,,,41.4,45.8,Overall,Overall,C2,T9,NH030,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH030~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),46.4,46.4,,,44.4,48.4,Overall,Overall,C2,T9,NH030,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH030~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),48.5,48.5,,,45.5,51.5,Gender,Male,C2,T9,NH030,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH030~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),47.2,47.2,,,44.0,50.4,Gender,Male,C2,T9,NH030,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH030~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),39.7,39.7,,,37.2,42.2,Gender,Female,C2,T9,NH030,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH030~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),44.3,44.3,,,42.1,46.5,Gender,Female,C2,T9,NH030,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH030~AGE01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),12.2,12.2,,,9.7,15.1,Age,18-24,C2,T9,NH030,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH030~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),27.6,27.6,,,24.5,31.0,Age,25-44,C2,T9,NH030,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH030~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),58.6,58.6,,,54.9,62.2,Age,45-64,C2,T9,NH030,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH030~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),74.8,74.8,,,69.5,79.4,Age,65+,C2,T9,NH030,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH030~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),58.2,58.2,,,55.5,60.8,Age,35+,C2,T9,NH030,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH030~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),82.6,82.6,,,78.8,85.8,Age,75+,C2,T9,NH030,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH030~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),42.4,42.4,,,39.6,45.2,Race,Non-Hispanic White,C2,T9,NH030,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH030~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),47.4,47.4,,,44.9,50.0,Race,Non-Hispanic White,C2,T9,NH030,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH030~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),53.9,53.9,,,51.0,56.8,Race,Non-Hispanic Black,C2,T9,NH030,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH030~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),54.1,54.1,,,51.1,57.0,Race,Non-Hispanic Black,C2,T9,NH030,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH030~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),42.9,42.9,,,39.1,46.7,Race,Non-Hispanic Asian,C2,T9,NH030,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH030~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),42.5,42.5,,,37.0,48.1,Race,Non-Hispanic Asian,C2,T9,NH030,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH030~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),38.2,38.2,,,34.9,41.5,Race,Hispanic,C2,T9,NH030,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH030~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),43.0,43.0,,,40.6,45.4,Race,Hispanic,C2,T9,NH030,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH030~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),43.7,43.7,,,38.6,49.0,Race,Other,C2,T9,NH030,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH030~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),43.6,43.6,,,40.3,47.0,Race,Other,C2,T9,NH030,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH030~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),45.4,45.4,,,42.7,48.2,Overall,Overall,C2,T9,NH030,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH030~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),48.1,48.1,,,45.6,50.7,Overall,Overall,C2,T9,NH030,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH030~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),52.5,52.5,,,49.4,55.7,Gender,Male,C2,T9,NH030,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH030~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),51.1,51.1,,,47.5,54.6,Gender,Male,C2,T9,NH030,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH030~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),43.9,43.9,,,40.8,47.0,Gender,Female,C2,T9,NH030,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH030~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),39.7,39.7,,,36.8,42.6,Gender,Female,C2,T9,NH030,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH030~AGE01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),10.7,10.7,,,7.8,14.5,Age,18-24,C2,T9,NH030,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH030~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),31.4,31.4,,,28.9,34.1,Age,25-44,C2,T9,NH030,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH030~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),60.3,60.3,,,56.4,64.1,Age,45-64,C2,T9,NH030,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH030~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),77.4,77.4,,,72.5,81.6,Age,65+,C2,T9,NH030,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH030~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),60.2,60.2,,,56.8,63.6,Age,35+,C2,T9,NH030,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH030~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),85.8,85.8,,,82.0,88.9,Age,75+,C2,T9,NH030,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH030~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),43.5,43.5,,,39.6,47.6,Race,Non-Hispanic White,C2,T9,NH030,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH030~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),48.5,48.5,,,44.7,52.4,Race,Non-Hispanic White,C2,T9,NH030,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH030~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),57.5,57.5,,,54.5,60.5,Race,Non-Hispanic Black,C2,T9,NH030,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH030~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),57.3,57.3,,,54.4,60.1,Race,Non-Hispanic Black,C2,T9,NH030,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH030~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),48.2,48.2,,,44.5,51.9,Race,Non-Hispanic Asian,C2,T9,NH030,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH030~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),48.0,48.0,,,44.4,51.5,Race,Non-Hispanic Asian,C2,T9,NH030,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH030~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),39.9,39.9,,,36.8,43.0,Race,Hispanic,C2,T9,NH030,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH030~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),43.7,43.7,,,41.6,45.8,Race,Hispanic,C2,T9,NH030,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH030~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Age-Standardized,Percent (%),47.4,47.4,,,43.8,51.0,Race,Other,C2,T9,NH030,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH030~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension (BP =130/90) among US adults (18+); NHANES,Crude,Percent (%),48.0,48.0,,,43.1,52.9,Race,Other,C2,T9,NH030,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH031~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),39.3,39.3,,,36.0,42.8,Overall,Overall,C2,T9,NH031,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH031~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),45.5,45.5,,,41.9,49.2,Overall,Overall,C2,T9,NH031,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH031~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),35.7,35.7,,,31.6,40.1,Gender,Male,C2,T9,NH031,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH031~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),38.8,38.8,,,34.9,42.7,Gender,Male,C2,T9,NH031,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH031~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),42.7,42.7,,,38.4,47.2,Gender,Female,C2,T9,NH031,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH031~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),53.4,53.4,,,48.4,58.2,Gender,Female,C2,T9,NH031,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH031~AGE01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH031,Crude,BOC03,AGE01,59,
NHANES~1999-2000~59~NH031~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),30.1,30.1,,,23.9,37.1,Age,25-44,C2,T9,NH031,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH031~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),50.5,50.5,,,45.7,55.2,Age,45-64,C2,T9,NH031,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH031~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),60.0,60.0,,,56.9,63.1,Age,65+,C2,T9,NH031,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH031~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),49.8,49.8,,,45.9,53.7,Age,35+,C2,T9,NH031,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH031~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),60.5,60.5,,,56.8,64.1,Age,75+,C2,T9,NH031,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH031~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),38.3,38.3,,,34.8,41.9,Race,Non-Hispanic White,C2,T9,NH031,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH031~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),45.6,45.6,,,41.6,49.6,Race,Non-Hispanic White,C2,T9,NH031,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH031~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),47.6,47.6,,,41.8,53.4,Race,Non-Hispanic Black,C2,T9,NH031,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH031~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),51.3,51.3,,,45.6,56.9,Race,Non-Hispanic Black,C2,T9,NH031,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH031~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH031~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH031~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH031,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH031~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH031,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH031~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),37.5,37.5,,,30.0,45.6,Race,Other,C2,T9,NH031,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH031~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),35.7,35.7,,,28.5,43.7,Race,Other,C2,T9,NH031,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH031~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),42.2,42.2,,,39.4,45.1,Overall,Overall,C2,T9,NH031,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH031~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),48.7,48.7,,,45.4,52.0,Overall,Overall,C2,T9,NH031,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH031~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),40.9,40.9,,,38.0,43.8,Gender,Male,C2,T9,NH031,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH031~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),37.7,37.7,,,35.1,40.4,Gender,Male,C2,T9,NH031,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH031~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),48.6,48.6,,,43.8,53.5,Gender,Female,C2,T9,NH031,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH031~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),57.4,57.4,,,52.0,62.6,Gender,Female,C2,T9,NH031,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH031~AGE01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH031,Crude,BOC03,AGE01,59,
NHANES~2001-2002~59~NH031~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),31.1,31.1,,,25.3,37.6,Age,25-44,C2,T9,NH031,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH031~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),52.0,52.0,,,47.4,56.5,Age,45-64,C2,T9,NH031,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH031~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),66.2,66.2,,,62.4,69.8,Age,65+,C2,T9,NH031,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH031~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),52.5,52.5,,,48.8,56.2,Age,35+,C2,T9,NH031,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH031~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),65.0,65.0,,,59.2,70.3,Age,75+,C2,T9,NH031,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH031~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),49.4,49.4,,,45.6,53.2,Race,Non-Hispanic White,C2,T9,NH031,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH031~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),41.9,41.9,,,38.0,45.8,Race,Non-Hispanic White,C2,T9,NH031,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH031~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),57.3,57.3,,,51.8,62.6,Race,Non-Hispanic Black,C2,T9,NH031,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH031~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),54.6,54.6,,,50.7,58.5,Race,Non-Hispanic Black,C2,T9,NH031,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH031~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH031~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH031~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH031,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH031~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH031,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH031~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),33.6,33.6,,,24.2,44.5,Race,Other,C2,T9,NH031,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH031~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),26.9,26.9,,,19.4,36.0,Race,Other,C2,T9,NH031,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH031~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),47.4,47.4,,,42.9,51.9,Overall,Overall,C2,T9,NH031,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH031~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),55.7,55.7,,,51.5,59.8,Overall,Overall,C2,T9,NH031,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH031~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),52.3,52.3,,,46.9,57.7,Gender,Male,C2,T9,NH031,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH031~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),46.3,46.3,,,41.3,51.3,Gender,Male,C2,T9,NH031,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH031~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),49.5,49.5,,,43.0,56.0,Gender,Female,C2,T9,NH031,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH031~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),59.6,59.6,,,54.2,64.7,Gender,Female,C2,T9,NH031,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH031~AGE01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH031,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH031~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),39.1,39.1,,,32.4,46.2,Age,25-44,C2,T9,NH031,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH031~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),58.0,58.0,,,52.8,63.2,Age,45-64,C2,T9,NH031,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH031~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),71.3,71.3,,,66.8,75.5,Age,65+,C2,T9,NH031,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH031~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),59.7,59.7,,,55.4,63.9,Age,35+,C2,T9,NH031,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH031~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),67.4,67.4,,,61.1,73.1,Age,75+,C2,T9,NH031,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH031~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),47.2,47.2,,,41.7,52.9,Race,Non-Hispanic White,C2,T9,NH031,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH031~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),56.3,56.3,,,51.2,61.2,Race,Non-Hispanic White,C2,T9,NH031,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH031~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),57.2,57.2,,,52.6,61.6,Race,Non-Hispanic Black,C2,T9,NH031,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH031~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),51.1,51.1,,,45.1,57.1,Race,Non-Hispanic Black,C2,T9,NH031,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH031~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH031~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH031~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH031,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH031~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH031,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH031~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),45.1,45.1,,,32.9,57.8,Race,Other,C2,T9,NH031,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH031~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),52.5,52.5,,,41.9,62.9,Race,Other,C2,T9,NH031,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH031~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),46.6,46.6,,,42.7,50.7,Overall,Overall,C2,T9,NH031,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH031~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),56.5,56.5,,,52.0,60.8,Overall,Overall,C2,T9,NH031,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH031~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),43.5,43.5,,,39.4,47.6,Gender,Male,C2,T9,NH031,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH031~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),49.8,49.8,,,45.6,54.0,Gender,Male,C2,T9,NH031,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH031~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),63.9,63.9,,,56.9,70.4,Gender,Female,C2,T9,NH031,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH031~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),52.8,52.8,,,44.1,61.4,Gender,Female,C2,T9,NH031,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH031~AGE01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH031,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH031~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),35.5,35.5,,,29.3,42.2,Age,25-44,C2,T9,NH031,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH031~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),59.0,59.0,,,53.1,64.6,Age,45-64,C2,T9,NH031,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH031~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),73.9,73.9,,,70.3,77.3,Age,65+,C2,T9,NH031,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH031~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),60.6,60.6,,,56.0,65.1,Age,35+,C2,T9,NH031,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH031~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),70.9,70.9,,,65.1,76.2,Age,75+,C2,T9,NH031,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH031~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),44.6,44.6,,,39.6,49.6,Race,Non-Hispanic White,C2,T9,NH031,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH031~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),56.5,56.5,,,51.2,61.6,Race,Non-Hispanic White,C2,T9,NH031,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH031~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),63.8,63.8,,,59.5,67.8,Race,Non-Hispanic Black,C2,T9,NH031,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH031~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),56.6,56.6,,,52.1,60.9,Race,Non-Hispanic Black,C2,T9,NH031,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH031~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH031~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH031~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH031,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH031~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH031,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH031~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH031,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH031~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH031,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH031~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),59.8,59.8,,,57.5,62.0,Overall,Overall,C2,T9,NH031,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH031~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),51.1,51.1,,,48.0,54.3,Overall,Overall,C2,T9,NH031,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH031~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),47.0,47.0,,,43.1,51.0,Gender,Male,C2,T9,NH031,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH031~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),54.1,54.1,,,49.7,58.4,Gender,Male,C2,T9,NH031,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH031~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),65.8,65.8,,,62.8,68.6,Gender,Female,C2,T9,NH031,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH031~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),57.3,57.3,,,53.4,61.1,Gender,Female,C2,T9,NH031,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH031~AGE01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH031,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH031~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),47.2,47.2,,,41.1,53.3,Age,25-44,C2,T9,NH031,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH031~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),60.1,60.1,,,56.7,63.5,Age,45-64,C2,T9,NH031,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH031~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),74.5,74.5,,,70.8,77.9,Age,65+,C2,T9,NH031,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH031~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),63.8,63.8,,,61.5,65.9,Age,35+,C2,T9,NH031,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH031~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),75.4,75.4,,,70.4,79.9,Age,75+,C2,T9,NH031,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH031~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),60.6,60.6,,,57.7,63.5,Race,Non-Hispanic White,C2,T9,NH031,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH031~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),51.3,51.3,,,46.5,56.0,Race,Non-Hispanic White,C2,T9,NH031,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH031~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),60.4,60.4,,,55.6,65.1,Race,Non-Hispanic Black,C2,T9,NH031,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH031~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),66.4,66.4,,,61.3,71.2,Race,Non-Hispanic Black,C2,T9,NH031,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH031~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH031~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH031~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH031,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH031~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH031,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH031~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH031,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH031~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH031,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH031~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),49.6,49.6,,,45.1,54.2,Overall,Overall,C2,T9,NH031,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH031~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),60.4,60.4,,,56.3,64.4,Overall,Overall,C2,T9,NH031,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH031~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),46.9,46.9,,,41.6,52.3,Gender,Male,C2,T9,NH031,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH031~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),55.2,55.2,,,50.1,60.2,Gender,Male,C2,T9,NH031,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH031~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),66.0,66.0,,,61.7,70.1,Gender,Female,C2,T9,NH031,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH031~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),54.1,54.1,,,49.4,58.6,Gender,Female,C2,T9,NH031,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH031~AGE01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH031,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH031~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),34.0,34.0,,,28.4,40.1,Age,25-44,C2,T9,NH031,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH031~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),64.4,64.4,,,59.3,69.1,Age,45-64,C2,T9,NH031,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH031~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),77.0,77.0,,,73.6,80.2,Age,65+,C2,T9,NH031,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH031~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),64.5,64.5,,,60.4,68.3,Age,35+,C2,T9,NH031,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH031~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),77.7,77.7,,,73.0,81.7,Age,75+,C2,T9,NH031,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH031~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),49.3,49.3,,,43.3,55.3,Race,Non-Hispanic White,C2,T9,NH031,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH031~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),61.1,61.1,,,55.8,66.1,Race,Non-Hispanic White,C2,T9,NH031,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH031~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),65.7,65.7,,,61.5,69.6,Race,Non-Hispanic Black,C2,T9,NH031,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH031~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),57.3,57.3,,,53.0,61.5,Race,Non-Hispanic Black,C2,T9,NH031,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH031~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH031~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH031,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH031~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH031,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH031~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH031,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH031~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),49.4,49.4,,,38.9,59.9,Race,Other,C2,T9,NH031,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH031~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),56.6,56.6,,,45.2,67.3,Race,Other,C2,T9,NH031,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH031~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),50.6,50.6,,,47.8,53.5,Overall,Overall,C2,T9,NH031,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH031~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),60.9,60.9,,,57.4,64.2,Overall,Overall,C2,T9,NH031,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH031~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),46.1,46.1,,,42.8,49.4,Gender,Male,C2,T9,NH031,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH031~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),55.0,55.0,,,51.0,58.8,Gender,Male,C2,T9,NH031,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH031~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),67.3,67.3,,,63.3,71.0,Gender,Female,C2,T9,NH031,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH031~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),58.3,58.3,,,53.0,63.4,Gender,Female,C2,T9,NH031,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH031~AGE01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.9,20.9,,,11.9,34.0,Age,18-24,C2,T9,NH031,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH031~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),39.7,39.7,,,34.6,45.1,Age,25-44,C2,T9,NH031,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH031~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),63.2,63.2,,,58.9,67.3,Age,45-64,C2,T9,NH031,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH031~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),78.4,78.4,,,73.5,82.5,Age,65+,C2,T9,NH031,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH031~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),65.6,65.6,,,62.5,68.5,Age,35+,C2,T9,NH031,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH031~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),81.7,81.7,,,77.7,85.1,Age,75+,C2,T9,NH031,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH031~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),48.1,48.1,,,44.4,51.9,Race,Non-Hispanic White,C2,T9,NH031,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH031~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),61.2,61.2,,,56.8,65.5,Race,Non-Hispanic White,C2,T9,NH031,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH031~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),62.5,62.5,,,58.6,66.2,Race,Non-Hispanic Black,C2,T9,NH031,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH031~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),67.5,67.5,,,64.0,70.8,Race,Non-Hispanic Black,C2,T9,NH031,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH031~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),39.8,39.8,,,34.6,45.2,Race,Non-Hispanic Asian,C2,T9,NH031,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH031~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),48.7,48.7,,,43.5,54.0,Race,Non-Hispanic Asian,C2,T9,NH031,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH031~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),50.2,50.2,,,42.4,58.1,Race,Hispanic,C2,T9,NH031,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH031~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),56.0,56.0,,,48.3,63.4,Race,Hispanic,C2,T9,NH031,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH031~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),51.2,51.2,,,42.3,59.9,Race,Other,C2,T9,NH031,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH031~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),43.9,43.9,,,36.6,51.5,Race,Other,C2,T9,NH031,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH031~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),66.4,66.4,,,63.9,68.9,Overall,Overall,C2,T9,NH031,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH031~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),57.9,57.9,,,54.9,60.8,Overall,Overall,C2,T9,NH031,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH031~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),54.1,54.1,,,50.1,58.1,Gender,Male,C2,T9,NH031,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH031~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),61.1,61.1,,,58.1,64.0,Gender,Male,C2,T9,NH031,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH031~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),72.1,72.1,,,68.7,75.4,Gender,Female,C2,T9,NH031,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH031~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),63.2,63.2,,,58.8,67.5,Gender,Female,C2,T9,NH031,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH031~AGE01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),29.0,29.0,,,20.5,39.2,Age,18-24,C2,T9,NH031,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH031~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),50.2,50.2,,,45.4,55.1,Age,25-44,C2,T9,NH031,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH031~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),67.6,67.6,,,63.9,71.1,Age,45-64,C2,T9,NH031,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH031~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),78.7,78.7,,,73.9,82.9,Age,65+,C2,T9,NH031,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH031~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),69.5,69.5,,,66.8,72.1,Age,35+,C2,T9,NH031,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH031~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),82.3,82.3,,,77.1,86.5,Age,75+,C2,T9,NH031,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH031~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),61.2,61.2,,,56.3,65.8,Race,Non-Hispanic White,C2,T9,NH031,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH031~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),69.2,69.2,,,65.8,72.4,Race,Non-Hispanic White,C2,T9,NH031,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH031~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),61.2,61.2,,,55.8,66.4,Race,Non-Hispanic Black,C2,T9,NH031,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH031~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),67.8,67.8,,,63.6,71.8,Race,Non-Hispanic Black,C2,T9,NH031,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH031~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),44.1,44.1,,,36.2,52.4,Race,Non-Hispanic Asian,C2,T9,NH031,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH031~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),56.8,56.8,,,47.7,65.4,Race,Non-Hispanic Asian,C2,T9,NH031,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH031~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),54.0,54.0,,,49.7,58.2,Race,Hispanic,C2,T9,NH031,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH031~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),48.8,48.8,,,44.3,53.4,Race,Hispanic,C2,T9,NH031,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH031~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),48.1,48.1,,,41.7,54.6,Race,Other,C2,T9,NH031,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH031~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),57.0,57.0,,,49.6,64.2,Race,Other,C2,T9,NH031,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH031~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),61.5,61.5,,,57.7,65.1,Overall,Overall,C2,T9,NH031,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH031~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),52.5,52.5,,,49.3,55.6,Overall,Overall,C2,T9,NH031,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH031~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),50.3,50.3,,,46.9,53.8,Gender,Male,C2,T9,NH031,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH031~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),57.5,57.5,,,53.1,61.9,Gender,Male,C2,T9,NH031,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH031~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),65.6,65.6,,,60.5,70.4,Gender,Female,C2,T9,NH031,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH031~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),56.8,56.8,,,50.7,62.7,Gender,Female,C2,T9,NH031,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH031~AGE01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.0,20.0,,,11.2,32.9,Age,18-24,C2,T9,NH031,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH031~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),44.1,44.1,,,38.4,50.1,Age,25-44,C2,T9,NH031,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH031~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),61.5,61.5,,,57.0,65.8,Age,45-64,C2,T9,NH031,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH031~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),75.9,75.9,,,71.7,79.6,Age,65+,C2,T9,NH031,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH031~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),65.5,65.5,,,61.9,69.0,Age,35+,C2,T9,NH031,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH031~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),75.1,75.1,,,70.7,78.9,Age,75+,C2,T9,NH031,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH031~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),62.6,62.6,,,57.2,67.7,Race,Non-Hispanic White,C2,T9,NH031,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH031~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),52.1,52.1,,,46.6,57.5,Race,Non-Hispanic White,C2,T9,NH031,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH031~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),62.8,62.8,,,57.8,67.7,Race,Non-Hispanic Black,C2,T9,NH031,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH031~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),68.0,68.0,,,64.0,71.7,Race,Non-Hispanic Black,C2,T9,NH031,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH031~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),39.9,39.9,,,32.4,47.9,Race,Non-Hispanic Asian,C2,T9,NH031,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH031~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),48.2,48.2,,,39.7,56.8,Race,Non-Hispanic Asian,C2,T9,NH031,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH031~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),46.7,46.7,,,41.2,52.3,Race,Hispanic,C2,T9,NH031,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH031~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),52.8,52.8,,,45.2,60.3,Race,Hispanic,C2,T9,NH031,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH031~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),48.2,48.2,,,39.8,56.6,Race,Other,C2,T9,NH031,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH031~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),56.3,56.3,,,48.8,63.4,Race,Other,C2,T9,NH031,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH031~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),50.5,50.5,,,46.2,54.8,Overall,Overall,C2,T9,NH031,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH031~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),59.7,59.7,,,56.3,63.1,Overall,Overall,C2,T9,NH031,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH031~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),57.4,57.4,,,52.1,62.6,Gender,Male,C2,T9,NH031,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH031~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),50.8,50.8,,,45.3,56.4,Gender,Male,C2,T9,NH031,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH031~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),49.0,49.0,,,44.6,53.4,Gender,Female,C2,T9,NH031,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH031~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),62.4,62.4,,,58.0,66.6,Gender,Female,C2,T9,NH031,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH031~AGE01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH031,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH031~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),38.1,38.1,,,32.3,44.2,Age,25-44,C2,T9,NH031,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH031~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),62.2,62.2,,,57.2,67.0,Age,45-64,C2,T9,NH031,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH031~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),75.0,75.0,,,70.6,78.9,Age,65+,C2,T9,NH031,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH031~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),63.5,63.5,,,59.7,67.1,Age,35+,C2,T9,NH031,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH031~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),74.1,74.1,,,68.5,78.9,Age,75+,C2,T9,NH031,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH031~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),61.5,61.5,,,56.7,66.0,Race,Non-Hispanic White,C2,T9,NH031,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH031~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),52.2,52.2,,,45.2,59.0,Race,Non-Hispanic White,C2,T9,NH031,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH031~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),56.8,56.8,,,49.1,64.2,Race,Non-Hispanic Black,C2,T9,NH031,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH031~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),64.8,64.8,,,59.1,70.1,Race,Non-Hispanic Black,C2,T9,NH031,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH031~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),48.1,48.1,,,41.8,54.4,Race,Non-Hispanic Asian,C2,T9,NH031,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH031~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),55.3,55.3,,,50.0,60.5,Race,Non-Hispanic Asian,C2,T9,NH031,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH031~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),48.3,48.3,,,41.3,55.3,Race,Hispanic,C2,T9,NH031,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH031~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),41.4,41.4,,,34.9,48.1,Race,Hispanic,C2,T9,NH031,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH031~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),49.9,49.9,,,43.0,56.8,Race,Other,C2,T9,NH031,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH031~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),56.9,56.9,,,50.7,62.8,Race,Other,C2,T9,NH031,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH032~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),34.9,34.9,,,30.7,39.3,Overall,Overall,C2,T9,NH032,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH032~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),27.6,27.6,,,24.6,30.9,Overall,Overall,C2,T9,NH032,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH032~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),28.5,28.5,,,24.5,33.0,Gender,Male,C2,T9,NH032,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH032~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),24.7,24.7,,,21.1,28.7,Gender,Male,C2,T9,NH032,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH032~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),30.6,30.6,,,26.8,34.6,Gender,Female,C2,T9,NH032,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH032~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),42.2,42.2,,,37.1,47.5,Gender,Female,C2,T9,NH032,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH032~AGE01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),0.7,0.7,,,0.1,5.1,Age,18-24,C2,T9,NH032,Crude,BOC03,AGE01,59,
NHANES~1999-2000~59~NH032~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.6,16.6,,,11.9,22.9,Age,25-44,C2,T9,NH032,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH032~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),40.4,40.4,,,36.5,44.5,Age,45-64,C2,T9,NH032,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH032~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),51.6,51.6,,,46.5,56.7,Age,65+,C2,T9,NH032,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH032~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),40.0,40.0,,,35.5,44.7,Age,35+,C2,T9,NH032,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH032~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),52.5,52.5,,,45.7,59.2,Age,75+,C2,T9,NH032,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH032~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),36.1,36.1,,,31.6,40.8,Race,Non-Hispanic White,C2,T9,NH032,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH032~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),27.5,27.5,,,25.0,30.1,Race,Non-Hispanic White,C2,T9,NH032,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH032~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),34.5,34.5,,,30.1,39.1,Race,Non-Hispanic Black,C2,T9,NH032,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH032~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),38.7,38.7,,,33.7,43.9,Race,Non-Hispanic Black,C2,T9,NH032,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH032~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH032~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH032~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH032,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH032~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH032,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH032~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.4,20.4,,,11.6,33.3,Race,Other,C2,T9,NH032,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH032~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),22.6,22.6,,,13.0,36.2,Race,Other,C2,T9,NH032,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH032~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),28.5,28.5,,,26.2,30.9,Overall,Overall,C2,T9,NH032,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH032~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),36.0,36.0,,,32.7,39.4,Overall,Overall,C2,T9,NH032,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH032~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),27.2,27.2,,,24.2,30.4,Gender,Male,C2,T9,NH032,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH032~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),23.6,23.6,,,21.7,25.7,Gender,Male,C2,T9,NH032,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH032~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),35.5,35.5,,,31.6,39.5,Gender,Female,C2,T9,NH032,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH032~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),46.0,46.0,,,40.9,51.1,Gender,Female,C2,T9,NH032,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH032~AGE01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH032,Crude,BOC03,AGE01,59,
NHANES~2001-2002~59~NH032~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),14.2,14.2,,,11.1,18.0,Age,25-44,C2,T9,NH032,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH032~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),39.6,39.6,,,35.0,44.3,Age,45-64,C2,T9,NH032,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH032~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),58.2,58.2,,,52.6,63.5,Age,65+,C2,T9,NH032,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH032~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),40.9,40.9,,,37.3,44.7,Age,35+,C2,T9,NH032,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH032~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),57.7,57.7,,,50.4,64.7,Age,75+,C2,T9,NH032,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH032~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),36.4,36.4,,,32.8,40.2,Race,Non-Hispanic White,C2,T9,NH032,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH032~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),26.8,26.8,,,24.1,29.6,Race,Non-Hispanic White,C2,T9,NH032,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH032~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),42.7,42.7,,,37.5,48.1,Race,Non-Hispanic Black,C2,T9,NH032,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH032~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),39.3,39.3,,,36.0,42.7,Race,Non-Hispanic Black,C2,T9,NH032,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH032~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH032~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH032~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH032,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH032~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH032,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH032~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),28.1,28.1,,,19.7,38.4,Race,Other,C2,T9,NH032,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH032~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),23.9,23.9,,,16.4,33.3,Race,Other,C2,T9,NH032,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH032~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),42.7,42.7,,,39.5,46.1,Overall,Overall,C2,T9,NH032,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH032~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),33.2,33.2,,,30.4,36.1,Overall,Overall,C2,T9,NH032,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH032~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),32.2,32.2,,,29.2,35.3,Gender,Male,C2,T9,NH032,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH032~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),39.0,39.0,,,35.2,43.0,Gender,Male,C2,T9,NH032,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH032~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),35.1,35.1,,,29.8,40.9,Gender,Female,C2,T9,NH032,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH032~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),47.0,47.0,,,42.5,51.6,Gender,Female,C2,T9,NH032,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH032~AGE01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH032,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH032~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),22.4,22.4,,,17.1,28.7,Age,25-44,C2,T9,NH032,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH032~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),43.1,43.1,,,38.7,47.5,Age,45-64,C2,T9,NH032,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH032~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),64.1,64.1,,,59.3,68.6,Age,65+,C2,T9,NH032,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH032~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),47.3,47.3,,,43.6,50.9,Age,35+,C2,T9,NH032,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH032~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),59.2,59.2,,,53.0,65.2,Age,75+,C2,T9,NH032,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH032~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),43.3,43.3,,,39.6,47.1,Race,Non-Hispanic White,C2,T9,NH032,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH032~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),32.6,32.6,,,28.8,36.6,Race,Non-Hispanic White,C2,T9,NH032,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH032~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),38.6,38.6,,,33.7,43.6,Race,Non-Hispanic Black,C2,T9,NH032,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH032~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),46.0,46.0,,,40.8,51.2,Race,Non-Hispanic Black,C2,T9,NH032,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH032~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH032~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH032~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH032,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH032~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH032,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH032~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH032,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH032~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH032,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH032~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),33.6,33.6,,,30.5,36.8,Overall,Overall,C2,T9,NH032,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH032~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),45.1,45.1,,,40.4,50.0,Overall,Overall,C2,T9,NH032,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH032~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),30.1,30.1,,,27.3,33.0,Gender,Male,C2,T9,NH032,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH032~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),37.2,37.2,,,32.9,41.9,Gender,Male,C2,T9,NH032,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH032~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),39.6,39.6,,,33.1,46.4,Gender,Female,C2,T9,NH032,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH032~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),53.9,53.9,,,47.2,60.4,Gender,Female,C2,T9,NH032,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH032~AGE01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH032,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH032~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.8,16.8,,,13.6,20.6,Age,25-44,C2,T9,NH032,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH032~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),47.6,47.6,,,41.8,53.3,Age,45-64,C2,T9,NH032,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH032~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),68.8,68.8,,,65.3,72.0,Age,65+,C2,T9,NH032,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH032~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),49.5,49.5,,,45.1,54.0,Age,35+,C2,T9,NH032,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH032~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),64.5,64.5,,,59.0,69.6,Age,75+,C2,T9,NH032,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH032~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),31.8,31.8,,,28.0,35.7,Race,Non-Hispanic White,C2,T9,NH032,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH032~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),45.8,45.8,,,40.2,51.4,Race,Non-Hispanic White,C2,T9,NH032,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH032~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),45.6,45.6,,,42.2,49.0,Race,Non-Hispanic Black,C2,T9,NH032,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH032~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),53.6,53.6,,,49.5,57.6,Race,Non-Hispanic Black,C2,T9,NH032,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH032~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH032~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH032~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH032,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH032~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH032,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH032~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH032,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH032~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH032,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH032~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),39.0,39.0,,,35.8,42.2,Overall,Overall,C2,T9,NH032,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH032~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),49.4,49.4,,,46.9,51.8,Overall,Overall,C2,T9,NH032,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH032~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),34.1,34.1,,,30.6,37.9,Gender,Male,C2,T9,NH032,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH032~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),42.2,42.2,,,38.4,46.2,Gender,Male,C2,T9,NH032,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH032~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),46.3,46.3,,,42.1,50.5,Gender,Female,C2,T9,NH032,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH032~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),56.9,56.9,,,54.1,59.7,Gender,Female,C2,T9,NH032,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH032~AGE01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH032,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH032~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),27.3,27.3,,,22.6,32.5,Age,25-44,C2,T9,NH032,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH032~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),50.2,50.2,,,46.5,53.9,Age,45-64,C2,T9,NH032,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH032~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),70.0,70.0,,,66.2,73.4,Age,65+,C2,T9,NH032,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH032~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),53.9,53.9,,,51.5,56.3,Age,35+,C2,T9,NH032,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH032~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),71.1,71.1,,,66.4,75.4,Age,75+,C2,T9,NH032,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH032~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),39.6,39.6,,,35.2,44.1,Race,Non-Hispanic White,C2,T9,NH032,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH032~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),50.9,50.9,,,48.0,53.7,Race,Non-Hispanic White,C2,T9,NH032,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH032~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),47.1,47.1,,,41.7,52.6,Race,Non-Hispanic Black,C2,T9,NH032,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH032~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),53.8,53.8,,,48.3,59.2,Race,Non-Hispanic Black,C2,T9,NH032,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH032~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH032~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH032~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH032,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH032~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH032,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH032~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH032,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH032~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),25.1,25.1,,,16.0,37.1,Race,Other,C2,T9,NH032,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH032~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),40.1,40.1,,,36.1,44.3,Overall,Overall,C2,T9,NH032,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH032~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),52.7,52.7,,,48.2,57.2,Overall,Overall,C2,T9,NH032,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH032~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),36.7,36.7,,,32.2,41.5,Gender,Male,C2,T9,NH032,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH032~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),46.4,46.4,,,41.3,51.7,Gender,Male,C2,T9,NH032,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH032~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),45.5,45.5,,,41.3,49.9,Gender,Female,C2,T9,NH032,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH032~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),59.5,59.5,,,54.6,64.2,Gender,Female,C2,T9,NH032,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH032~AGE01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH032,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH032~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),22.6,22.6,,,18.1,27.9,Age,25-44,C2,T9,NH032,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH032~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),55.7,55.7,,,49.8,61.4,Age,45-64,C2,T9,NH032,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH032~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),73.3,73.3,,,69.8,76.6,Age,65+,C2,T9,NH032,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH032~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),57.2,57.2,,,52.6,61.7,Age,35+,C2,T9,NH032,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH032~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),74.7,74.7,,,69.7,79.1,Age,75+,C2,T9,NH032,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH032~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),40.3,40.3,,,35.2,45.6,Race,Non-Hispanic White,C2,T9,NH032,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH032~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),54.4,54.4,,,48.7,59.9,Race,Non-Hispanic White,C2,T9,NH032,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH032~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),46.4,46.4,,,40.1,52.9,Race,Non-Hispanic Black,C2,T9,NH032,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH032~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),55.7,55.7,,,49.7,61.5,Race,Non-Hispanic Black,C2,T9,NH032,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH032~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH032~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH032,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH032~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH032,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH032~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH032,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH032~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),47.6,47.6,,,39.2,56.1,Race,Other,C2,T9,NH032,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH032~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),38.7,38.7,,,31.0,47.0,Race,Other,C2,T9,NH032,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH032~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),50.3,50.3,,,46.0,54.5,Overall,Overall,C2,T9,NH032,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH032~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),38.0,38.0,,,35.1,41.1,Overall,Overall,C2,T9,NH032,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH032~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),32.9,32.9,,,30.2,35.8,Gender,Male,C2,T9,NH032,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH032~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),43.0,43.0,,,38.6,47.6,Gender,Male,C2,T9,NH032,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH032~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),46.2,46.2,,,40.7,51.7,Gender,Female,C2,T9,NH032,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH032~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),58.1,58.1,,,53.6,62.4,Gender,Female,C2,T9,NH032,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH032~AGE01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH032,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH032~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),23.0,23.0,,,19.1,27.5,Age,25-44,C2,T9,NH032,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH032~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),53.0,53.0,,,47.9,58.1,Age,45-64,C2,T9,NH032,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH032~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),72.6,72.6,,,66.5,77.9,Age,65+,C2,T9,NH032,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH032~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),55.5,55.5,,,51.7,59.2,Age,35+,C2,T9,NH032,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH032~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),76.0,76.0,,,69.8,81.3,Age,75+,C2,T9,NH032,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH032~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),37.7,37.7,,,33.4,42.3,Race,Non-Hispanic White,C2,T9,NH032,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH032~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),51.9,51.9,,,46.7,57.2,Race,Non-Hispanic White,C2,T9,NH032,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH032~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),48.0,48.0,,,43.7,52.2,Race,Non-Hispanic Black,C2,T9,NH032,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH032~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),55.1,55.1,,,49.7,60.4,Race,Non-Hispanic Black,C2,T9,NH032,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH032~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),28.5,28.5,,,23.7,34.0,Race,Non-Hispanic Asian,C2,T9,NH032,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH032~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),38.8,38.8,,,32.2,45.7,Race,Non-Hispanic Asian,C2,T9,NH032,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH032~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),33.7,33.7,,,28.5,39.3,Race,Hispanic,C2,T9,NH032,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH032~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),41.0,41.0,,,33.1,49.3,Race,Hispanic,C2,T9,NH032,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH032~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),37.1,37.1,,,29.4,45.7,Race,Other,C2,T9,NH032,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH032~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),27.4,27.4,,,22.9,32.3,Race,Other,C2,T9,NH032,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH032~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),54.2,54.2,,,51.2,57.1,Overall,Overall,C2,T9,NH032,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH032~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),41.6,41.6,,,38.6,44.6,Overall,Overall,C2,T9,NH032,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH032~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),38.2,38.2,,,34.8,41.7,Gender,Male,C2,T9,NH032,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH032~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),48.3,48.3,,,45.5,51.2,Gender,Male,C2,T9,NH032,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH032~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),46.4,46.4,,,42.7,50.3,Gender,Female,C2,T9,NH032,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH032~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),60.4,60.4,,,56.1,64.4,Gender,Female,C2,T9,NH032,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH032~AGE01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH032,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH032~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),29.4,29.4,,,24.3,35.2,Age,25-44,C2,T9,NH032,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH032~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),55.5,55.5,,,51.9,59.0,Age,45-64,C2,T9,NH032,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH032~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),72.7,72.7,,,67.2,77.6,Age,65+,C2,T9,NH032,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH032~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),58.4,58.4,,,54.8,61.9,Age,35+,C2,T9,NH032,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH032~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),75.1,75.1,,,69.2,80.2,Age,75+,C2,T9,NH032,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH032~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),43.4,43.4,,,39.3,47.7,Race,Non-Hispanic White,C2,T9,NH032,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH032~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),56.8,56.8,,,52.8,60.7,Race,Non-Hispanic White,C2,T9,NH032,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH032~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),45.3,45.3,,,40.9,49.7,Race,Non-Hispanic Black,C2,T9,NH032,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH032~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),56.0,56.0,,,51.6,60.3,Race,Non-Hispanic Black,C2,T9,NH032,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH032~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),46.2,46.2,,,37.7,54.8,Race,Non-Hispanic Asian,C2,T9,NH032,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH032~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),31.5,31.5,,,26.2,37.3,Race,Non-Hispanic Asian,C2,T9,NH032,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH032~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),41.1,41.1,,,36.1,46.3,Race,Hispanic,C2,T9,NH032,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH032~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),35.1,35.1,,,31.0,39.4,Race,Hispanic,C2,T9,NH032,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH032~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),45.5,45.5,,,38.2,53.0,Race,Other,C2,T9,NH032,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH032~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),35.5,35.5,,,30.5,40.8,Race,Other,C2,T9,NH032,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH032~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),38.6,38.6,,,35.8,41.5,Overall,Overall,C2,T9,NH032,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH032~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),50.7,50.7,,,46.8,54.7,Overall,Overall,C2,T9,NH032,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH032~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),44.0,44.0,,,39.5,48.5,Gender,Male,C2,T9,NH032,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH032~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),34.8,34.8,,,31.2,38.6,Gender,Male,C2,T9,NH032,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH032~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),45.1,45.1,,,39.4,50.9,Gender,Female,C2,T9,NH032,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH032~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),57.8,57.8,,,52.6,62.8,Gender,Female,C2,T9,NH032,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH032~AGE01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH032,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH032~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),26.7,26.7,,,22.0,32.0,Age,25-44,C2,T9,NH032,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH032~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),50.0,50.0,,,45.4,54.7,Age,45-64,C2,T9,NH032,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH032~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),70.7,70.7,,,66.2,74.8,Age,65+,C2,T9,NH032,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH032~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),55.7,55.7,,,51.8,59.5,Age,35+,C2,T9,NH032,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH032~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),69.8,69.8,,,65.4,73.8,Age,75+,C2,T9,NH032,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH032~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),38.6,38.6,,,34.3,43.0,Race,Non-Hispanic White,C2,T9,NH032,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH032~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),52.5,52.5,,,46.8,58.0,Race,Non-Hispanic White,C2,T9,NH032,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH032~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),47.4,47.4,,,42.7,52.2,Race,Non-Hispanic Black,C2,T9,NH032,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH032~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),55.7,55.7,,,51.6,59.7,Race,Non-Hispanic Black,C2,T9,NH032,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH032~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),30.5,30.5,,,24.0,37.9,Race,Non-Hispanic Asian,C2,T9,NH032,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH032~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),39.9,39.9,,,30.8,49.8,Race,Non-Hispanic Asian,C2,T9,NH032,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH032~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,29.4,36.2,Race,Hispanic,C2,T9,NH032,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH032~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),40.6,40.6,,,33.9,47.7,Race,Hispanic,C2,T9,NH032,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH032~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),34.5,34.5,,,28.5,41.1,Race,Other,C2,T9,NH032,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH032~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),45.1,45.1,,,39.9,50.5,Race,Other,C2,T9,NH032,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH032~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),35.7,35.7,,,32.4,39.2,Overall,Overall,C2,T9,NH032,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH032~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),48.3,48.3,,,45.0,51.7,Overall,Overall,C2,T9,NH032,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH032~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),33.9,33.9,,,29.7,38.4,Gender,Male,C2,T9,NH032,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH032~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),43.5,43.5,,,38.7,48.5,Gender,Male,C2,T9,NH032,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH032~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),38.6,38.6,,,34.7,42.6,Gender,Female,C2,T9,NH032,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH032~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),53.8,53.8,,,49.8,57.8,Gender,Female,C2,T9,NH032,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH032~AGE01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH032,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH032~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),18.7,18.7,,,14.3,24.2,Age,25-44,C2,T9,NH032,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH032~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),49.9,49.9,,,44.2,55.5,Age,45-64,C2,T9,NH032,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH032~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),70.0,70.0,,,65.7,74.1,Age,65+,C2,T9,NH032,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH032~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),53.3,53.3,,,49.8,56.8,Age,35+,C2,T9,NH032,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH032~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),70.3,70.3,,,64.3,75.6,Age,75+,C2,T9,NH032,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH032~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),34.5,34.5,,,28.9,40.6,Race,Non-Hispanic White,C2,T9,NH032,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH032~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),49.4,49.4,,,44.7,54.0,Race,Non-Hispanic White,C2,T9,NH032,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH032~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),53.2,53.2,,,48.3,58.1,Race,Non-Hispanic Black,C2,T9,NH032,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH032~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),43.6,43.6,,,38.6,48.8,Race,Non-Hispanic Black,C2,T9,NH032,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH032~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),45.8,45.8,,,40.5,51.2,Race,Non-Hispanic Asian,C2,T9,NH032,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH032~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),35.9,35.9,,,31.3,40.7,Race,Non-Hispanic Asian,C2,T9,NH032,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH032~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),31.8,31.8,,,27.1,36.9,Race,Hispanic,C2,T9,NH032,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH032~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),38.3,38.3,,,32.9,44.0,Race,Hispanic,C2,T9,NH032,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH032~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),37.6,37.6,,,32.4,43.0,Race,Other,C2,T9,NH032,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH032~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),48.1,48.1,,,42.9,53.3,Race,Other,C2,T9,NH032,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH033~OVR01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),9.1,9.1,,,7.9,10.6,Overall,Overall,C2,T9,NH033,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH033~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),7.6,7.6,,,6.5,8.7,Overall,Overall,C2,T9,NH033,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH033~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),6.6,6.6,,,5.6,7.8,Gender,Male,C2,T9,NH033,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH033~GEN01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),7.6,7.6,,,6.5,8.9,Gender,Male,C2,T9,NH033,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH033~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),8.7,8.7,,,6.6,11.4,Gender,Female,C2,T9,NH033,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH033~GEN02~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),10.9,10.9,,,8.7,13.7,Gender,Female,C2,T9,NH033,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH033~AGE01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,18-24,C2,T9,NH033,Crude,BOC03,AGE01,59,
NHANES~1999-2000~59~NH033~AGE04~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),5.5,5.5,,,3.6,8.2,Age,25-44,C2,T9,NH033,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH033~AGE05~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),11.9,11.9,,,10.2,13.8,Age,45-64,C2,T9,NH033,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH033~AGE06~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),10.5,10.5,,,8.2,13.5,Age,65+,C2,T9,NH033,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH033~AGE07~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),10.4,10.4,,,8.8,12.2,Age,35+,C2,T9,NH033,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH033~AGE08~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),7.6,7.6,,,5.2,11.2,Age,75+,C2,T9,NH033,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH033~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),8.5,8.5,,,7.4,9.8,Race,Non-Hispanic White,C2,T9,NH033,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH033~RAC01~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),10.1,10.1,,,8.7,11.7,Race,Non-Hispanic White,C2,T9,NH033,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH033~RAC02~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),8.0,8.0,,,5.7,11.1,Race,Non-Hispanic Black,C2,T9,NH033,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH033~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),6.9,6.9,,,4.9,9.6,Race,Non-Hispanic Black,C2,T9,NH033,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH033~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH033~RAC03~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH033~RAC04~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH033,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH033~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH033,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH033~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH033,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH033~RAC07~Crude,1999-2000,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH033,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH033~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),9.5,9.5,,,7.8,11.5,Overall,Overall,C2,T9,NH033,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH033~OVR01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),11.7,11.7,,,9.7,14.0,Overall,Overall,C2,T9,NH033,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH033~GEN01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),9.4,9.4,,,7.3,12.0,Gender,Male,C2,T9,NH033,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH033~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),8.0,8.0,,,6.4,10.0,Gender,Male,C2,T9,NH033,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH033~GEN02~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),14.3,14.3,,,11.1,18.2,Gender,Female,C2,T9,NH033,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH033~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),13.1,13.1,,,9.1,18.4,Gender,Female,C2,T9,NH033,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH033~AGE01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH033,Crude,BOC03,AGE01,59,
NHANES~2001-2002~59~NH033~AGE04~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),4.4,4.4,,,2.7,6.9,Age,25-44,C2,T9,NH033,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH033~AGE05~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),14.1,14.1,,,11.4,17.3,Age,45-64,C2,T9,NH033,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH033~AGE06~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.3,16.3,,,13.1,20.2,Age,65+,C2,T9,NH033,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH033~AGE07~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),13.1,13.1,,,10.9,15.7,Age,35+,C2,T9,NH033,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH033~AGE08~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),17.0,17.0,,,12.7,22.4,Age,75+,C2,T9,NH033,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH033~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),9.2,9.2,,,7.5,11.2,Race,Non-Hispanic White,C2,T9,NH033,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH033~RAC01~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),12.4,12.4,,,10.3,14.9,Race,Non-Hispanic White,C2,T9,NH033,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH033~RAC02~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),11.3,11.3,,,8.1,15.4,Race,Non-Hispanic Black,C2,T9,NH033,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH033~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,7.5,15.3,Race,Non-Hispanic Black,C2,T9,NH033,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH033~RAC03~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH033~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH033~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH033,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH033~RAC04~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH033,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH033~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH033,AgeStdz,BOC04,RAC07,59,
NHANES~2001-2002~59~NH033~RAC07~Crude,2001-2002,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH033,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH033~OVR01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),15.0,15.0,,,13.1,17.1,Overall,Overall,C2,T9,NH033,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH033~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),11.9,11.9,,,10.4,13.7,Overall,Overall,C2,T9,NH033,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH033~GEN01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),14.8,14.8,,,12.4,17.5,Gender,Male,C2,T9,NH033,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH033~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),12.4,12.4,,,10.8,14.2,Gender,Male,C2,T9,NH033,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH033~GEN02~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),15.2,15.2,,,12.5,18.3,Gender,Female,C2,T9,NH033,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH033~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),11.6,11.6,,,9.0,14.9,Gender,Female,C2,T9,NH033,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH033~AGE01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH033,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH033~AGE04~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),7.9,7.9,,,5.2,11.8,Age,25-44,C2,T9,NH033,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH033~AGE05~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),17.6,17.6,,,14.5,21.2,Age,45-64,C2,T9,NH033,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH033~AGE06~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),18.3,18.3,,,14.9,22.1,Age,65+,C2,T9,NH033,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH033~AGE07~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.5,16.5,,,14.5,18.9,Age,35+,C2,T9,NH033,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH033~AGE08~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),13.3,13.3,,,10.3,17.0,Age,75+,C2,T9,NH033,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH033~RAC01~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.1,16.1,,,13.8,18.7,Race,Non-Hispanic White,C2,T9,NH033,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH033~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),12.8,12.8,,,10.5,15.6,Race,Non-Hispanic White,C2,T9,NH033,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH033~RAC02~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),15.4,15.4,,,12.4,18.9,Race,Non-Hispanic Black,C2,T9,NH033,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH033~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),13.1,13.1,,,10.8,15.8,Race,Non-Hispanic Black,C2,T9,NH033,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH033~RAC03~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH033~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH033~RAC04~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH033,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH033~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH033,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH033~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH033,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH033~RAC07~Crude,2003-2004,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH033,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH033~OVR01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.9,16.9,,,14.0,20.4,Overall,Overall,C2,T9,NH033,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH033~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),13.0,13.0,,,11.0,15.2,Overall,Overall,C2,T9,NH033,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH033~GEN01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),14.7,14.7,,,11.6,18.5,Gender,Male,C2,T9,NH033,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH033~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),11.8,11.8,,,9.8,14.2,Gender,Male,C2,T9,NH033,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH033~GEN02~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),19.4,19.4,,,15.5,24.0,Gender,Female,C2,T9,NH033,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH033~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),16.0,16.0,,,12.4,20.3,Gender,Female,C2,T9,NH033,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH033~AGE01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH033,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH033~AGE04~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),6.9,6.9,,,4.8,9.8,Age,25-44,C2,T9,NH033,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH033~AGE05~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),19.4,19.4,,,16.2,23.0,Age,45-64,C2,T9,NH033,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH033~AGE06~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),22.9,22.9,,,19.2,27.0,Age,65+,C2,T9,NH033,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH033~AGE07~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),18.4,18.4,,,15.5,21.8,Age,35+,C2,T9,NH033,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH033~AGE08~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.5,20.5,,,16.0,25.9,Age,75+,C2,T9,NH033,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH033~RAC01~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),17.4,17.4,,,14.1,21.2,Race,Non-Hispanic White,C2,T9,NH033,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH033~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),12.7,12.7,,,10.6,15.1,Race,Non-Hispanic White,C2,T9,NH033,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH033~RAC02~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),18.8,18.8,,,16.5,21.5,Race,Non-Hispanic Black,C2,T9,NH033,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH033~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),16.5,16.5,,,14.4,18.8,Race,Non-Hispanic Black,C2,T9,NH033,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH033~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH033~RAC03~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH033~RAC04~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH033,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH033~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH033,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH033~RAC07~Crude,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH033,Crude,BOC04,RAC07,59,
NHANES~2005-2006~59~NH033~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH033,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH033~OVR01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.8,20.8,,,17.8,24.3,Overall,Overall,C2,T9,NH033,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH033~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),17.3,17.3,,,14.4,20.7,Overall,Overall,C2,T9,NH033,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH033~GEN01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.8,16.8,,,14.2,19.9,Gender,Male,C2,T9,NH033,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH033~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),13.8,13.8,,,11.3,16.9,Gender,Male,C2,T9,NH033,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH033~GEN02~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),25.1,25.1,,,21.1,29.6,Gender,Female,C2,T9,NH033,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH033~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),22.6,22.6,,,17.7,28.4,Gender,Female,C2,T9,NH033,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH033~AGE01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH033,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH033~AGE04~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),13.0,13.0,,,9.6,17.5,Age,25-44,C2,T9,NH033,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH033~AGE05~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),21.9,21.9,,,17.9,26.5,Age,45-64,C2,T9,NH033,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH033~AGE06~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),27.3,27.3,,,23.1,31.9,Age,65+,C2,T9,NH033,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH033~AGE07~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),22.5,22.5,,,19.3,26.0,Age,35+,C2,T9,NH033,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH033~AGE08~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),24.1,24.1,,,20.3,28.4,Age,75+,C2,T9,NH033,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH033~RAC01~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),21.7,21.7,,,17.9,26.0,Race,Non-Hispanic White,C2,T9,NH033,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH033~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),18.3,18.3,,,14.6,22.7,Race,Non-Hispanic White,C2,T9,NH033,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH033~RAC02~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),21.0,21.0,,,17.3,25.3,Race,Non-Hispanic Black,C2,T9,NH033,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH033~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),18.1,18.1,,,14.8,22.0,Race,Non-Hispanic Black,C2,T9,NH033,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH033~RAC03~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH033~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH033~RAC04~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH033,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH033~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH033,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH033~RAC07~Crude,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),15.8,15.8,,,9.5,25.2,Race,Other,C2,T9,NH033,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH033~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Other,C2,T9,NH033,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH033~OVR01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),23.6,23.6,,,21.2,26.2,Overall,Overall,C2,T9,NH033,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH033~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),17.6,17.6,,,15.4,20.0,Overall,Overall,C2,T9,NH033,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH033~GEN01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.1,20.1,,,16.7,24.0,Gender,Male,C2,T9,NH033,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH033~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),15.2,15.2,,,12.6,18.3,Gender,Male,C2,T9,NH033,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH033~GEN02~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),27.3,27.3,,,23.7,31.4,Gender,Female,C2,T9,NH033,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH033~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),21.6,21.6,,,18.1,25.5,Gender,Female,C2,T9,NH033,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH033~AGE01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH033,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH033~AGE04~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),7.8,7.8,,,5.2,11.5,Age,25-44,C2,T9,NH033,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH033~AGE05~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),26.4,26.4,,,22.7,30.5,Age,45-64,C2,T9,NH033,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH033~AGE06~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),32.5,32.5,,,29.4,35.7,Age,65+,C2,T9,NH033,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH033~AGE07~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),25.7,25.7,,,23.2,28.5,Age,35+,C2,T9,NH033,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH033~AGE08~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),29.1,29.1,,,25.1,33.5,Age,75+,C2,T9,NH033,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH033~RAC01~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),25.6,25.6,,,23.1,28.3,Race,Non-Hispanic White,C2,T9,NH033,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH033~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),18.2,18.2,,,16.1,20.5,Race,Non-Hispanic White,C2,T9,NH033,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH033~RAC02~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),21.4,21.4,,,17.7,25.7,Race,Non-Hispanic Black,C2,T9,NH033,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH033~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),17.8,17.8,,,13.7,22.8,Race,Non-Hispanic Black,C2,T9,NH033,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH033~RAC03~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH033~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH033,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH033~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH033,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH033~RAC04~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH033,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH033~RAC07~Crude,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.1,20.1,,,13.1,29.5,Race,Other,C2,T9,NH033,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH033~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),17.2,17.2,,,10.6,26.6,Race,Other,C2,T9,NH033,AgeStdz,BOC04,RAC07,59,
NHANES~2011-2012~59~NH033~OVR01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),22.9,22.9,,,19.5,26.8,Overall,Overall,C2,T9,NH033,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH033~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),18.1,18.1,,,15.1,21.6,Overall,Overall,C2,T9,NH033,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH033~GEN01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),21.7,21.7,,,18.5,25.2,Gender,Male,C2,T9,NH033,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH033~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),16.3,16.3,,,14.1,18.8,Gender,Male,C2,T9,NH033,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH033~GEN02~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),24.3,24.3,,,19.4,29.9,Gender,Female,C2,T9,NH033,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH033~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),22.4,22.4,,,16.7,29.4,Gender,Female,C2,T9,NH033,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH033~AGE01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),0.0,0.0,,,,,Age,18-24,C2,T9,NH033,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH033~AGE04~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),11.0,11.0,,,7.6,15.7,Age,25-44,C2,T9,NH033,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH033~AGE05~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),27.9,27.9,,,23.8,32.3,Age,45-64,C2,T9,NH033,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH033~AGE06~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),27.1,27.1,,,22.5,32.4,Age,65+,C2,T9,NH033,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH033~AGE07~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),25.3,25.3,,,22.1,28.9,Age,35+,C2,T9,NH033,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH033~AGE08~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),19.7,19.7,,,14.5,26.1,Age,75+,C2,T9,NH033,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH033~RAC01~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),24.8,24.8,,,20.7,29.4,Race,Non-Hispanic White,C2,T9,NH033,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH033~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),19.4,19.4,,,15.6,24.0,Race,Non-Hispanic White,C2,T9,NH033,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH033~RAC02~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.6,20.6,,,16.3,25.6,Race,Non-Hispanic Black,C2,T9,NH033,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH033~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),18.5,18.5,,,14.5,23.4,Race,Non-Hispanic Black,C2,T9,NH033,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH033~RAC03~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.0,16.0,,,11.3,22.4,Race,Non-Hispanic Asian,C2,T9,NH033,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH033~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),12.7,12.7,,,8.2,19.0,Race,Non-Hispanic Asian,C2,T9,NH033,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH033~RAC04~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.1,16.1,,,12.6,20.4,Race,Hispanic,C2,T9,NH033,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH033~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),13.0,13.0,,,10.4,16.0,Race,Hispanic,C2,T9,NH033,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH033~RAC07~Crude,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),18.8,18.8,,,12.0,28.2,Race,Other,C2,T9,NH033,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH033~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),14.1,14.1,,,9.6,20.1,Race,Other,C2,T9,NH033,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH033~OVR01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),25.0,25.0,,,22.2,28.1,Overall,Overall,C2,T9,NH033,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH033~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),20.1,20.1,,,18.1,22.3,Overall,Overall,C2,T9,NH033,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH033~GEN01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),21.8,21.8,,,19.0,24.8,Gender,Male,C2,T9,NH033,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH033~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),17.3,17.3,,,15.2,19.5,Gender,Male,C2,T9,NH033,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH033~GEN02~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),28.5,28.5,,,24.6,32.6,Gender,Female,C2,T9,NH033,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH033~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),24.6,24.6,,,21.6,27.9,Gender,Female,C2,T9,NH033,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH033~AGE01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH033,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH033~AGE04~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.4,16.4,,,13.3,20.0,Age,25-44,C2,T9,NH033,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH033~AGE05~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),27.1,27.1,,,23.1,31.5,Age,45-64,C2,T9,NH033,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH033~AGE06~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),29.7,29.7,,,24.7,35.3,Age,65+,C2,T9,NH033,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH033~AGE07~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),27.0,27.0,,,23.5,30.9,Age,35+,C2,T9,NH033,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH033~AGE08~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),29.1,29.1,,,23.4,35.5,Age,75+,C2,T9,NH033,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH033~RAC01~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),27.9,27.9,,,24.3,31.8,Race,Non-Hispanic White,C2,T9,NH033,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH033~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),22.7,22.7,,,20.3,25.4,Race,Non-Hispanic White,C2,T9,NH033,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH033~RAC02~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.4,20.4,,,16.3,25.1,Race,Non-Hispanic Black,C2,T9,NH033,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH033~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),16.6,16.6,,,13.2,20.7,Race,Non-Hispanic Black,C2,T9,NH033,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH033~RAC03~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.0,16.0,,,11.3,22.2,Race,Non-Hispanic Asian,C2,T9,NH033,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH033~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),12.9,12.9,,,8.1,19.8,Race,Non-Hispanic Asian,C2,T9,NH033,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH033~RAC04~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),19.6,19.6,,,15.6,24.2,Race,Hispanic,C2,T9,NH033,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH033~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),16.7,16.7,,,13.3,20.8,Race,Hispanic,C2,T9,NH033,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH033~RAC07~Crude,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),14.9,14.9,,,10.5,20.6,Race,Other,C2,T9,NH033,Crude,BOC04,RAC07,59,
NHANES~2013-2014~59~NH033~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),12.9,12.9,,,8.8,18.6,Race,Other,C2,T9,NH033,AgeStdz,BOC04,RAC07,59,
NHANES~2015-2016~59~NH033~OVR01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),21.8,21.8,,,18.4,25.7,Overall,Overall,C2,T9,NH033,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH033~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),16.6,16.6,,,13.7,19.9,Overall,Overall,C2,T9,NH033,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH033~GEN01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),19.1,19.1,,,15.3,23.6,Gender,Male,C2,T9,NH033,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH033~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),14.5,14.5,,,11.7,17.8,Gender,Male,C2,T9,NH033,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH033~GEN02~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),24.6,24.6,,,20.4,29.4,Gender,Female,C2,T9,NH033,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH033~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),20.7,20.7,,,16.3,25.9,Gender,Female,C2,T9,NH033,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH033~AGE01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH033,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH033~AGE04~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),12.3,12.3,,,8.7,17.1,Age,25-44,C2,T9,NH033,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH033~AGE05~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),24.2,24.2,,,19.0,30.2,Age,45-64,C2,T9,NH033,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH033~AGE06~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),26.2,26.2,,,21.8,31.2,Age,65+,C2,T9,NH033,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH033~AGE07~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),23.9,23.9,,,20.3,27.9,Age,35+,C2,T9,NH033,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH033~AGE08~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),23.1,23.1,,,17.6,29.7,Age,75+,C2,T9,NH033,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH033~RAC01~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),23.4,23.4,,,18.4,29.3,Race,Non-Hispanic White,C2,T9,NH033,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH033~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),17.2,17.2,,,13.1,22.3,Race,Non-Hispanic White,C2,T9,NH033,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH033~RAC02~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.5,20.5,,,18.1,23.1,Race,Non-Hispanic Black,C2,T9,NH033,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH033~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),17.9,17.9,,,14.9,21.3,Race,Non-Hispanic Black,C2,T9,NH033,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH033~RAC03~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),11.5,11.5,,,8.6,15.3,Race,Non-Hispanic Asian,C2,T9,NH033,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH033~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),8.1,8.1,,,5.9,11.0,Race,Non-Hispanic Asian,C2,T9,NH033,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH033~RAC04~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.6,16.6,,,13.4,20.4,Race,Hispanic,C2,T9,NH033,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH033~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),13.4,13.4,,,11.0,16.1,Race,Hispanic,C2,T9,NH033,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH033~RAC07~Crude,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),19.4,19.4,,,14.7,25.0,Race,Other,C2,T9,NH033,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH033~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),14.3,14.3,,,10.4,19.3,Race,Other,C2,T9,NH033,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH033~OVR01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),19.1,19.1,,,16.9,21.6,Overall,Overall,C2,T9,NH033,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH033~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),13.8,13.8,,,11.7,16.2,Overall,Overall,C2,T9,NH033,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH033~GEN01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),17.1,17.1,,,14.3,20.4,Gender,Male,C2,T9,NH033,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH033~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),12.7,12.7,,,10.6,15.2,Gender,Male,C2,T9,NH033,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH033~GEN02~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),21.4,21.4,,,18.5,24.7,Gender,Female,C2,T9,NH033,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH033~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),16.0,16.0,,,12.4,20.3,Gender,Female,C2,T9,NH033,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH033~AGE01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,18-24,C2,T9,NH033,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH033~AGE04~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),6.1,6.1,,,4.1,9.1,Age,25-44,C2,T9,NH033,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH033~AGE05~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.6,20.6,,,17.3,24.4,Age,45-64,C2,T9,NH033,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH033~AGE06~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),27.2,27.2,,,23.5,31.1,Age,65+,C2,T9,NH033,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH033~AGE07~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),21.0,21.0,,,18.7,23.5,Age,35+,C2,T9,NH033,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH033~AGE08~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.8,20.8,,,16.8,25.4,Age,75+,C2,T9,NH033,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH033~RAC01~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),20.3,20.3,,,16.9,24.3,Race,Non-Hispanic White,C2,T9,NH033,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH033~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),13.4,13.4,,,9.9,17.9,Race,Non-Hispanic White,C2,T9,NH033,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH033~RAC02~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),16.1,16.1,,,14.1,18.3,Race,Non-Hispanic Black,C2,T9,NH033,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH033~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),13.3,13.3,,,11.3,15.6,Race,Non-Hispanic Black,C2,T9,NH033,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH033~RAC03~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),15.2,15.2,,,11.6,19.7,Race,Non-Hispanic Asian,C2,T9,NH033,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH033~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),12.1,12.1,,,8.6,16.9,Race,Non-Hispanic Asian,C2,T9,NH033,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH033~RAC04~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),12.5,12.5,,,9.3,16.7,Race,Hispanic,C2,T9,NH033,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH033~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),11.0,11.0,,,7.8,15.3,Race,Hispanic,C2,T9,NH033,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH033~RAC07~Crude,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Crude,Percent (%),24.0,24.0,,,19.5,29.2,Race,Other,C2,T9,NH033,Crude,BOC04,RAC07,59,
NHANES~2017-2018~59~NH033~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,Million Hearts,,None,,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (BP =130/90); NHANES,Age-Standardized,Percent (%),18.3,18.3,,,14.8,22.5,Race,Other,C2,T9,NH033,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH034~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.7,12.7,,,11.1,14.5,Overall,Overall,C2,T9,NH034,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH034~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.6,12.6,,,11.0,14.4,Overall,Overall,C2,T9,NH034,AgeStdz,BOC01,OVR01,59,
NHANES~1999-2000~59~NH034~GEN01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),16.5,16.5,,,14.3,19.0,Gender,Male,C2,T9,NH034,Crude,BOC02,GEN01,59,
NHANES~1999-2000~59~NH034~GEN01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),15.8,15.8,,,13.7,18.2,Gender,Male,C2,T9,NH034,AgeStdz,BOC02,GEN01,59,
NHANES~1999-2000~59~NH034~GEN02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),9.0,9.0,,,7.2,11.1,Gender,Female,C2,T9,NH034,AgeStdz,BOC02,GEN02,59,
NHANES~1999-2000~59~NH034~GEN02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),8.9,8.9,,,7.2,11.0,Gender,Female,C2,T9,NH034,Crude,BOC02,GEN02,59,
NHANES~1999-2000~59~NH034~AGE01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),15.7,15.7,,,12.5,19.6,Age,18-24,C2,T9,NH034,Crude,BOC03,AGE01,59,
NHANES~1999-2000~59~NH034~AGE04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.3,14.3,,,11.8,17.3,Age,25-44,C2,T9,NH034,Crude,BOC03,AGE04,59,
NHANES~1999-2000~59~NH034~AGE05~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.7,10.7,,,8.8,13.0,Age,45-64,C2,T9,NH034,Crude,BOC03,AGE05,59,
NHANES~1999-2000~59~NH034~AGE06~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),9.5,9.5,,,6.2,14.2,Age,65+,C2,T9,NH034,Crude,BOC03,AGE06,59,
NHANES~1999-2000~59~NH034~AGE07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.2,11.2,,,9.3,13.5,Age,35+,C2,T9,NH034,Crude,BOC03,AGE07,59,
NHANES~1999-2000~59~NH034~AGE08~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Age,75+,C2,T9,NH034,Crude,BOC03,AGE08,59,
NHANES~1999-2000~59~NH034~RAC01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.7,12.7,,,10.5,15.3,Race,Non-Hispanic White,C2,T9,NH034,AgeStdz,BOC04,RAC01,59,
NHANES~1999-2000~59~NH034~RAC01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.6,12.6,,,10.4,15.3,Race,Non-Hispanic White,C2,T9,NH034,Crude,BOC04,RAC01,59,
NHANES~1999-2000~59~NH034~RAC02~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),10.2,10.2,,,8.6,12.0,Race,Non-Hispanic Black,C2,T9,NH034,AgeStdz,BOC04,RAC02,59,
NHANES~1999-2000~59~NH034~RAC02~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.7,10.7,,,8.9,12.6,Race,Non-Hispanic Black,C2,T9,NH034,Crude,BOC04,RAC02,59,
NHANES~1999-2000~59~NH034~RAC03~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,Crude,BOC04,RAC03,59,
NHANES~1999-2000~59~NH034~RAC03~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,AgeStdz,BOC04,RAC03,59,
NHANES~1999-2000~59~NH034~RAC04~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH034,AgeStdz,BOC04,RAC04,59,
NHANES~1999-2000~59~NH034~RAC04~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH034,Crude,BOC04,RAC04,59,
NHANES~1999-2000~59~NH034~RAC07~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),10.1,10.1,,,7.1,14.3,Race,Other,C2,T9,NH034,AgeStdz,BOC04,RAC07,59,
NHANES~1999-2000~59~NH034~RAC07~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),9.0,9.0,,,5.8,13.5,Race,Other,C2,T9,NH034,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH034~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.7,11.7,,,10.7,12.8,Overall,Overall,C2,T9,NH034,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH034~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.8,11.8,,,10.8,12.9,Overall,Overall,C2,T9,NH034,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH034~GEN01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.7,14.7,,,13.0,16.6,Gender,Male,C2,T9,NH034,Crude,BOC02,GEN01,59,
NHANES~2001-2002~59~NH034~GEN01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),14.4,14.4,,,12.8,16.2,Gender,Male,C2,T9,NH034,AgeStdz,BOC02,GEN01,59,
NHANES~2001-2002~59~NH034~GEN02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),8.9,8.9,,,7.7,10.3,Gender,Female,C2,T9,NH034,AgeStdz,BOC02,GEN02,59,
NHANES~2001-2002~59~NH034~GEN02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),9.0,9.0,,,7.7,10.4,Gender,Female,C2,T9,NH034,Crude,BOC02,GEN02,59,
NHANES~2001-2002~59~NH034~AGE01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.6,13.6,,,10.4,17.7,Age,18-24,C2,T9,NH034,Crude,BOC03,AGE01,59,
NHANES~2001-2002~59~NH034~AGE04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.2,12.2,,,10.4,14.3,Age,25-44,C2,T9,NH034,Crude,BOC03,AGE04,59,
NHANES~2001-2002~59~NH034~AGE05~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.3,12.3,,,10.4,14.4,Age,45-64,C2,T9,NH034,Crude,BOC03,AGE05,59,
NHANES~2001-2002~59~NH034~AGE06~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),8.1,8.1,,,6.5,10.0,Age,65+,C2,T9,NH034,Crude,BOC03,AGE06,59,
NHANES~2001-2002~59~NH034~AGE07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.3,11.3,,,10.5,12.2,Age,35+,C2,T9,NH034,Crude,BOC03,AGE07,59,
NHANES~2001-2002~59~NH034~AGE08~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),5.9,5.9,,,4.4,7.8,Age,75+,C2,T9,NH034,Crude,BOC03,AGE08,59,
NHANES~2001-2002~59~NH034~RAC01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.0,12.0,,,11.0,13.1,Race,Non-Hispanic White,C2,T9,NH034,Crude,BOC04,RAC01,59,
NHANES~2001-2002~59~NH034~RAC01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.0,12.0,,,10.9,13.1,Race,Non-Hispanic White,C2,T9,NH034,AgeStdz,BOC04,RAC01,59,
NHANES~2001-2002~59~NH034~RAC02~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),9.6,9.6,,,7.5,12.3,Race,Non-Hispanic Black,C2,T9,NH034,AgeStdz,BOC04,RAC02,59,
NHANES~2001-2002~59~NH034~RAC02~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.3,10.3,,,8.0,13.0,Race,Non-Hispanic Black,C2,T9,NH034,Crude,BOC04,RAC02,59,
NHANES~2001-2002~59~NH034~RAC03~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,Crude,BOC04,RAC03,59,
NHANES~2001-2002~59~NH034~RAC03~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,AgeStdz,BOC04,RAC03,59,
NHANES~2001-2002~59~NH034~RAC04~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH034,Crude,BOC04,RAC04,59,
NHANES~2001-2002~59~NH034~RAC04~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH034,AgeStdz,BOC04,RAC04,59,
NHANES~2001-2002~59~NH034~RAC07~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.1,12.1,,,7.9,18.0,Race,Other,C2,T9,NH034,Crude,BOC04,RAC07,59,
NHANES~2001-2002~59~NH034~RAC07~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.7,11.7,,,8.1,16.7,Race,Other,C2,T9,NH034,AgeStdz,BOC04,RAC07,59,
NHANES~2003-2004~59~NH034~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.2,13.2,,,11.7,14.8,Overall,Overall,C2,T9,NH034,Crude,BOC01,OVR01,59,
NHANES~2003-2004~59~NH034~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),13.1,13.1,,,11.7,14.7,Overall,Overall,C2,T9,NH034,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH034~GEN01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),15.3,15.3,,,12.6,18.5,Gender,Male,C2,T9,NH034,Crude,BOC02,GEN01,59,
NHANES~2003-2004~59~NH034~GEN01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),15.1,15.1,,,12.5,18.1,Gender,Male,C2,T9,NH034,AgeStdz,BOC02,GEN01,59,
NHANES~2003-2004~59~NH034~GEN02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.0,11.0,,,9.8,12.3,Gender,Female,C2,T9,NH034,AgeStdz,BOC02,GEN02,59,
NHANES~2003-2004~59~NH034~GEN02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.1,11.1,,,9.8,12.5,Gender,Female,C2,T9,NH034,Crude,BOC02,GEN02,59,
NHANES~2003-2004~59~NH034~AGE01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.2,14.2,,,11.1,18.0,Age,18-24,C2,T9,NH034,Crude,BOC03,AGE01,59,
NHANES~2003-2004~59~NH034~AGE04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.4,14.4,,,11.6,17.8,Age,25-44,C2,T9,NH034,Crude,BOC03,AGE04,59,
NHANES~2003-2004~59~NH034~AGE05~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.0,14.0,,,11.3,17.0,Age,45-64,C2,T9,NH034,Crude,BOC03,AGE05,59,
NHANES~2003-2004~59~NH034~AGE06~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),7.8,7.8,,,6.2,9.7,Age,65+,C2,T9,NH034,Crude,BOC03,AGE06,59,
NHANES~2003-2004~59~NH034~AGE07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.3,12.3,,,10.8,14.0,Age,35+,C2,T9,NH034,Crude,BOC03,AGE07,59,
NHANES~2003-2004~59~NH034~AGE08~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),8.0,8.0,,,6.0,10.6,Age,75+,C2,T9,NH034,Crude,BOC03,AGE08,59,
NHANES~2003-2004~59~NH034~RAC01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.3,13.3,,,11.2,15.6,Race,Non-Hispanic White,C2,T9,NH034,Crude,BOC04,RAC01,59,
NHANES~2003-2004~59~NH034~RAC01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),13.3,13.3,,,11.3,15.6,Race,Non-Hispanic White,C2,T9,NH034,AgeStdz,BOC04,RAC01,59,
NHANES~2003-2004~59~NH034~RAC02~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.7,12.7,,,10.7,14.9,Race,Non-Hispanic Black,C2,T9,NH034,Crude,BOC04,RAC02,59,
NHANES~2003-2004~59~NH034~RAC02~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.1,12.1,,,10.1,14.3,Race,Non-Hispanic Black,C2,T9,NH034,AgeStdz,BOC04,RAC02,59,
NHANES~2003-2004~59~NH034~RAC03~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,Crude,BOC04,RAC03,59,
NHANES~2003-2004~59~NH034~RAC03~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,AgeStdz,BOC04,RAC03,59,
NHANES~2003-2004~59~NH034~RAC04~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH034,Crude,BOC04,RAC04,59,
NHANES~2003-2004~59~NH034~RAC04~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH034,AgeStdz,BOC04,RAC04,59,
NHANES~2003-2004~59~NH034~RAC07~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),16.5,16.5,,,11.2,23.8,Race,Other,C2,T9,NH034,Crude,BOC04,RAC07,59,
NHANES~2003-2004~59~NH034~RAC07~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),16.1,16.1,,,11.1,22.9,Race,Other,C2,T9,NH034,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH034~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.2,13.2,,,12.2,14.4,Overall,Overall,C2,T9,NH034,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH034~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),13.4,13.4,,,12.4,14.5,Overall,Overall,C2,T9,NH034,AgeStdz,BOC01,OVR01,59,
NHANES~2005-2006~59~NH034~GEN01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),16.2,16.2,,,14.6,17.9,Gender,Male,C2,T9,NH034,AgeStdz,BOC02,GEN01,59,
NHANES~2005-2006~59~NH034~GEN01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),16.2,16.2,,,14.5,18.0,Gender,Male,C2,T9,NH034,Crude,BOC02,GEN01,59,
NHANES~2005-2006~59~NH034~GEN02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),10.4,10.4,,,9.1,11.9,Gender,Female,C2,T9,NH034,AgeStdz,BOC02,GEN02,59,
NHANES~2005-2006~59~NH034~GEN02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.4,10.4,,,9.0,11.9,Gender,Female,C2,T9,NH034,Crude,BOC02,GEN02,59,
NHANES~2005-2006~59~NH034~AGE01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),20.4,20.4,,,16.4,25.0,Age,18-24,C2,T9,NH034,Crude,BOC03,AGE01,59,
NHANES~2005-2006~59~NH034~AGE04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),15.1,15.1,,,13.2,17.2,Age,25-44,C2,T9,NH034,Crude,BOC03,AGE04,59,
NHANES~2005-2006~59~NH034~AGE05~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.0,11.0,,,9.7,12.4,Age,45-64,C2,T9,NH034,Crude,BOC03,AGE05,59,
NHANES~2005-2006~59~NH034~AGE06~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),8.5,8.5,,,7.0,10.1,Age,65+,C2,T9,NH034,Crude,BOC03,AGE06,59,
NHANES~2005-2006~59~NH034~AGE07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.8,10.8,,,10.0,11.6,Age,35+,C2,T9,NH034,Crude,BOC03,AGE07,59,
NHANES~2005-2006~59~NH034~AGE08~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.0,10.0,,,7.8,12.8,Age,75+,C2,T9,NH034,Crude,BOC03,AGE08,59,
NHANES~2005-2006~59~NH034~RAC01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),13.5,13.5,,,12.0,15.2,Race,Non-Hispanic White,C2,T9,NH034,AgeStdz,BOC04,RAC01,59,
NHANES~2005-2006~59~NH034~RAC01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.0,13.0,,,11.6,14.6,Race,Non-Hispanic White,C2,T9,NH034,Crude,BOC04,RAC01,59,
NHANES~2005-2006~59~NH034~RAC02~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.4,14.4,,,12.4,16.6,Race,Non-Hispanic Black,C2,T9,NH034,Crude,BOC04,RAC02,59,
NHANES~2005-2006~59~NH034~RAC02~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),13.8,13.8,,,12.2,15.5,Race,Non-Hispanic Black,C2,T9,NH034,AgeStdz,BOC04,RAC02,59,
NHANES~2005-2006~59~NH034~RAC03~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,AgeStdz,BOC04,RAC03,59,
NHANES~2005-2006~59~NH034~RAC03~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,Crude,BOC04,RAC03,59,
NHANES~2005-2006~59~NH034~RAC04~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH034,Crude,BOC04,RAC04,59,
NHANES~2005-2006~59~NH034~RAC04~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH034,AgeStdz,BOC04,RAC04,59,
NHANES~2005-2006~59~NH034~RAC07~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),10.5,10.5,,,7.0,15.4,Race,Other,C2,T9,NH034,AgeStdz,BOC04,RAC07,59,
NHANES~2005-2006~59~NH034~RAC07~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.7,10.7,,,7.2,15.6,Race,Other,C2,T9,NH034,Crude,BOC04,RAC07,59,
NHANES~2007-2008~59~NH034~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.2,13.2,,,12.1,14.5,Overall,Overall,C2,T9,NH034,Crude,BOC01,OVR01,59,
NHANES~2007-2008~59~NH034~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),13.3,13.3,,,12.1,14.7,Overall,Overall,C2,T9,NH034,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH034~GEN01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),16.8,16.8,,,15.1,18.8,Gender,Male,C2,T9,NH034,Crude,BOC02,GEN01,59,
NHANES~2007-2008~59~NH034~GEN01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),16.8,16.8,,,15.1,18.7,Gender,Male,C2,T9,NH034,AgeStdz,BOC02,GEN01,59,
NHANES~2007-2008~59~NH034~GEN02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),9.7,9.7,,,8.4,11.1,Gender,Female,C2,T9,NH034,AgeStdz,BOC02,GEN02,59,
NHANES~2007-2008~59~NH034~GEN02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),9.8,9.8,,,8.6,11.2,Gender,Female,C2,T9,NH034,Crude,BOC02,GEN02,59,
NHANES~2007-2008~59~NH034~AGE01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),16.5,16.5,,,13.1,20.5,Age,18-24,C2,T9,NH034,Crude,BOC03,AGE01,59,
NHANES~2007-2008~59~NH034~AGE04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.2,14.2,,,11.5,17.4,Age,25-44,C2,T9,NH034,Crude,BOC03,AGE04,59,
NHANES~2007-2008~59~NH034~AGE05~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.3,13.3,,,11.6,15.2,Age,45-64,C2,T9,NH034,Crude,BOC03,AGE05,59,
NHANES~2007-2008~59~NH034~AGE06~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),8.5,8.5,,,6.8,10.7,Age,65+,C2,T9,NH034,Crude,BOC03,AGE06,59,
NHANES~2007-2008~59~NH034~AGE07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.2,12.2,,,11.2,13.2,Age,35+,C2,T9,NH034,Crude,BOC03,AGE07,59,
NHANES~2007-2008~59~NH034~AGE08~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),6.6,6.6,,,4.8,9.0,Age,75+,C2,T9,NH034,Crude,BOC03,AGE08,59,
NHANES~2007-2008~59~NH034~RAC01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.9,12.9,,,11.3,14.7,Race,Non-Hispanic White,C2,T9,NH034,Crude,BOC04,RAC01,59,
NHANES~2007-2008~59~NH034~RAC01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),13.2,13.2,,,11.3,15.3,Race,Non-Hispanic White,C2,T9,NH034,AgeStdz,BOC04,RAC01,59,
NHANES~2007-2008~59~NH034~RAC02~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.6,12.6,,,10.5,15.1,Race,Non-Hispanic Black,C2,T9,NH034,Crude,BOC04,RAC02,59,
NHANES~2007-2008~59~NH034~RAC02~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.4,12.4,,,10.4,14.6,Race,Non-Hispanic Black,C2,T9,NH034,AgeStdz,BOC04,RAC02,59,
NHANES~2007-2008~59~NH034~RAC03~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,Crude,BOC04,RAC03,59,
NHANES~2007-2008~59~NH034~RAC03~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,AgeStdz,BOC04,RAC03,59,
NHANES~2007-2008~59~NH034~RAC04~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH034,AgeStdz,BOC04,RAC04,59,
NHANES~2007-2008~59~NH034~RAC04~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH034,Crude,BOC04,RAC04,59,
NHANES~2007-2008~59~NH034~RAC07~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.4,11.4,,,8.1,15.7,Race,Other,C2,T9,NH034,AgeStdz,BOC04,RAC07,59,
NHANES~2007-2008~59~NH034~RAC07~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.2,11.2,,,8.1,15.3,Race,Other,C2,T9,NH034,Crude,BOC04,RAC07,59,
NHANES~2009-2010~59~NH034~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.2,12.2,,,11.4,13.1,Overall,Overall,C2,T9,NH034,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH034~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.4,12.4,,,11.5,13.3,Overall,Overall,C2,T9,NH034,AgeStdz,BOC01,OVR01,59,
NHANES~2009-2010~59~NH034~GEN01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),16.4,16.4,,,15.3,17.5,Gender,Male,C2,T9,NH034,Crude,BOC02,GEN01,59,
NHANES~2009-2010~59~NH034~GEN01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),16.6,16.6,,,15.4,17.7,Gender,Male,C2,T9,NH034,AgeStdz,BOC02,GEN01,59,
NHANES~2009-2010~59~NH034~GEN02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),8.1,8.1,,,6.7,9.8,Gender,Female,C2,T9,NH034,AgeStdz,BOC02,GEN02,59,
NHANES~2009-2010~59~NH034~GEN02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),8.2,8.2,,,6.9,9.8,Gender,Female,C2,T9,NH034,Crude,BOC02,GEN02,59,
NHANES~2009-2010~59~NH034~AGE01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.8,14.8,,,12.0,18.1,Age,18-24,C2,T9,NH034,Crude,BOC03,AGE01,59,
NHANES~2009-2010~59~NH034~AGE04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.8,13.8,,,12.0,15.8,Age,25-44,C2,T9,NH034,Crude,BOC03,AGE04,59,
NHANES~2009-2010~59~NH034~AGE05~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.3,12.3,,,10.0,15.1,Age,45-64,C2,T9,NH034,Crude,BOC03,AGE05,59,
NHANES~2009-2010~59~NH034~AGE06~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),7.1,7.1,,,6.0,8.3,Age,65+,C2,T9,NH034,Crude,BOC03,AGE06,59,
NHANES~2009-2010~59~NH034~AGE07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.7,10.7,,,9.7,11.8,Age,35+,C2,T9,NH034,Crude,BOC03,AGE07,59,
NHANES~2009-2010~59~NH034~AGE08~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),7.1,7.1,,,5.5,9.1,Age,75+,C2,T9,NH034,Crude,BOC03,AGE08,59,
NHANES~2009-2010~59~NH034~RAC01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.0,12.0,,,11.0,13.2,Race,Non-Hispanic White,C2,T9,NH034,Crude,BOC04,RAC01,59,
NHANES~2009-2010~59~NH034~RAC01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.5,12.5,,,11.4,13.7,Race,Non-Hispanic White,C2,T9,NH034,AgeStdz,BOC04,RAC01,59,
NHANES~2009-2010~59~NH034~RAC02~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),10.9,10.9,,,8.9,13.1,Race,Non-Hispanic Black,C2,T9,NH034,AgeStdz,BOC04,RAC02,59,
NHANES~2009-2010~59~NH034~RAC02~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.1,11.1,,,9.3,13.2,Race,Non-Hispanic Black,C2,T9,NH034,Crude,BOC04,RAC02,59,
NHANES~2009-2010~59~NH034~RAC03~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,AgeStdz,BOC04,RAC03,59,
NHANES~2009-2010~59~NH034~RAC03~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH034,Crude,BOC04,RAC03,59,
NHANES~2009-2010~59~NH034~RAC04~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH034,Crude,BOC04,RAC04,59,
NHANES~2009-2010~59~NH034~RAC04~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,"Statistically unstable estimates are suppressed, based on the NCHS Data Presentation Standards for Proportions: Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics Data Presentation Standards for Proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017.",,,Race,Hispanic,C2,T9,NH034,AgeStdz,BOC04,RAC04,59,
NHANES~2009-2010~59~NH034~RAC07~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.0,11.0,,,7.3,16.3,Race,Other,C2,T9,NH034,AgeStdz,BOC04,RAC07,59,
NHANES~2009-2010~59~NH034~RAC07~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.1,11.1,,,7.4,16.5,Race,Other,C2,T9,NH034,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH034~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.8,12.8,,,11.1,14.7,Overall,Overall,C2,T9,NH034,Crude,BOC01,OVR01,59,
NHANES~2011-2012~59~NH034~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.9,12.9,,,11.3,14.8,Overall,Overall,C2,T9,NH034,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH034~GEN01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),15.1,15.1,,,13.1,17.4,Gender,Male,C2,T9,NH034,Crude,BOC02,GEN01,59,
NHANES~2011-2012~59~NH034~GEN01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),15.3,15.3,,,13.3,17.5,Gender,Male,C2,T9,NH034,AgeStdz,BOC02,GEN01,59,
NHANES~2011-2012~59~NH034~GEN02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),10.3,10.3,,,8.2,13.0,Gender,Female,C2,T9,NH034,AgeStdz,BOC02,GEN02,59,
NHANES~2011-2012~59~NH034~GEN02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.5,10.5,,,8.5,12.9,Gender,Female,C2,T9,NH034,Crude,BOC02,GEN02,59,
NHANES~2011-2012~59~NH034~AGE01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.9,14.9,,,12.3,17.9,Age,18-24,C2,T9,NH034,Crude,BOC03,AGE01,59,
NHANES~2011-2012~59~NH034~AGE04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.2,13.2,,,11.0,15.6,Age,25-44,C2,T9,NH034,Crude,BOC03,AGE04,59,
NHANES~2011-2012~59~NH034~AGE05~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.9,13.9,,,10.7,17.9,Age,45-64,C2,T9,NH034,Crude,BOC03,AGE05,59,
NHANES~2011-2012~59~NH034~AGE06~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),8.0,8.0,,,5.6,11.2,Age,65+,C2,T9,NH034,Crude,BOC03,AGE06,59,
NHANES~2011-2012~59~NH034~AGE07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.8,11.8,,,9.8,14.2,Age,35+,C2,T9,NH034,Crude,BOC03,AGE07,59,
NHANES~2011-2012~59~NH034~AGE08~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),5.3,5.3,,,3.3,8.5,Age,75+,C2,T9,NH034,Crude,BOC03,AGE08,59,
NHANES~2011-2012~59~NH034~RAC01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),13.6,13.6,,,11.3,16.4,Race,Non-Hispanic White,C2,T9,NH034,AgeStdz,BOC04,RAC01,59,
NHANES~2011-2012~59~NH034~RAC01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.2,13.2,,,10.8,16.0,Race,Non-Hispanic White,C2,T9,NH034,Crude,BOC04,RAC01,59,
NHANES~2011-2012~59~NH034~RAC02~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.5,11.5,,,9.9,13.4,Race,Non-Hispanic Black,C2,T9,NH034,Crude,BOC04,RAC02,59,
NHANES~2011-2012~59~NH034~RAC02~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.3,11.3,,,9.8,13.1,Race,Non-Hispanic Black,C2,T9,NH034,AgeStdz,BOC04,RAC02,59,
NHANES~2011-2012~59~NH034~RAC03~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.7,10.7,,,8.0,14.2,Race,Non-Hispanic Asian,C2,T9,NH034,Crude,BOC04,RAC03,59,
NHANES~2011-2012~59~NH034~RAC03~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,8.1,14.4,Race,Non-Hispanic Asian,C2,T9,NH034,AgeStdz,BOC04,RAC03,59,
NHANES~2011-2012~59~NH034~RAC04~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.5,11.5,,,9.2,14.2,Race,Hispanic,C2,T9,NH034,Crude,BOC04,RAC04,59,
NHANES~2011-2012~59~NH034~RAC04~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.3,11.3,,,9.2,13.8,Race,Hispanic,C2,T9,NH034,AgeStdz,BOC04,RAC04,59,
NHANES~2011-2012~59~NH034~RAC07~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.4,13.4,,,9.9,17.7,Race,Other,C2,T9,NH034,Crude,BOC04,RAC07,59,
NHANES~2011-2012~59~NH034~RAC07~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),13.4,13.4,,,9.9,18.0,Race,Other,C2,T9,NH034,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH034~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.6,11.6,,,10.7,12.6,Overall,Overall,C2,T9,NH034,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH034~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.5,11.5,,,10.6,12.4,Overall,Overall,C2,T9,NH034,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH034~GEN01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.9,14.9,,,13.5,16.4,Gender,Male,C2,T9,NH034,Crude,BOC02,GEN01,59,
NHANES~2013-2014~59~NH034~GEN01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),15.1,15.1,,,13.7,16.6,Gender,Male,C2,T9,NH034,AgeStdz,BOC02,GEN01,59,
NHANES~2013-2014~59~NH034~GEN02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),8.2,8.2,,,7.1,9.5,Gender,Female,C2,T9,NH034,Crude,BOC02,GEN02,59,
NHANES~2013-2014~59~NH034~GEN02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),8.1,8.1,,,7.0,9.4,Gender,Female,C2,T9,NH034,AgeStdz,BOC02,GEN02,59,
NHANES~2013-2014~59~NH034~AGE01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.3,14.3,,,11.7,17.3,Age,18-24,C2,T9,NH034,Crude,BOC03,AGE01,59,
NHANES~2013-2014~59~NH034~AGE04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.3,12.3,,,10.1,14.7,Age,25-44,C2,T9,NH034,Crude,BOC03,AGE04,59,
NHANES~2013-2014~59~NH034~AGE05~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.2,11.2,,,9.7,12.9,Age,45-64,C2,T9,NH034,Crude,BOC03,AGE05,59,
NHANES~2013-2014~59~NH034~AGE06~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),8.7,8.7,,,7.0,10.8,Age,65+,C2,T9,NH034,Crude,BOC03,AGE06,59,
NHANES~2013-2014~59~NH034~AGE07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.6,10.6,,,9.5,11.9,Age,35+,C2,T9,NH034,Crude,BOC03,AGE07,59,
NHANES~2013-2014~59~NH034~AGE08~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),7.7,7.7,,,5.8,10.2,Age,75+,C2,T9,NH034,Crude,BOC03,AGE08,59,
NHANES~2013-2014~59~NH034~RAC01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.2,11.2,,,9.9,12.6,Race,Non-Hispanic White,C2,T9,NH034,Crude,BOC04,RAC01,59,
NHANES~2013-2014~59~NH034~RAC01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.4,11.4,,,10.0,12.9,Race,Non-Hispanic White,C2,T9,NH034,AgeStdz,BOC04,RAC01,59,
NHANES~2013-2014~59~NH034~RAC02~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,9.5,12.2,Race,Non-Hispanic Black,C2,T9,NH034,AgeStdz,BOC04,RAC02,59,
NHANES~2013-2014~59~NH034~RAC02~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.9,10.9,,,9.5,12.4,Race,Non-Hispanic Black,C2,T9,NH034,Crude,BOC04,RAC02,59,
NHANES~2013-2014~59~NH034~RAC03~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.3,11.3,,,8.7,14.4,Race,Non-Hispanic Asian,C2,T9,NH034,AgeStdz,BOC04,RAC03,59,
NHANES~2013-2014~59~NH034~RAC03~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.3,11.3,,,8.8,14.5,Race,Non-Hispanic Asian,C2,T9,NH034,Crude,BOC04,RAC03,59,
NHANES~2013-2014~59~NH034~RAC04~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.7,13.7,,,12.1,15.5,Race,Hispanic,C2,T9,NH034,Crude,BOC04,RAC04,59,
NHANES~2013-2014~59~NH034~RAC04~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),13.5,13.5,,,11.9,15.1,Race,Hispanic,C2,T9,NH034,AgeStdz,BOC04,RAC04,59,
NHANES~2013-2014~59~NH034~RAC07~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),10.7,10.7,,,8.4,13.5,Race,Other,C2,T9,NH034,AgeStdz,BOC04,RAC07,59,
NHANES~2013-2014~59~NH034~RAC07~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.9,10.9,,,8.7,13.7,Race,Other,C2,T9,NH034,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH034~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.2,14.2,,,12.4,16.1,Overall,Overall,C2,T9,NH034,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH034~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),14.4,14.4,,,12.6,16.5,Overall,Overall,C2,T9,NH034,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH034~GEN01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),16.6,16.6,,,14.1,19.3,Gender,Male,C2,T9,NH034,Crude,BOC02,GEN01,59,
NHANES~2015-2016~59~NH034~GEN01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),16.9,16.9,,,14.4,19.7,Gender,Male,C2,T9,NH034,AgeStdz,BOC02,GEN01,59,
NHANES~2015-2016~59~NH034~GEN02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.9,11.9,,,10.3,13.7,Gender,Female,C2,T9,NH034,Crude,BOC02,GEN02,59,
NHANES~2015-2016~59~NH034~GEN02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.8,11.8,,,10.2,13.6,Gender,Female,C2,T9,NH034,AgeStdz,BOC02,GEN02,59,
NHANES~2015-2016~59~NH034~AGE01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),18.4,18.4,,,14.4,23.1,Age,18-24,C2,T9,NH034,Crude,BOC03,AGE01,59,
NHANES~2015-2016~59~NH034~AGE04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),15.8,15.8,,,12.7,19.5,Age,25-44,C2,T9,NH034,Crude,BOC03,AGE04,59,
NHANES~2015-2016~59~NH034~AGE05~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.2,13.2,,,11.4,15.2,Age,45-64,C2,T9,NH034,Crude,BOC03,AGE05,59,
NHANES~2015-2016~59~NH034~AGE06~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.1,11.1,,,9.1,13.3,Age,65+,C2,T9,NH034,Crude,BOC03,AGE06,59,
NHANES~2015-2016~59~NH034~AGE07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),13.0,13.0,,,11.4,14.7,Age,35+,C2,T9,NH034,Crude,BOC03,AGE07,59,
NHANES~2015-2016~59~NH034~AGE08~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.0,11.0,,,8.9,13.7,Age,75+,C2,T9,NH034,Crude,BOC03,AGE08,59,
NHANES~2015-2016~59~NH034~RAC01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.4,14.4,,,12.2,16.9,Race,Non-Hispanic White,C2,T9,NH034,Crude,BOC04,RAC01,59,
NHANES~2015-2016~59~NH034~RAC01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),14.7,14.7,,,12.5,17.4,Race,Non-Hispanic White,C2,T9,NH034,AgeStdz,BOC04,RAC01,59,
NHANES~2015-2016~59~NH034~RAC02~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.2,12.2,,,10.7,13.9,Race,Non-Hispanic Black,C2,T9,NH034,Crude,BOC04,RAC02,59,
NHANES~2015-2016~59~NH034~RAC02~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.2,12.2,,,10.6,13.9,Race,Non-Hispanic Black,C2,T9,NH034,AgeStdz,BOC04,RAC02,59,
NHANES~2015-2016~59~NH034~RAC03~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),9.5,9.5,,,7.6,11.7,Race,Non-Hispanic Asian,C2,T9,NH034,Crude,BOC04,RAC03,59,
NHANES~2015-2016~59~NH034~RAC03~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),9.5,9.5,,,7.6,11.7,Race,Non-Hispanic Asian,C2,T9,NH034,AgeStdz,BOC04,RAC03,59,
NHANES~2015-2016~59~NH034~RAC04~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),17.4,17.4,,,14.7,20.4,Race,Hispanic,C2,T9,NH034,Crude,BOC04,RAC04,59,
NHANES~2015-2016~59~NH034~RAC04~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),16.6,16.6,,,13.9,19.6,Race,Hispanic,C2,T9,NH034,AgeStdz,BOC04,RAC04,59,
NHANES~2015-2016~59~NH034~RAC07~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),9.9,9.9,,,8.1,12.1,Race,Other,C2,T9,NH034,Crude,BOC04,RAC07,59,
NHANES~2015-2016~59~NH034~RAC07~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),10.0,10.0,,,8.2,12.2,Race,Other,C2,T9,NH034,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH034~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.1,12.1,,,10.9,13.3,Overall,Overall,C2,T9,NH034,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH034~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.3,12.3,,,11.0,13.6,Overall,Overall,C2,T9,NH034,AgeStdz,BOC01,OVR01,59,
NHANES~2017-2018~59~NH034~GEN01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.0,14.0,,,12.0,16.3,Gender,Male,C2,T9,NH034,Crude,BOC02,GEN01,59,
NHANES~2017-2018~59~NH034~GEN01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),14.3,14.3,,,12.2,16.6,Gender,Male,C2,T9,NH034,AgeStdz,BOC02,GEN01,59,
NHANES~2017-2018~59~NH034~GEN02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),10.0,10.0,,,8.9,11.3,Gender,Female,C2,T9,NH034,AgeStdz,BOC02,GEN02,59,
NHANES~2017-2018~59~NH034~GEN02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.2,10.2,,,9.1,11.5,Gender,Female,C2,T9,NH034,Crude,BOC02,GEN02,59,
NHANES~2017-2018~59~NH034~AGE01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),14.5,14.5,,,11.4,18.4,Age,18-24,C2,T9,NH034,Crude,BOC03,AGE01,59,
NHANES~2017-2018~59~NH034~AGE04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.9,12.9,,,10.5,15.9,Age,25-44,C2,T9,NH034,Crude,BOC03,AGE04,59,
NHANES~2017-2018~59~NH034~AGE05~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.3,11.3,,,9.0,14.2,Age,45-64,C2,T9,NH034,Crude,BOC03,AGE05,59,
NHANES~2017-2018~59~NH034~AGE06~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.5,10.5,,,7.4,14.6,Age,65+,C2,T9,NH034,Crude,BOC03,AGE06,59,
NHANES~2017-2018~59~NH034~AGE07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),11.0,11.0,,,9.7,12.5,Age,35+,C2,T9,NH034,Crude,BOC03,AGE07,59,
NHANES~2017-2018~59~NH034~AGE08~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),6.1,6.1,,,3.9,9.3,Age,75+,C2,T9,NH034,Crude,BOC03,AGE08,59,
NHANES~2017-2018~59~NH034~RAC01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.5,12.5,,,11.2,14.0,Race,Non-Hispanic White,C2,T9,NH034,Crude,BOC04,RAC01,59,
NHANES~2017-2018~59~NH034~RAC01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.8,12.8,,,11.2,14.5,Race,Non-Hispanic White,C2,T9,NH034,AgeStdz,BOC04,RAC01,59,
NHANES~2017-2018~59~NH034~RAC02~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),9.7,9.7,,,7.6,12.2,Race,Non-Hispanic Black,C2,T9,NH034,Crude,BOC04,RAC02,59,
NHANES~2017-2018~59~NH034~RAC02~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),9.7,9.7,,,7.7,12.2,Race,Non-Hispanic Black,C2,T9,NH034,AgeStdz,BOC04,RAC02,59,
NHANES~2017-2018~59~NH034~RAC03~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),8.6,8.6,,,6.2,11.9,Race,Non-Hispanic Asian,C2,T9,NH034,AgeStdz,BOC04,RAC03,59,
NHANES~2017-2018~59~NH034~RAC03~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),8.6,8.6,,,6.2,11.8,Race,Non-Hispanic Asian,C2,T9,NH034,Crude,BOC04,RAC03,59,
NHANES~2017-2018~59~NH034~RAC04~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),12.9,12.9,,,10.7,15.5,Race,Hispanic,C2,T9,NH034,Crude,BOC04,RAC04,59,
NHANES~2017-2018~59~NH034~RAC04~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),12.7,12.7,,,10.8,14.9,Race,Hispanic,C2,T9,NH034,AgeStdz,BOC04,RAC04,59,
NHANES~2017-2018~59~NH034~RAC07~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Age-Standardized,Percent (%),11.0,11.0,,,8.2,14.4,Race,Other,C2,T9,NH034,AgeStdz,BOC04,RAC07,59,
NHANES~2017-2018~59~NH034~RAC07~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of prehypertension (BP 120/80 - 129/80) among US adults (18+); NHANES,Crude,Percent (%),10.9,10.9,,,8.1,14.4,Race,Other,C2,T9,NH034,Crude,BOC04,RAC07,59,
NHANES~1999-2000~59~NH040~OVR01~Crude,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,Crude,BOC01,OVR01,59,
NHANES~1999-2000~59~NH040~OVR01~Age-Standardized,1999-2000,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,AgeStdz,BOC01,OVR01,59,
NHANES~2001-2002~59~NH040~OVR01~Crude,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,Crude,BOC01,OVR01,59,
NHANES~2001-2002~59~NH040~OVR01~Age-Standardized,2001-2002,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH040~OVR01~Age-Standardized,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,AgeStdz,BOC01,OVR01,59,
NHANES~2003-2004~59~NH040~OVR01~Crude,2003-2004,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH040~OVR01~Crude,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,Crude,BOC01,OVR01,59,
NHANES~2005-2006~59~NH040~OVR01~Age-Standardized,2005-2006,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH040~OVR01~Age-Standardized,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,AgeStdz,BOC01,OVR01,59,
NHANES~2007-2008~59~NH040~OVR01~Crude,2007-2008,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH040~OVR01~Crude,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,Crude,BOC01,OVR01,59,
NHANES~2009-2010~59~NH040~OVR01~Age-Standardized,2009-2010,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH040~OVR01~Age-Standardized,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,AgeStdz,BOC01,OVR01,59,
NHANES~2011-2012~59~NH040~OVR01~Crude,2011-2012,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,Crude,BOC01,OVR01,59,
NHANES~2013-2014~59~NH040~OVR01~Age-Standardized,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,AgeStdz,BOC01,OVR01,59,
NHANES~2013-2014~59~NH040~OVR01~Crude,2013-2014,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,Crude,BOC01,OVR01,59,
NHANES~2015-2016~59~NH040~OVR01~Age-Standardized,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,AgeStdz,BOC01,OVR01,59,
NHANES~2015-2016~59~NH040~OVR01~Crude,2015-2016,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH040~OVR01~Crude,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,Crude,BOC01,OVR01,59,
NHANES~2017-2018~59~NH040~OVR01~Age-Standardized,2017-2018,US,United States,NHANES,None,,None,,Risk Factors,Hypertension,Prevalence of hypertension among US children/adolescents (8-17); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T9,NH040,AgeStdz,BOC01,OVR01,59,
